EurekaMag PDF full texts Chapter 51,578

Safari, D.; Dekker, H.A.T.; de Jong, B.; Rijkers, G.T.; Kamerling, J.P.; Snippe, H. 2011: Antibody- and cell-mediated immune responses to a synthetic oligosaccharide conjugate vaccine after booster immunization. Vaccine 29(38): 6498-6504

Araujo, A.C. 2012: Antibody- and genome-based identification of recent HCV infection. Antiviral Therapy 17(7 Part B): 1459-1464

Perez, L.G.; Zolla-Pazner, S.; Montefiori, D.C. 2013: Antibody-DEPENDENT, FcγRI-mediated neutralization of HIV-1 in TZM-bl cells occurs independently of phagocytosis. Journal of Virology 87(9): 5287-5290

Lopus, M. 2011: Antibody-DM1 conjugates as cancer therapeutics. Cancer Letters 307(2): 113-118

Isitman, G.; Stratov, I.; Kent, S.J. 2012: Antibody-Dependent Cellular Cytotoxicity and NK Cell-Driven Immune Escape in HIV Infection: Implications for HIV Vaccine Development. Advances in Virology 2012: 637208

Carlson, B. 2012: Antibody-Drug Conjugates: Where the Action Is: ADCs - the new Frontier. Biotechnology Healthcare 9(4): 28-31

Desquesnes, M.; Kamyingkird, K.; Pruvot, M.; Kengradomkij, C.; Bossard, G.; Sarataphan, N.; Jittapalapong, S. 2009: Antibody-ELISA for Trypanosoma evansi: application in a serological survey of dairy cattle, Thailand, and validation of a locally produced antigen. Preventive Veterinary Medicine 90(3-4): 233-241

Joller, N.; Weber, S.S.; Oxenius, A. 2011: Antibody-Fc receptor interactions in protection against intracellular pathogens. European Journal of Immunology 41(4): 889-897

Botosoa, E.P.; Maillasson, M.; Mougin-Degraef, M.; Remaud-Le Saëc, P.; Gestin, J.-F.ço.; Jacques, Y.; Barbet, J.; Faivre-Chauvet, A. 2011: Antibody-Hapten Recognition at the Surface of Functionalized Liposomes Studied by SPR: Steric Hindrance of Pegylated Phospholipids in Stealth Liposomes Prepared for Targeted Radionuclide Delivery. Journal of Drug Delivery 2011: 368535

Hombach, A.A.; Abken, H. 2012: Antibody-IL2 fusion proteins for tumor targeting. Methods in Molecular Biology 907: 611-626

Holl, V.; Peressin, M.; Moog, C. 2009: Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and new Vaccination Strategies. Viruses 1(3): 1265-1294

Bae, E-Jin.; Lee, H-Jin.; Rockenstein, E.; Ho, D-Hwan.; Park, E-Bi.; Yang, N-Young.; Desplats, P.; Masliah, E.; Lee, S-Jae. 2012: Antibody-aided clearance of extracellular α-synuclein prevents cell-to-cell aggregate transmission. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 32(39): 13454-13469

Monson, C.F.; Driscoll, L.N.; Bennion, E.; Miller, C.J.; Majda, M. 2009: Antibody-antigen exchange equilibria in a field of an external force: design of reagentless biosensors. Analytical Chemistry 81(17): 7510-7514

Svensson, O.; Arnebrant, T. 2012: Antibody-antigen interaction on polystyrene: an in situ ellipsometric study. Journal of Colloid and Interface Science 368(1): 533-539

Kreutz, M.; Giquel, B.; Hu, Q.; Abuknesha, R.; Uematsu, S.; Akira, S.; Nestle, F.O.; Diebold, S.S. 2012: Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity. Plos one 7(7): E40208

Ohk, S.H.; Koo, O.K.; Sen, T.; Yamamoto, C.M.; Bhunia, A.K. 2010: Antibody-aptamer functionalized fibre-optic biosensor for specific detection of Listeria monocytogenes from food. Journal of Applied Microbiology 109(3): 808-817

Bergsma, D.; Chen, S.; Buchweitz, J.; Gerszten, R.; Haab, B.B. 2010: Antibody-array interaction mapping, a new method to detect protein complexes applied to the discovery and study of serum amyloid P interactions with kininogen in human plasma. Molecular and Cellular Proteomics: Mcp 9(3): 446-456

Tanegashima, K.; Suzuki, K.; Nakayama, Y.; Hara, T. 2010: Antibody-assisted enhancement of biological activities of CXCL14 in human monocytic leukemia-derived THP-1 cells and high fat diet-induced obese mice. Experimental Cell Research 316(7): 1263-1270

Bien, C.G. 2011: Antibody-associated diseases of the gray matter of the CNS: diagnosis and treatment. Der Nervenarzt 82(8): 986-993

Briggs, D.; Adams, D.H. 2011: Antibody-associated rejection in liver transplantation: keep on knocking, and the door will be opened to you. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 11(9): 1767-1768

Montefiori, D.; Sattentau, Q.; Flores, J.; Esparza, J.é; Mascola, J. 2007: Antibody-based HIV-1 vaccines: recent developments and future directions. Plos Medicine 4(12): E348

Kumeta, M.; Hirai, Y.; Yoshimura, S.H.; Horigome, T.; Takeyasu, K. 2013: Antibody-based analysis reveals "filamentous vs. non-filamentous" and "cytoplasmic vs. nuclear" crosstalk of cytoskeletal proteins. Experimental Cell Research 319(20): 3226-3237

Bzowska, M.; Mężyk-Kopeć, R.; Próchnicki, T.; Kulesza, Młgorzata.; Klaus, T.; Bereta, J. 2013: Antibody-based antiangiogenic and antilymphangiogenic therapies to prevent tumor growth and progression. Acta Biochimica Polonica 60(3): 263-275

Kerkvliet, E.; Sinnige, N.; Franso, C.; van Ree, R.; van den Hout, R. 2013: Antibody-based assays for potency determination of mite allergoids and for stability studies of alum-adsorbed mite vaccines. Arbeiten aus dem Paul-Ehrlich-Institut Langen/Hessen 97: 106-111

Baxevanis, C.N. 2008: Antibody-based cancer therapy. Expert Opinion on Drug Discovery 3(4): 441-452

Karagiannis, T.C. 2007: Antibody-based cancer treatment with ultra-short range Auger electron-emitting radionuclides: dual receptor and DNA targeting strategies. Hellenic Journal of Nuclear Medicine 10(3): 155-159

Chen, W.; Ying, T.; Dimitrov, D.S. 2013: Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design. Expert Opinion on Biological Therapy 13(5): 657-671

Whaley, K.J.; Zeitlin, L. 2013: Antibody-based concepts for multipurpose prevention technologies. Antiviral Research 100 Suppl: S48-S53

Gutbrodt, K.L.; Casi, G.; Neri, D. 2014: Antibody-based delivery of IL2 and cytotoxics eradicates tumors in immunocompetent mice. Molecular Cancer Therapeutics 13(7): 1772-1776

Hemmerle, T.; Doll, F.; Neri, D. 2014: Antibody-based delivery of IL4 to the neovasculature cures mice with arthritis. Proceedings of the National Academy of Sciences of the United States of America 111(33): 12008-12012

Gutbrodt, K.L.; Schliemann, C.; Giovannoni, L.; Frey, K.; Pabst, T.; Klapper, W.; Berdel, W.E.; Neri, D. 2013: Antibody-based delivery of interleukin-2 to neovasculature has potent activity against acute myeloid leukemia. Science Translational Medicine 5(201): 201ra118

Kim, H.L. 2014: Antibody-based depletion of Foxp3+ T cells potentiates antitumor immune memory stimulated by mTOR inhibition. Oncoimmunology 3: E29081

Randis, T.M.; Kulkarni, R.; Aguilar, J.L.; Ratner, A.J. 2009: Antibody-based detection and inhibition of vaginolysin, the Gardnerella vaginalis cytolysin. Plos one 4(4): E5207

Park, K.; Tomlins, S.A.; Mudaliar, K.M.; Chiu, Y.-L.; Esgueva, R.; Mehra, R.; Suleman, K.; Varambally, S.; Brenner, J.C.; MacDonald, T.; Srivastava, A.; Tewari, A.K.; Sathyanarayana, U.; Nagy, D.; Pestano, G.; Kunju, L.P.; Demichelis, F.; Chinnaiyan, A.M.; Rubin, M.A. 2010: Antibody-based detection of ERG rearrangement-positive prostate cancer. Neoplasia 12(7): 590-598

Tomlins, S.A.; Palanisamy, N.; Siddiqui, J.; Chinnaiyan, A.M.; Kunju, L.P. 2012: Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies. Archives of Pathology and Laboratory Medicine 136(8): 935-946

Khan, R.A.; Rashid, M.; Wang, D.; Zhang, Y.L. 2013: Antibody-based detection of alkaline phosphatase in lepidopteran insects (Lepidoptera: Noctuidae). Genetics and Molecular Research: Gmr 12(4): 4371-4382

Leal, Y.A.; Flores, L.L.; García-Cortés, L.B.; Cedillo-Rivera, R.; Torres, J. 2008: Antibody-based detection tests for the diagnosis of Helicobacter pylori infection in children: a meta-analysis. Plos one 3(11): E3751

Ramírez, H.; Román, B.S.; Glaria, I.; Reina, R.; Hernández, M.M.; de Andrés, X.; Crespo, H.; Hichou, B.; Cianca, S.; Goñi, C.; Grandas, A.; García-Pastor, L.; Vijil, L.E.; Quintín, F.; Grilló, M.J.; de Andrés, D.; Amorena, B. 2009: Antibody-based diagnosis of small ruminant lentivirus infection in seminal fluid. Theriogenology 72(8): 1085-1096

Kim, H.J.; Lee, S.J.; Kim, H.-J. 2008: Antibody-based enzyme-linked lectin assay (ABELLA) for the sialylated recombinant human erythropoietin present in culture supernatant. Journal of Pharmaceutical and Biomedical Analysis 48(3): 716-721

Loo, D.T.; Mather, J.P. 2008: Antibody-based identification of cell surface antigens: targets for cancer therapy. Current Opinion in Pharmacology 8(5): 627-631

Wang, R.E.; Zhang, Y.; Tian, L.; Cai, W.; Cai, J. 2013: Antibody-based imaging of HER-2: moving into the clinic. Current Molecular Medicine 13(10): 1523-1537

Warram, J.M.; de Boer, E.; Sorace, A.G.; Chung, T.K.; Kim, H.; Pleijhuis, R.G.; van Dam, G.M.; Rosenthal, E.L. 2014: Antibody-based imaging strategies for cancer. Cancer Metastasis Reviews 33(2-3): 809-822

Premkumar, J.R.; Lev, O.; Marks, R.S.; Polyak, B.; Rosen, R.; Belkin, S. 2001: Antibody-based immobilization of bioluminescent bacterial sensor cells. Talanta 55(5): 1029-1038

Heimbach, J.K.; Charlton, M.R. 2010: Antibody-based immunosuppression following liver transplantation: the plot thickens. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 10(3): 445-446

Sakaguchi, S.; Ishibashi, D.; Matsuda, H. 2009: Antibody-based immunotherapeutic attempts in experimental animal models of prion diseases. Expert Opinion on Therapeutic Patents 19(7): 907-917

Gedeon, P.C.; Riccione, K.A.; Fecci, P.E.; Sampson, J.H. 2014: Antibody-based immunotherapy for malignant glioma. Seminars in Oncology 41(4): 496-510

Tse, B.W.C.; Collins, A.; Oehler, M.K.; Zippelius, A.; Heinzelmann-Schwarz, V.A. 2014: Antibody-based immunotherapy for ovarian cancer: where are we at?. Annals of Oncology: Official Journal of the European Society for Medical Oncology 25(2): 322-331

Johnson, E.; Dean, S.M.; Sondel, P.M. 2007: Antibody-based immunotherapy in high-risk neuroblastoma. Expert Reviews in Molecular Medicine 9(34): 1-21

Weiner, L.M.; Murray, J.C.; Shuptrine, C.W. 2012: Antibody-based immunotherapy of cancer. Cell 148(6): 1081-1084

Kim, C-Beom.; Choi, Y.Yong.; Song, W.Keun.; Song, K-Bong. 2014: Antibody-based magnetic nanoparticle immunoassay for quantification of Alzheimer's disease pathogenic factor. Journal of Biomedical Optics 19(5): 051205

Fiebig, H.; Kahlert, H.; Weber, B.; Suck, R.; Nandy, A.; Cromwell, O. 2009: Antibody-based methods for standardization of allergoids and recombinant hypoallergens. Arbeiten aus dem Paul-Ehrlich-Institut Langen/Hessen 96: 71-82; Discussion: 82-83

Wingren, C.; Borrebaeck, C.A.K. 2009: Antibody-based microarrays. Methods in Molecular Biology 509: 57-84

Kassa, T.; Undesser, L.P.; Hofstetter, H.; Hofstetter, O. 2011: Antibody-based multiplex analysis of structurally closely related chiral molecules. Analyst 136(6): 1113-1115

Rauch, A.; Legendre, P.; Christophe, O.D.; Goudemand, J.; van Belle, E.; Vincentelli, Aé.; Denis, Cécile.V.; Susen, S.; Lenting, P.J. 2014: Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devices. Thrombosis and Haemostasis 112(5): 1014-1023

Häggmark, A.; Byström, S.; Ayoglu, B.; Qundos, U.; Uhlén, M.; Khademi, M.; Olsson, T.; Schwenk, J.M.; Nilsson, P. 2013: Antibody-based profiling of cerebrospinal fluid within multiple sclerosis. Proteomics 13(15): 2256-2267

Ellington, A.A.; Kullo, I.J.; Bailey, K.R.; Klee, G.G. 2010: Antibody-based protein multiplex platforms: technical and operational challenges. Clinical Chemistry 56(2): 186-193

Uhlén, M.; Oksvold, P.; Älgenäs, C.; Hamsten, C.; Fagerberg, L.; Klevebring, D.; Lundberg, E.; Odeberg, J.; Pontén, F.; Kondo, T.; Sivertsson, Ås. 2012: Antibody-based protein profiling of the human chromosome 21. Molecular and Cellular Proteomics: Mcp 11(3): M111.013458

Solier, C.; Langen, H. 2014: Antibody-based proteomics and biomarker research - current status and limitations. Proteomics 14(6): 774-783

Lindskog, C.; Asplund, A.; Engkvist, M.; Uhlen, M.; Korsgren, O.; Ponten, F. 2010: Antibody-based proteomics for discovery and exploration of proteins expressed in pancreatic islets. Discovery Medicine 9(49): 565-578

Uemura, N.; Nakanishi, Y.; Kato, H.; Nagino, M.; Hirohashi, S.; Kondo, T. 2009: Antibody-based proteomics for esophageal cancer: Identification of proteins in the nuclear factor-kappaB pathway and mitotic checkpoint. Cancer Science 100(9): 1612-1622

Voshol, H.; Ehrat, M.; Traenkle, J.; Bertrand, E.; van Oostrum, J. 2009: Antibody-based proteomics: analysis of signaling networks using reverse protein arrays. Febs Journal 276(23): 6871-6879

Ivey, R.G.; Subramanian, O.; Lorentzen, T.D.; Paulovich, A.G. 2009: Antibody-based screen for ionizing radiation-dependent changes in the Mammalian proteome for use in biodosimetry. Radiation Research 171(5): 549-561

Byrne, B.; Stack, E.; Gilmartin, N.; O'Kennedy, R. 2009: Antibody-based sensors: principles, problems and potential for detection of pathogens and associated toxins. Sensors 9(6): 4407-4445

Clancy, C.J.; Cheng, S.; Nguyen, M.H. 2009: Antibody-based strategy to identify Candida albicans genes expressed during infections. Methods in Molecular Biology 470: 169-185

Moreau, T.; Faye, Cément.; Baqué, M.; Desvignes, I.; Coussot, Gëlle.; Pascal, R.; Vandenabeele-Trambouze, O. 2011: Antibody-based surfaces: rapid characterization using two complementary colorimetric assays. Analytica Chimica Acta 706(2): 354-360

Qing, J.; Du, X.; Chen, Y.; Chan, P.; Li, H.; Wu, P.; Marsters, S.; Stawicki, S.; Tien, J.; Totpal, K.; Ross, S.; Stinson, S.; Dornan, D.; French, D.; Wang, Q.-R.; Stephan, J.-P.; Wu, Y.; Wiesmann, C.; Ashkenazi, A. 2009: Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice. Journal of Clinical Investigation 119(5): 1216-1229

Frey, K.; Zivanovic, A.; Schwager, K.; Neri, D. 2011: Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation. Integrative Biology: Quantitative Biosciences from Nano to Macro 3(4): 468-478

Parry, P.V.; Engh, J.A. 2013: Antibody-based therapeutic targeting of human neuroblastoma. Neurosurgery 72(2): N16-N17

Feng, Y.; Dimitrov, D.S. 2012: Antibody-based therapeutics against components of the IGF system. Oncoimmunology 1(8): 1390-1391

Reichert, J.M. 2011: Antibody-based therapeutics to watch in 2011. Mabs 3(1): 76-99

Le Jeune, C.; Thomas, X. 2015: Antibody-based therapies in B-cell lineage acute lymphoblastic leukaemia. European Journal of Haematology 94(2): 99-108

Oral, H.B.; Akdis, C.A. 2000: Antibody-based therapies in infectious diseases. Methods in Molecular Medicine 40: 157-178

Iikuni, N.; La Cava, A. 2009: Antibody-based therapies in systemic lupus erythematosus. Mini Reviews in Medicinal Chemistry 9(7): 829-846

Pul, R.; Dodel, R.; Stangel, M. 2011: Antibody-based therapy in Alzheimer's disease. Expert Opinion on Biological Therapy 11(3): 343-357

Noguchi, T.; Ritter, G.; Nishikawa, H. 2013: Antibody-based therapy in colorectal cancer. ImmunoTherapy 5(5): 533-545

Cowan, A.J.; Laszlo, G.S.; Estey, E.H.; Walter, R.B. 2013: Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin. Frontiers in Bioscience 18(4): 1311-1334

Morris, J.C.; Waldmann, T.A. 2009: Antibody-based therapy of leukaemia. Expert Reviews in Molecular Medicine 11: E29

Li, C.; Chacko, A.-M.; Hu, J.; Hasegawa, K.; Swails, J.; Grasso, L.; El-Deiry, W.S.; Nicolaides, N.; Muzykantov, V.R.; Divgi, C.R.; Coukos, G. 2014: Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular model. Cancer Biology and Therapy 15(4): 443-451

Schliemann, C.; Neri, D. 2010: Antibody-based vascular tumor targeting. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 180: 201-216

Agrawal, A.K.; Gupta, C.M. 2000: Antibody-bearing liposomes as chloroquine vehicles in treatment of murine malaria. Methods in Molecular Medicine 25: 227-239

Varich, N.L.; Sadykova, G.K.; Prilipov, A.G.; Kochergin-Nikitsky, K.S.; Kushch, A.A.; Masalova, O.V.; Klimova, R.R.; Gitelman, A.K.; Kaverin, N.V. 2011: Antibody-binding epitope differences in the nucleoprotein of avian and mammalian influenza a viruses. Viral Immunology 24(2): 101-107

Liu, X.; Liu, R.; Tang, Y.; Zhang, L.; Hou, X.; Lv, Y. 2012: Antibody-biotemplated HgS nanoparticles: extremely sensitive labels for atomic fluorescence spectrometric immunoassay. Analyst 137(6): 1473-1480

Fujii, Y.; Anderson, J.M.; Matsuda, T. 2008: Antibody-bound cell microarray for immunophenotyping: surface modification and lymphocyte subpopulations. Journal of Biomedical Materials Research. Part B Applied Biomaterials 87(2): 525-537

Climent, E.; Martínez-Máñez, R.ón.; Maquieira, A.; Sancenón, F.él.; Marcos, M.D.; Brun, E.M.; Soto, J.; Amorós, P. 2012: Antibody-capped mesoporous nanoscopic materials: design of a probe for the selective chromo-fluorogenic detection of finasteride. Chemistryopen 1(6): 251-259

Ishikawa, F.; Uno, K.; Nishikawa, M.; Tsumuraya, T.; Fujii, I. 2013: Antibody-catalyzed decarboxylation and aldol reactions using a primary amine molecule as a functionalized small nonprotein component. Bioorganic and Medicinal Chemistry 21(22): 7011-7017

Saleh, M.; Soliman, H.; Haenen, O.; El-Matbouli, M. 2011: Antibody-coated gold nanoparticles immunoassay for direct detection of Aeromonas salmonicida in fish tissues. Journal of Fish Diseases 34(11): 845-852

Cimini, A.; D'Angelo, B.; Das, S.; Gentile, R.; Benedetti, E.; Singh, V.; Monaco, A.Maria.; Santucci, S.; Seal, S. 2012: Antibody-conjugated PEGylated cerium oxide nanoparticles for specific targeting of Aβ aggregates modulate neuronal survival pathways. Acta Biomaterialia 8(6): 2056-2067

Jacobs, M.; Panneer Selvam, A.; Craven, J.Engel.; Prasad, S. 2014: Antibody-conjugated gold nanoparticle-based immunosensor for ultra-sensitive detection of troponin-T. Journal of Laboratory Automation 19(6): 546-554

Day, E.S.; Bickford, L.R.; Slater, J.H.; Riggall, N.S.; Drezek, R.A.; West, J.L. 2010: Antibody-conjugated gold-gold sulfide nanoparticles as multifunctional agents for imaging and therapy of breast cancer. International Journal of Nanomedicine 5: 445-454

Waseem, S.; Allen, M.A.; Schreier, S.; Udomsangpetch, R.; Bhakdi, S.C. 2014: Antibody-conjugated paramagnetic nanobeads: kinetics of bead-cell binding. International Journal of Molecular Sciences 15(5): 8821-8834

Skaat, H.; Corem-Slakmon, E.; Grinberg, I.; Last, D.; Goez, D.; Mardor, Y.; Margel, S. 2013: Antibody-conjugated, dual-modal, near-infrared fluorescent iron oxide nanoparticles for antiamyloidgenic activity and specific detection of amyloid-β fibrils. International Journal of Nanomedicine 8: 4063-4076

Kontermann, R.E. 2012: Antibody-cytokine fusion proteins. Archives of Biochemistry and Biophysics 526(2): 194-205

Müller, D. 2014: Antibody-cytokine fusion proteins for cancer immunotherapy: an update on recent developments. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 28(2): 123-131

Ortiz-Sánchez, E.; Helguera, G.; Daniels, T.R.; Penichet, M.L. 2008: Antibody-cytokine fusion proteins: applications in cancer therapy. Expert Opinion on Biological Therapy 8(5): 609-632

Singh, R.; Erickson, H.K. 2009: Antibody-cytotoxic agent conjugates: preparation and characterization. Methods in Molecular Biology 525: 445-467 Xiv

Cabeza Meckert, P.M.; Chambo, J.G.; Spinelli, O.M.; Laguens, R.P. 1991: Antibody-dependent Cytotoxicity of Human Platelets Against Trypanosoma Cruzi. Platelets 2(2): 89-92

Wang, S.-F.; Tseng, S.-P.; Yen, C.-H.; Yang, J.-Y.; Tsao, C.-H.; Shen, C.-W.; Chen, K.-H.; Liu, F.-T.; Liu, W.-T.; Chen, Y.-M.A.; Huang, J.C. 2014: Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins. Biochemical and Biophysical Research Communications 451(2): 208-214

Couzi, L.; Pitard, V.; Sicard, X.; Garrigue, I.; Hawchar, O.; Merville, P.; Moreau, J.-F.ço.; Déchanet-Merville, J. 2012: Antibody-dependent anti-cytomegalovirus activity of human γδ T cells expressing CD16 (FcγRIIIa). Blood 119(6): 1418-1427

Hubert, P.; Amigorena, S. 2012: Antibody-dependent cell cytotoxicity in monoclonal antibody-mediated tumor immunotherapy. Oncoimmunology 1(1): 103-105

Bruckheimer, E.M.; Fazenbaker, C.A.; Gallagher, S.; Mulgrew, K.; Fuhrmann, S.; Coffman, K.T.; Walsh, W.; Ready, S.; Cook, K.; Damschroder, M.; Kinch, M.; Kiener, P.A.; Woods, R.; Gao, C.; Dall'Acqua, W.; Wu, H.; Coats, S. 2009: Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors. Neoplasia 11(6): 509

Hamada-Tsutsumi, S.; Suzuki, K.; Akahori, Y. 2011: Antibody-dependent cell-mediated cytotoxicity is induced by a single-chain Fv-protein IIi fusion in the presence of a rabbit anti-protein IIi polyclonal antibody. Immunology Letters 136(1): 44-48

Chan, W.K.; Kung Sutherland, M.; Li, Y.; Zalevsky, J.; Schell, S.; Leung, W. 2012: Antibody-dependent cell-mediated cytotoxicity overcomes NK cell resistance in MLL-rearranged leukemia expressing inhibitory KIR ligands but not activating ligands. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 18(22): 6296-6305

Xie, X.; McLean, M.D.; Hall, J.Christopher. 2010: Antibody-dependent cell-mediated cytotoxicity- and complement-dependent cytotoxicity-independent bactericidal activity of an IgG against Pseudomonas aeruginosa O6ad. Journal of Immunology 184(7): 3725-3733

Asmal, M.; Sun, Y.; Lane, S.; Yeh, W.; Schmidt, S.D.; Mascola, J.R.; Letvin, N.L. 2011: Antibody-dependent cell-mediated viral inhibition emerges after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys coincident with gp140-binding antibodies and is effective against neutralization-resistant viruses. Journal of Virology 85(11): 5465-5475

Forthal, D.N.; Landucci, G.; Chohan, B.; Richardson, B.A.; McClelland, R.S.; Jaoko, W.; Blish, C.; Overbaugh, J. 2013: Antibody-dependent cell-mediated virus inhibition antibody activity does not correlate with risk of HIV-1 superinfection. Journal of Acquired Immune Deficiency Syndromes 63(1): 31-33

Kobayashi, E.; Motoi, S.; Sugiura, M.; Kajikawa, M.; Kojima, S.; Kohroki, J.; Masuho, Y. 2014: Antibody-dependent cellular cytotoxicity and cytokine/chemokine secretion by KHYG-1 cells stably expressing FcγRIIIA. Immunology Letters 161(1): 59-64

Koch, T.; Derer, S.; Staudinger, M.; Rossen, K.; Glorius, P.; Peipp, M.; Kellner, C.; Kunzendorf, U.; Valerius, T.; Dechant, M. 2013: Antibody-dependent cellular cytotoxicity in patients on chronic hemodialysis. American Journal of Nephrology 38(5): 379-387

Shimodaira, H.; Komine, K.; Soeda, H.; Ishioka, C. 2010: Antibody-dependent cellular cytotoxicity in the immunotherapeutic mechanisms of anti-EGFR monoclonal antibody. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(5): 795-798

Madhavi, V.; Ana-Sosa-Batiz, F.E.; Jegaskanda, S.; Center, R.J.; Winnall, W.R.; Parsons, M.S.; Ananworanich, J.; Cooper, D.A.; Kelleher, A.D.; Hsu, D.; Pett, S.; Stratov, I.; Kramski, M.; Kent, S.J. 2015: Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy. Journal of Infectious Diseases 211(4): 529-538

Gorlani, A.; Forthal, D.N. 2013: Antibody-dependent enhancement and the risk of HIV infection. Current HIV Research 11(5): 421-426

Tsai, T.-T.; Chuang, Y.-J.; Lin, Y.-S.; Chang, C.-P.; Wan, S.-W.; Lin, S.-H.; Chen, C.-L.; Lin, C.-F. 2014: Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes. Plos Neglected Tropical Diseases 8(11): E3320

Takano, T.; Kawakami, C.; Yamada, S.; Satoh, R.; Hohdatsu, T. 2008: Antibody-dependent enhancement occurs upon re-infection with the identical serotype virus in feline infectious peritonitis virus infection. Journal of Veterinary Medical Science 70(12): 1315-1321

Nakayama, E.; Tomabechi, D.; Matsuno, K.; Kishida, N.; Yoshida, R.; Feldmann, H.; Takada, A. 2011: Antibody-dependent enhancement of Marburg virus infection. Journal of Infectious Diseases 204(Suppl 3): S978-S985

Bao, D.; Wang, R.; Qiao, S.; Wan, B.; Wang, Y.; Liu, M.; Shi, X.; Guo, J.; Zhang, G. 2013: Antibody-dependent enhancement of PRRSV infection down-modulates TNF-α and IFN-β transcription in macrophages. Veterinary Immunology and Immunopathology 156(1-2): 128-134

Jarasch-Althof, N.; Wiesener, N.; Schmidtke, M.; Wutzler, P.; Henke, A. 2010: Antibody-dependent enhancement of coxsackievirus B3 infection of primary CD19+ B lymphocytes. Viral Immunology 23(4): 369-376

Ito, M.; Mukai, R.-z.; Takasaki, T.; Kotaki, A.; Kurane, I. 2010: Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus. Archives of Virology 155(10): 1617-1624

Ayala-Nuñez, N.V.; Jarupathirun, P.; Kaptein, S.J.F.; Neyts, J.; Smit, J.M. 2013: Antibody-dependent enhancement of dengue virus infection is inhibited by SA-17, a doxorubicin derivative. Antiviral Research 100(1): 238-245

Yip, M.S.; Leung, N.H.L.; Cheung, C.Y.; Li, P.H.; Lee, H.H.Y.; Daëron, M.; Peiris, J.S.M.; Bruzzone, R.; Jaume, M. 2014: Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus. Virology Journal 11: 82

Longmire, R.L.; Ryan, S.; McMillan, R.; Lightsey, A.; Heath, V. 1978: Antibody-dependent lymphocytotoxicity induced by immunoglobulin G from Hodgkin's disease splenic lymphocytes. Science 199(4324): 71-72

Triulzi, C.; Vertuani, S.; Curcio, C.; Antognoli, A.; Seibt, J.; Akusjärvi, G.ör.; Wei, W.-Z.; Cavallo, F.; Kiessling, R. 2010: Antibody-dependent natural killer cell-mediated cytotoxicity engendered by a kinase-inactive human HER2 adenovirus-based vaccination mediates resistance to breast tumors. Cancer Research 70(19): 7431-7441

May, K.; Grube, M.; Malhotra, I.; Long, C.A.; Singh, S.; Mandaliya, K.; Siegmund, W.; Fusch, C.; Schneider, H.; King, C.L. 2009: Antibody-dependent transplacental transfer of malaria blood-stage antigen using a human ex vivo placental perfusion model. Plos one 4(11): E7986

Dong, X.-Y.; Wang, W.-Q.; Zhao, Y.; Li, X.-D.; Fang, Z.-G.; Lin, D.-J.; Xiao, R.-Z.; Huang, R.-W.; Pan, G.-J.; Liu, J.-J. 2013: Antibody-directed double suicide gene therapy targeting of MUC1- positive leukemia cells in vitro and in vivo. Current Gene Therapy 13(5): 346-357

Tietze, L.F.; Krewer, B. 2009: Antibody-directed enzyme prodrug therapy: a promising approach for a selective treatment of cancer based on prodrugs and monoclonal antibodies. Chemical Biology and Drug Design 74(3): 205-211

Wu, D-tze.; Seita, Y.; Zhang, X.; Lu, C-Wei.; Roth, M.J. 2012: Antibody-directed lentiviral gene transduction for live-cell monitoring and selection of human iPS and hES cells. Plos one 7(4): E34778

Zhang, X.; Roth, M.J. 2010: Antibody-directed lentiviral gene transduction in early immature hematopoietic progenitor cells. Journal of Gene Medicine 12(12): 945-955

Murphy, K.T.; Ryall, J.G.; Snell, S.M.; Nair, L.; Koopman, R.é; Krasney, P.A.; Ibebunjo, C.; Holden, K.S.; Loria, P.M.; Salatto, C.T.; Lynch, G.S. 2010: Antibody-directed myostatin inhibition improves diaphragm pathology in young but not adult dystrophic mdx mice. American Journal of Pathology 176(5): 2425-2434

Murphy, K.T.; Koopman, Ré.; Naim, T.; Léger, B.; Trieu, J.; Ibebunjo, C.; Lynch, G.S. 2010: Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 24(11): 4433-4442

Satishkumar, R.; Vertegel, A.A. 2011: Antibody-directed targeting of lysostaphin adsorbed onto polylactide nanoparticles increases its antimicrobial activity against S. aureus in vitro. Nanotechnology 22(50): 505103

Grundy, A. 2013: Antibody-discovery company announces partnership with two pharmaceutical corporations. Bioanalysis 5(19): 2339

Sassoon, I.; Blanc, V.ér. 2013: Antibody-drug conjugate (ADC) clinical pipeline: a review. Methods in Molecular Biology 1045: 1-27

Wright, L.; Baughman, S.; Wake, A. 2013: Antibody-drug conjugate drug development: where are the challenges?. Bioanalysis 5(12): 1467-1469

Tsoucalas, G.; Karamanou, M.; Laios, K.; Androutsos, G.; Barone, R. 2014: The eminent and forgotten Roger Barone (c. 13th century): a great and innovative surgeon in Montpellier. Surgical Innovation 21(3): 337

Wagner-Rousset, E.; Janin-Bussat, M-Claire.; Colas, O.; Excoffier, M.; Ayoub, D.; Haeuw, J-François.; Rilatt, I.; Perez, M.; Corvaïa, N.; Beck, A. 2014: Antibody-drug conjugate model fast characterization by LC-MS following IdeS proteolytic digestion. Mabs 6(1): 173-184

Anderl, J.; Faulstich, H.; Hechler, T.; Kulke, M. 2013: Antibody-drug conjugate payloads. Methods in Molecular Biology 1045: 51-70

Bander, N.H. 2013: Antibody-drug conjugate target selection: critical factors. Methods in Molecular Biology 1045: 29-40

Teicher, B.A. 2009: Antibody-drug conjugate targets. Current Cancer Drug Targets 9(8): 982-1004

Bander, N.H.; Czuczman, M.S.; Younes, A. 2012: Antibody-drug conjugate technology development for hematologic disorders. Clinical Advances in Hematology and Oncology: H&o 10(8 Suppl 10: 1-16

Bertholjotti, I. 2011: Antibody-drug conjugate--a new age for personalized cancer treatment. Chimia 65(9): 746-748

Ornes, S. 2013: Antibody-drug conjugates. Proceedings of the National Academy of Sciences of the United States of America 110(34): 13695

Adair, J.R.; Howard, P.W.; Hartley, J.A.; Williams, D.G.; Chester, K.A. 2012: Antibody-drug conjugates - a perfect synergy. Expert Opinion on Biological Therapy 12(9): 1191-1206

Lin, L.; Ding, Q.; Tang, Q.; Zhang, Z.-z.; Dai, Z.; Zhan, J.-b. 2012: Antibody-drug conjugates and their application in the treatment of hematological malignancies. Yao Xue Xue Bao 47(10): 1287-1296

Sun, Y.; Yu, F.; Sun, B.-W. 2009: Antibody-drug conjugates as targeted cancer therapeutics. Yao Xue Xue Bao 44(9): 943-952

Chu, Y.-W.; Polson, A. 2013: Antibody-drug conjugates for the treatment of B-cell non-Hodgkin's lymphoma and leukemia. Future Oncology 9(3): 355-368

Polson, A.G.; Calemine-Fenaux, J.; Chan, P.; Chang, W.; Christensen, E.; Clark, S.; de Sauvage, F.J.; Eaton, D.; Elkins, K.; Elliott, J.Michael.; Frantz, G.; Fuji, R.N.; Gray, A.; Harden, K.; Ingle, G.S.; Kljavin, N.M.; Koeppen, H.; Nelson, C.; Prabhu, S.; Raab, H.; Ross, S.; Slaga, D.S.; Stephan, J-Philippe.; Scales, S.J.; Spencer, S.D.; Vandlen, R.; Wranik, B.; Yu, S-Fan.; Zheng, B.; Ebens, A. 2009: Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selection. Cancer Research 69(6): 2358-2364

Sievers, E.L.; Senter, P.D. 2013: Antibody-drug conjugates in cancer therapy. Annual Review of Medicine 64: 15-29

Leslie, L.A.; Younes, A. 2013: Antibody-drug conjugates in hematologic malignancies. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting 2013

Gonçalves, A.; Trédan, O.; Villanueva, C.; Dumontet, C. 2012: Antibody-drug conjugates in oncology: from the concept to trastuzumab emtansine (T-DM1). Bulletin du Cancer 99(12): 1183-1191

Sammet, B.; Steinkühler, C.; Sewald, N. 2012: Antibody-drug conjugates in tumor therapy. Pharmaceutical Patent Analyst 1(1): 65-73

Ricart, A.D. 2011: Antibody-drug conjugates of calicheamicin derivative: gemtuzumab ozogamicin and inotuzumab ozogamicin. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(20): 6417-6427

Olson, W.C.; Israel, R.J. 2014: Antibody-drug conjugates targeting prostate-specific membrane antigen. Frontiers in Bioscience 19(1): 12-33

Chofflon, I.; Dietrich, P.-Y.; Thang, N.-N.T. 2013: Antibody-drug conjugates: a new therapeutic class?. Revue Medicale Suisse 9(387): 1080-1082; 1084-1086

Chari, R.V.J.; Miller, M.L.; Widdison, W.C. 2014: Antibody-drug conjugates: an emerging concept in cancer therapy. Angewandte Chemie 53(15): 3796-3827

Leal, M.; Sapra, P.; Hurvitz, S.A.; Senter, P.; Wahl, A.; Schutten, M.; Shah, D.K.; Haddish-Berhane, N.; Kabbarah, O. 2014: Antibody-drug conjugates: an emerging modality for the treatment of cancer. Annals of the new York Academy of Sciences 1321: 41-54

Perez, H.L.; Cardarelli, P.M.; Deshpande, S.; Gangwar, S.; Schroeder, G.M.; Vite, G.D.; Borzilleri, R.M. 2014: Antibody-drug conjugates: current status and future directions. Drug Discovery Today 19(7): 869-881

Ducry, L.; Stump, B. 2010: Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies. Bioconjugate Chemistry 21(1): 5-13

Beck, A.; Reichert, J.M. 2014: Antibody-drug conjugates: present and future. Mabs 6(1): 15-17

Alley, S.C.; Okeley, N.M.; Senter, P.D. 2010: Antibody-drug conjugates: targeted drug delivery for cancer. Current Opinion in Chemical Biology 14(4): 529-537

Falvo, E.; Tremante, E.; Fraioli, R.; Leonetti, C.; Zamparelli, C.; Boffi, A.; Morea, V.; Ceci, P.; Giacomini, P. 2013: Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin. Nanoscale 5(24): 12278-12285

Drachman, J.G.; Senter, P.D. 2013: Antibody-drug conjugates: the chemistry behind empowering antibodies to fight cancer. HEMATOLOGY. American Society of Hematology. Education Program 2013: 306-310

Goldmacher, V.S.; Kovtun, Y.V. 2011: Antibody-drug conjugates: using monoclonal antibodies for delivery of cytotoxic payloads to cancer cells. Therapeutic Delivery 2(3): 397-416

Conde, J.ão.; Bao, C.; Cui, D.; Baptista, P.V.; Tian, F. 2014: Antibody-drug gold nanoantennas with Raman spectroscopic fingerprints for in vivo tumour theranostics. Journal of Controlled Release: Official Journal of the Controlled Release Society 183: 87-93

Cova, E.; Colombo, M.; Inghilleri, S.; Morosini, M.; Miserere, S.; Peñaranda-Avila, J.; Santini, B.; Piloni, D.; Magni, S.; Gramatica, F.; Prosperi, D.; Meloni, F. 2015: Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction. Nanomedicine 10(1): 9-23

Harbers, S.O.; Crocker, A.; Catalano, G.; D'Agati, V.; Jung, S.; Desai, D.D.; Clynes, R. 2007: Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance. Journal of Clinical Investigation 117(5): 1361-1369

He, X.; Sun, X.; Wang, J.; Wang, X.; Zhang, Q.; Tzipori, S.; Feng, H. 2009: Antibody-enhanced, Fc gamma receptor-mediated endocytosis of Clostridium difficile toxin a. Infection and Immunity 77(6): 2294-2303

Wisdom, G.B. 1988: Antibody-enzyme conjugate formation. Methods in Molecular Biology 3: 373-382

Andrady, C.; Sharma, S.K.; Chester, K.A. 2011: Antibody-enzyme fusion proteins for cancer therapy. ImmunoTherapy 3(2): 193-211

Wilffert, D.; Reis, C.R.; Hermans, J.; Govorukhina, N.; Tomar, T.; de Jong, S.; Quax, W.J.; van de Merbel, N.C.; Bischoff, R. 2013: Antibody-free LC-MS/MS quantification of rhTRAIL in human and mouse serum. Analytical Chemistry 85(22): 10754-10760

Shi, T.; Qian, W.-J. 2013: Antibody-free PRISM-SRM for multiplexed protein quantification: is this the new competition for immunoassays in bioanalysis?. Bioanalysis 5(3): 267-269

Rossetti, C.; Abdel Qader, A.; Halvorsen, T.G.øn.; Sellergren, B.ör.; Reubsaet, L.éo. 2014: Antibody-free biomarker determination: exploring molecularly imprinted polymers for pro-gastrin releasing peptide. Analytical Chemistry 86(24): 12291-12298

Wu, H.-J.; Li, Y.; Fan, J.; Deng, Z.; Hu, Z.; Liu, X.; Graviss, E.A.; Ferrari, M.; Ma, X.; Hu, Y. 2014: Antibody-free detection of Mycobacterium tuberculosis antigen using customized nanotraps. Analytical Chemistry 86(4): 1988-1996

Ding, X.; Yang, K.-L. 2013: Antibody-free detection of human chorionic gonadotropin by use of liquid crystals. Analytical Chemistry 85(22): 10710-10716

Alpha-Bazin, B.éa.; Quéméneur, E. 2012: Antibody-free detection of phosphoserine/threonine containing peptides by homogeneous time-resolved fluorescence. Analytical Chemistry 84(22): 9963-9970

Wisastra, R.; Poelstra, K.; Bischoff, R.; Maarsingh, H.; Haisma, H.J.; Dekker, F.J. 2011: Antibody-free detection of protein tyrosine nitration in tissue sections. Chembiochem: a European Journal of Chemical Biology 12(13): 2016-2020

Matheson, N.J.; Peden, A.A.; Lehner, P.J. 2014: Antibody-free magnetic cell sorting of genetically modified primary human CD4+ T cells by one-step streptavidin affinity purification. Plos one 9(10): E111437

Kim, M.; Park, Y.-S.; Shin, D.-S.; Kim, J.; Kim, B.-G.; Lee, Y.-S. 2011: Antibody-free peptide substrate screening of serine/threonine kinase (protein kinase A) with a biotinylated detection probe. Analytical Biochemistry 413(1): 30-35

Minaker, S.A.; Daze, K.D.; Ma, M.C.F.; Hof, F. 2012: Antibody-free reading of the histone code using a simple chemical sensor array. Journal of the American Chemical Society 134(28): 11674-11680

Shi, T.; Fillmore, T.L.; Sun, X.; Zhao, R.; Schepmoes, A.A.; Hossain, M.; Xie, F.; Wu, S.; Kim, J.-S.; Jones, N.; Moore, R.J.; Pasa-Tolić, L.; Kagan, J.; Rodland, K.D.; Liu, T.; Tang, K.; Camp, D.G.; Smith, R.D.; Qian, W.-J. 2012: Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum. Proceedings of the National Academy of Sciences of the United States of America 109(38): 15395-15400

Guarrotxena, N.; Bazan, G.C. 2011: Antibody-functionalized SERS tags with improved sensitivity. Chemical Communications 47(31): 8784-8786

Mittal, S.; Wong, I.Y.; Deen, W.M.; Toner, M. 2012: Antibody-functionalized fluid-permeable surfaces for rolling cell capture at high flow rates. Biophysical Journal 102(4): 721-730

Buyukserin, F.; Medley, C.D.; Mota, M.O.; Kececi, K.; Rogers, R.R.; Tan, W.; Martin, C.R. 2008: Antibody-functionalized nano test tubes target breast cancer cells. Nanomedicine 3(3): 283-292

Karmani, L.; Labar, D.; Valembois, V.; Bouchat, V.; Nagaswaran, P.Ganesh.; Bol, A.; Gillart, J.; Levêque, P.; Bouzin, C.; Bonifazi, D.; Michiels, C.; Feron, O.; Grégoire, V.; Lucas, Séphane.; Vander Borght, T.; Gallez, B. 2013: Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice. Contrast Media and Molecular Imaging 8(5): 402-408

Wen, Y.; Liu, W.; Bagia, C.; Zhang, S.; Bai, M.; Janjic, J.M.; Giannoukakis, N.; Gawalt, E.S.; Meng, W.S. 2014: Antibody-functionalized peptidic membranes for neutralization of allogeneic skin antigen-presenting cells. Acta Biomaterialia 10(11): 4759-4767

Triulzi, R.C.; Micic, M.; Orbulescu, J.; Giordani, S.; Mueller, B.; Leblanc, R.M. 2008: Antibody-gold quantum dot-PAMAM dendrimer complex as an immunoglobulin immunoassay. Analyst 133(5): 667-672

Anonymous 2009: Antibody-guided drug shows encouraging activity in metastatic breast cancer. Cancer Biology and Therapy 8(24): Ii

Sack, J.T.; Stephanopoulos, N.; Austin, D.C.; Francis, M.B.; Trimmer, J.S. 2013: Antibody-guided photoablation of voltage-gated potassium currents. Journal of General Physiology 142(3): 315-324

Mahara, A.; Yamaoka, T. 2010: Antibody-immobilized column for quick cell separation based on cell rolling. Biotechnology Progress 26(2): 441-447

Yin, D.; Ulbricht, M. 2013: Antibody-imprinted membrane adsorber via two-step surface grafting. Biomacromolecules 14(12): 4489-4496

Ireland, S.J.; Blazek, M.; Harp, C.T.; Greenberg, B.; Frohman, E.M.; Davis, L.S.; Monson, N.L. 2012: Antibody-independent B cell effector functions in relapsing remitting multiple sclerosis: clues to increased inflammatory and reduced regulatory B cell capacity. Autoimmunity 45(5): 400-414

Shim, S.; Stemke-Hale, K.; Tsimberidou, A.M.; Noshari, J.; Anderson, T.E.; Gascoyne, P.R.C. 2013: Antibody-independent isolation of circulating tumor cells by continuous-flow dielectrophoresis. Biomicrofluidics 7(1): 11807

He, J.; Sun, X.; Shi, T.; Schepmoes, A.A.; Fillmore, T.L.; Petyuk, V.A.; Xie, F.; Zhao, R.; Gritsenko, M.A.; Yang, F.; Kitabayashi, N.; Chae, S.-S.; Rubin, M.A.; Siddiqui, J.; Wei, J.T.; Chinnaiyan, A.M.; Qian, W.-J.; Smith, R.D.; Kagan, J.; Srivastava, S.; Rodland, K.D.; Liu, T.; Camp, D.G. 2014: Antibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancer. Molecular Oncology 8(7): 1169-1180

Kamerbeek, C.B.; Borroni, V.; Pediconi, M.ía.F.; Sato, S.B.; Kobayashi, T.; Barrantes, F.J. 2013: Antibody-induced acetylcholine receptor clusters inhabit liquid-ordered and liquid-disordered domains. Biophysical Journal 105(7): 1601-1611

Andersen, L.M.; Andreasen, P.A.; Svendsen, I.; Keemink, J.; Østergaard, H.; Persson, E. 2012: Antibody-induced enhancement of factor VIIa activity through distinct allosteric pathways. Journal of Biological Chemistry 287(12): 8994-9001

Dressler, D.; Wohlfahrt, K.; Meyer-Rogge, E.; Wiest, L.; Bigalke, H. 2010: Antibody-induced failure of botulinum toxin a therapy in cosmetic indications. Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery 36(Suppl 4): 2182-2187

Modjtahedi, H.; Dean, C. 1995: Antibody-induced inhibition of growth of egfr overexpressing tumors occurs in the absence of receptor down-regulation. International Journal of Oncology 7(4): 783-788

Geddie, M.L.; Matsumura, I. 2007: Antibody-induced oligomerization and activation of an engineered reporter enzyme. Journal of Molecular Biology 369(4): 1052-1059

Michaelsen, T.E.; Aase, A. 2001: Antibody-induced opsonophagocytosis of serogroup B meningococci measured by flow cytometry. Methods in Molecular Medicine 66: 331-337

Stengel, G.; Bee, E.K. 2011: Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type a for glabellar frown lines. Clinical Interventions in Aging 6: 281-284

Cummings, R.J.; Mitra, S.; Lord, E.M.; Foster, T.H. 2008: Antibody-labeled fluorescence imaging of dendritic cell populations in vivo. Journal of Biomedical Optics 13(4): 044041

Danila, D.; Partha, R.; Elrod, D.B.; Lackey, M.; Casscells, S.W.; Conyers, J.L. 2009: Antibody-labeled liposomes for CT imaging of atherosclerotic plaques: in vitro investigation of an anti-ICAM antibody-labeled liposome containing iohexol for molecular imaging of atherosclerotic plaques via computed tomography. Texas Heart Institute Journal 36(5): 393-403

Haab, B.B. 2010: Antibody-lectin sandwich arrays for biomarker and glycobiology studies. Expert Review of Proteomics 7(1): 9-11

Zhang, K.; Hao, L.; Hurst, S.J.; Mirkin, C.A. 2012: Antibody-linked spherical nucleic acids for cellular targeting. Journal of the American Chemical Society 134(40): 16488-16491

Kovtun, Y.V.; Audette, C.A.; Mayo, M.F.; Jones, G.E.; Doherty, H.; Maloney, E.K.; Erickson, H.K.; Sun, X.; Wilhelm, S.; Ab, O.; Lai, K.C.; Widdison, W.C.; Kellogg, B.; Johnson, H.; Pinkas, J.; Lutz, R.J.; Singh, R.; Goldmacher, V.S.; Chari, R.V.J. 2010: Antibody-maytansinoid conjugates designed to bypass multidrug resistance. Cancer Research 70(6): 2528-2537

Lutz, R.J.; Whiteman, K.R. 2009: Antibody-maytansinoid conjugates for the treatment of myeloma. Mabs 1(6): 548-551

Bux, J. 2011: Antibody-mediated (immune) transfusion-related acute lung injury. Vox Sanguinis 100(1): 122-128

James, S.E.; Orgun, N.N.; Tedder, T.F.; Shlomchik, M.J.; Jensen, M.C.; Lin, Y.; Greenberg, P.D.; Press, O.W. 2009: Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice. Blood 114(27): 5454-5463

Heinze, E.; Baldwin, S.; Chan, G.; Hansen, J.; Song, J.; Clements, D.; Aragon, R.; Nishimura, R.; Reeves, M.; Weisbart, R. 2009: Antibody-mediated FOXP3 protein therapy induces apoptosis in cancer cells in vitro and inhibits metastasis in vivo. International Journal of Oncology 35(1): 167-173

Onzuka, T.; Tomita, Y.; Okano, S.; Shimizu, I.; Yamada, H.; Yoshikai, Y.; Tominaga, R. 2010: Antibody-mediated T-cell reduction or increased levels of chimerism overcome resistance to cyclophosphamide-induced tolerance in NKT-deficient mice. Scandinavian Journal of Immunology 72(2): 106-117

Wu, A.-L.; Feng, B.; Chen, M.Z.; Kolumam, G.; Zavala-Solorio, J.; Wyatt, S.K.; Gandham, V.D.; Carano, R.A.D.; Sonoda, J. 2013: Antibody-mediated activation of FGFR1 induces FGF23 production and hypophosphatemia. Plos one 8(2): E57322

Lefaucheur, C.; Nochy, D.; Glotz, D. 2008: Antibody-mediated acute rejection. Nephrologie and Therapeutique 4(Suppl 3): S188-S191

Papadimitriou, J.C.; Drachenberg, C.B.; Ramos, E.; Kukuruga, D.; Klassen, D.K.; Ugarte, R.; Nogueira, J.; Cangro, C.; Weir, M.R.; Haririan, A. 2013: Antibody-mediated allograft rejection: morphologic spectrum and serologic correlations in surveillance and for cause biopsies. Transplantation 95(1): 128-136

Arévalo-Herrera, M.; Soto, L.; Perlaza, B.L.; Céspedes, N.; Vera, O.; Lenis, A.M.; Bonelo, A.; Corradin, G.; Herrera, S.óc. 2011: Antibody-mediated and cellular immune responses induced in naive volunteers by vaccination with long synthetic peptides derived from the Plasmodium vivax circumsporozoite protein. American Journal of Tropical Medicine and Hygiene 84(2 Suppl): 35-42

Reiche, S.; Bussmann, B.M.; Dwai, Y.; Jassoy, C. 2010: Antibody-mediated binding of fluorescent HIV Gag and influenza nucleoprotein tetramers to blood cells. Immunobiology 215(3): 223-229

Yokoyama, S.; Watanabe, N.; Sato, N.; Perera, P.-Y.; Filkoski, L.; Tanaka, T.; Miyasaka, M.; Waldmann, T.A.; Hiroi, T.; Perera, L.P. 2009: Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes. Proceedings of the National Academy of Sciences of the United States of America 106(37): 15849-15854

Van Aarsen, L.A.Koopman.; Leone, D.R.; Ho, S.; Dolinski, B.M.; McCoon, P.E.; LePage, D.J.; Kelly, R.; Heaney, G.; Rayhorn, P.; Reid, C.; Simon, K.J.; Horan, G.S.; Tao, N.; Gardner, H.A.; Skelly, M.M.; Gown, A.M.; Thomas, G.J.; Weinreb, P.H.; Fawell, S.E.; Violette, S.M. 2008: Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism. Cancer Research 68(2): 561-570

Shapiro, E.M.; Medford-Davis, L.N.; Fahmy, T.M.; Dunbar, C.E.; Koretsky, A.P. 2007: Antibody-mediated cell labeling of peripheral T cells with micron-sized iron oxide particles (MPIOs) allows single cell detection by MRI. Contrast Media and Molecular Imaging 2(3): 147-153

Pálóczi, K. 2007: Antibody-mediated cell-specific hematopoietic autoimmune disorders. Orvosi Hetilap 148(Suppl 1): 39-42

Horton, H.M.; Chu, S.Y.; Ortiz, E.C.; Pong, E.; Cemerski, S.; Leung, I.W.L.; Jacob, N.; Zalevsky, J.; Desjarlais, J.R.; Stohl, W.; Szymkowski, D.E. 2011: Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus. Journal of Immunology 186(7): 4223-4233

La Greca, F.; Haynes, C.; Stijlemans, B.; De Trez, C.; Magez, S. 2014: Antibody-mediated control of Trypanosoma vivax infection fails in the absence of tumour necrosis factor. Parasite Immunology 36(6): 271-276

Hemmerle, T.; Zgraggen, S.; Matasci, M.; Halin, C.; Detmar, M.; Neri, D. 2014: Antibody-mediated delivery of interleukin 4 to the neo-vasculature reduces chronic skin inflammation. Journal of Dermatological Science 76(2): 96-103

Mårlind, J.; Kaspar, M.; Trachsel, E.; Sommavilla, R.; Hindle, S.; Bacci, C.; Giovannoni, L.; Neri, D. 2008: Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(20): 6515-6524

Kim, S.-S.; Subramanya, S.; Peer, D.; Shimaoka, M.; Shankar, P. 2011: Antibody-mediated delivery of si RNAs for anti-HIV therapy. Methods in Molecular Biology 721: 339-353

Poirier, N.; Haudebourg, T.; Brignone, C.; Dilek, N.; Hervouet, J.; Minault, D.; Coulon, F.; de Silly, R.V.; Triebel, F.; Blancho, G.; Vanhove, B. 2011: Antibody-mediated depletion of lymphocyte-activation gene-3 (LAG-3(+) )-activated T lymphocytes prevents delayed-type hypersensitivity in non-human primates. Clinical and Experimental Immunology 164(2): 265-274

Duff, C.J.; Scott, M.J.; Kirby, I.T.; Hutchinson, S.E.; Martin, S.L.; Hooper, N.M. 2009: Antibody-mediated disruption of the interaction between PCSK9 and the low-density lipoprotein receptor. Biochemical Journal 419(3): 577-584

Pollak, T.A.; Lennox, B.R.; Vincent, A.; Nicholson, T.R. 2012: Antibody-mediated encephalitis and psychosis. British journal of psychiatry: the journal of mental science 200(4): 344; author reply 344-5

Lennox, B.R.; Coles, A.J.; Vincent, A. 2012: Antibody-mediated encephalitis: a treatable cause of schizophrenia. British Journal of Psychiatry: the Journal of Mental Science 200(2): 92-94

Yoong, P.; Pier, G.B. 2010: Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection. Proceedings of the National Academy of Sciences of the United States of America 107(5): 2241-2246

von Kietzell, K.; Pozzuto, T.; Heilbronn, R.; Grössl, T.; Fechner, H.; Weger, S. 2014: Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q. Journal of Virology 88(14): 8102-8115

Itoh, H.; Inoue, M. 2014: Antibody-mediated functional control of a dansylated polytheonamide mimic. Chemical Communications 50(8): 939-941

Valenzuela, N.M.; McNamara, J.T.; Reed, E.F. 2014: Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms. Current Opinion in Organ Transplantation 19(1): 33-40

Baldwin, W.M.; Sanfilippo, F. 1987: Antibody-mediated graft versus host reactions in renal transplantation. Immunology Today 8(7-8): 219-220

Dent, A.E.; Bergmann-Leitner, E.S.; Wilson, D.W.; Tisch, D.J.; Kimmel, R.; Vulule, J.; Sumba, P.O.; Beeson, J.G.; Angov, E.; Moormann, A.M.; Kazura, J.W. 2008: Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults. Plos one 3(10): E3557

Robertson, E.J.; Casadevall, A. 2009: Antibody-mediated immobilization of Cryptococcus neoformans promotes biofilm formation. Applied and Environmental Microbiology 75(8): 2528-2533

Wilks, J.; Beilinson, H.; Theriault, B.; Chervonsky, A.; Golovkina, T. 2014: Antibody-mediated immune control of a retrovirus does not require the microbiota. Journal of Virology 88(11): 6524-6527

Yu, H.; Stowell, S.R.; Bernardo, L.; Hendrickson, J.E.; Zimring, J.C.; Amash, A.; Uchikawa, M.; Lazarus, A.H. 2014: Antibody-mediated immune suppression of erythrocyte alloimmunization can occur independently from red cell clearance or epitope masking in a murine model. Journal of Immunology 193(6): 2902-2910

Fantappiè, L.; de Santis, M.; Chiarot, E.; Carboni, F.; Bensi, G.; Jousson, O.; Margarit, I.; Grandi, G. 2014: Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen. Journal of Extracellular Vesicles 3

Shannon, J.G.; Cockrell, D.C.; Takahashi, K.; Stahl, G.L.; Heinzen, R.A. 2009: Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor- and complement-independent. Bmc Immunology 10: 26

Solomon, B. 2007: Antibody-mediated immunotherapy for Alzheimer's disease. Current Opinion in Investigational Drugs 8(7): 519-524

Wang, Z.; Low, P.A.; Vernino, S. 2010: Antibody-mediated impairment and homeostatic plasticity of autonomic ganglionic synaptic transmission. Experimental Neurology 222(1): 114-119

Hegerle, N.; Guiso, N. 2014: Antibody-mediated inhibition of Bordetella pertussis adenylate cyclase-haemolysin-induced macrophage cytotoxicity is influenced by variations in the bacterial population. Microbiology 160(Part 5): 962-969

Williams, S.K.; Maier, O.; Fischer, R.; Fairless, R.; Hochmeister, S.; Stojic, A.; Pick, L.; Haar, D.; Musiol, S.; Storch, M.K.; Pfizenmaier, K.; Diem, R. 2014: Antibody-mediated inhibition of TNFR1 attenuates disease in a mouse model of multiple sclerosis. Plos one 9(2): E90117

Burden, R.E.; Gormley, J.A.; Jaquin, T.J.; Small, D.M.; Quinn, D.J.; Hegarty, S.M.; Ward, C.; Walker, B.; Johnston, J.A.; Olwill, S.A.; Scott, C.J. 2009: Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(19): 6042-6051

Pai, R.; French, D.; Ma, N.; Hotzel, K.; Plise, E.; Salphati, L.; Setchell, K.D.R.; Ware, J.; Lauriault, V.; Schutt, L.; Hartley, D.; Dambach, D. 2012: Antibody-mediated inhibition of fibroblast growth factor 19 results in increased bile acids synthesis and ileal malabsorption of bile acids in cynomolgus monkeys. Toxicological Sciences: An Official Journal of the Society of Toxicology 126(2): 446-456

Chang, J.; Yang, L.; Kouadir, M.; Peng, Y.; Zhang, S.; Shi, F.; Zhou, X.; Yin, X.; Zhao, D. 2012: Antibody-mediated inhibition of integrin α5β1 blocks neurotoxic prion peptide PrP106-126-induced activation of BV2 microglia. Journal of Molecular Neuroscience: Mn 48(1): 248-252

Yermakova, A.; Klokk, T.I.; Cole, R.; Sandvig, K.; Mantis, N.J. 2014: Antibody-mediated inhibition of ricin toxin retrograde transport. Mbio 5(2): E00995

Loupy, A.; Hill, G.S.; Nochy, D.; Legendre, C. 2010: Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 10(4): 952

Nimmerjahn, F.; Ravetch, J.V. 2010: Antibody-mediated modulation of immune responses. Immunological Reviews 236: 265-275

Sato, S.; Johnson, W. 2007: Antibody-mediated neutralization and simian immunodeficiency virus models of HIV/AIDS. Current HIV Research 5(6): 594-607

Shedlock, D.J.; Bailey, M.A.; Popernack, P.M.; Cunningham, J.M.; Burton, D.R.; Sullivan, N.J. 2010: Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms. Virology 401(2): 228-235

Dowd, K.A.; Pierson, T.C. 2011: Antibody-mediated neutralization of flaviviruses: a reductionist view. Virology 411(2): 306-315

Chehadeh, W.; Halim, M.A.; Al-Nakib, W. 2009: Antibody-mediated opsonization of red blood cells in parvovirus B19 infection. Virology 390(1): 56-63

Freire, M.O.; You, H.-K.; Kook, J.-K.; Choi, J.-H.; Zadeh, H.H. 2011: Antibody-mediated osseous regeneration: a novel strategy for bioengineering bone by immobilized anti-bone morphogenetic protein-2 antibodies. Tissue Engineering. Part a 17(23-24): 2911-2918

Freire, M.O.; Kim, H.Kyun.; Kook, J-Ki.; Nguyen, A.; Zadeh, H.H. 2013: Antibody-mediated osseous regeneration: the early events in the healing response. Tissue Engineering. Part a 19(9-10): 1165-1174

Lu, Y.; Wang, W.; Mao, H.; Hu, H.; Wu, Y.; Chen, B.-G.; Liu, Z. 2011: Antibody-mediated platelet phagocytosis by human macrophages is inhibited by siRNA specific for sequences in the SH2 tyrosine kinase, Syk. Cellular Immunology 268(1): 1-3

Hu, Z-Quan.; Li, H-Ping.; Zhang, J-Bo.; Glinka, E.; Liao, Y-Cai. 2008: Antibody-mediated prevention of Fusarium mycotoxins in the field. International Journal of Molecular Sciences 9(10): 1915-1926

Gorrell, R.J.; Robins-Browne, R.M. 2009: Antibody-mediated protection against infection with Helicobacter pylori in a suckling mouse model of passive immunity. Infection and Immunity 77(11): 5116-5129

Barnett, S.W.; Burke, B.; Sun, Y.; Kan, E.; Legg, H.; Lian, Y.; Bost, K.; Zhou, F.; Goodsell, A.; Zur Megede, J.; Polo, J.; Donnelly, J.; Ulmer, J.; Otten, G.R.; Miller, C.J.; Vajdy, M.; Srivastava, I.K. 2010: Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant. Journal of Virology 84(12): 5975-5985

Mestecky, J.; Raska, M.; Novak, J.; Alexander, R.C.; Moldoveanu, Z. 2010: Antibody-mediated protection and the mucosal immune system of the genital tract: relevance to vaccine design. Journal of Reproductive Immunology 85(1): 81-85

Suchkov, S.V.; Vvedenskaia, O.I.; Vostrikova, I.L.; Gabibov, A.G.; Kimova, M.V.; Burdakova, I.A.; Ponomarenko, N.A.; Pal'tsev, M.A. 2007: Antibody-mediated proteolysis of myelin-associated proteins as a new mechanism of control over demyelinization processes in multiple sclerosis. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 7: 32-36

Bossi, S.; Ferranti, B.; Martinelli, C.; Capasso, P.; de Marco, A. 2010: Antibody-mediated purification of co-expressed antigen-antibody complexes. Protein Expression and Purification 72(1): 55-58

Akalin, E.; Watschinger, B. 2007: Antibody-mediated rejection. Seminars in Nephrology 27(4): 393-407

Kittleson, M.M.; Kobashigawa, J.A. 2012: Antibody-mediated rejection. Current Opinion in Organ Transplantation 17(5): 551-557

Rangel, E.B.; Malheiros, D.M.A.C.; de Castro, M.C.R.; Antunes, I.; Torres, M.A.; Crescentini, F.áb.; Genzini, T.ér.; Perosa, M. 2010: Antibody-mediated rejection (AMR) after pancreas and pancreas-kidney transplantation. Transplant International: Official Journal of the European Society for Organ Transplantation 23(6): 602-610

Hori, T.; Egawa, H.; Uemoto, S. 2012: Antibody-mediated rejection after adult living-donor liver transplantation triggered by positive lymphocyte cross-match combination. Annals of Gastroenterology 25(1): 66-72

Willicombe, M.; Roufosse, C.; Brookes, P.; Galliford, J.W.; McLean, A.G.; Dorling, A.; Warrens, A.N.; Cook, T.H.; Cairns, T.D.; Taube, D. 2011: Antibody-mediated rejection after alemtuzumab induction: incidence, risk factors, and predictors of poor outcome. Transplantation 92(2): 176-182

Dick, A.é A.S.; Horslen, S. 2012: Antibody-mediated rejection after intestinal transplantation. Current Opinion in Organ Transplantation 17(3): 250-257

Hsu, C-Y.; Chi, N-H.; Chou, N-K.; Shun, C-T.; Chen, Y-S.; Huang, S-C.; Yu, H-Y.; Wang, S-S. 2014: Antibody-mediated rejection after orthotopic heart transplantation: a 9-year single-institution experience. Transplantation Proceedings 46(3): 925-928

Gulleroglu, K.; Baskin, E.; Bayrakci, U.S.; Turan, M.; Ozdemir, B.H.; Moray, G.; Karakayali, H.; Haberal, M. 2013: Antibody-mediated rejection and treatment in pediatric patients: one center's experience. Experimental and Clinical Transplantation: Official Journal of the Middle East Society for Organ Transplantation 11(5): 404-407

O'Leary, J.G.; Kaneku, H.; Demetris, A.J.; Marr, J.D.; Shiller, S.Michelle.; Susskind, B.M.; Tillery, G.W.; Terasaki, P.I.; Klintmalm, Göran.B. 2014: Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20(2): 218-227

Bentall, A.; Tyan, D.B.; Sequeira, F.; Everly, M.J.; Gandhi, M.J.; Cornell, L.D.; Li, H.; Henderson, N.A.; Raghavaiah, S.; Winters, J.L.; Dean, P.G.; Stegall, M.D. 2014: Antibody-mediated rejection despite inhibition of terminal complement. Transplant International: Official Journal of the European Society for Organ Transplantation 27(12): 1235-1243

Sureshkumar, K.K.; Hussain, S.M.; Carpenter, B.J.; Sandroni, S.E.; Marcus, R.J. 2007: Antibody-mediated rejection following renal transplantation. Expert Opinion on PharmacoTherapy 8(7): 913-921

Grafft, C.A.; Cornell, L.D.; Gloor, J.M.; Cosio, F.G.; Gandhi, M.J.; Dean, P.G.; Stegall, M.D.; Amer, H. 2010: Antibody-mediated rejection following transplantation from an HLA-identical sibling. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 25(1): 307-310

Kheradmand, T.; Anthony, T.L.; Harland, R.C.; Testa, G.; Hart, J.; Renz, J.; Te, H.S.; Marino, S.R. 2014: Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature. Human Immunology 75(6): 578-583

Weissenbacher, A.; Hautz, T.; Zelger, B.; Zelger, B.G.; Mayr, V.; Brandacher, G.; Pratschke, J.; Schneeberger, S. 2014: Antibody-mediated rejection in hand transplantation. Transplant International: Official Journal of the European Society for Organ Transplantation 27(2): E13-E17

Ticehurst, E.H.; Molina, M.R.; Frank, R.; Kearns, J.; Lal, P.; Goldberg, L.R.; Tsai, D.; Wald, J.; Kamoun, M. 2011: Antibody-mediated rejection in heart transplant patients: long-term follow up of patients with high levels of donor-directed anti-DQ antibodies. Clinical Transplants 2011: 409-414

Bierl, C.; Miller, B.; Prak, E.L.; Gasiewski, A.; Kearns, J.; Tsai, D.; Jessup, M.; Kamoun, M. 2006: Antibody-mediated rejection in heart transplant recipients: potential efficacy of B-cell depletion and antibody removal. Clinical Transplants 2006: 489-496

Pajaro, O.E.; Jaroszewski, D.E.; Scott, R.L.; Kalya, A.V.; Tazelaar, H.D.; Arabia, F.A. 2011: Antibody-mediated rejection in heart transplantation: case presentation with a review of current international guidelines. Journal of Transplantation 2011: 351950

Kim, M.; Martin, S.T.; Townsend, K.R.; Gabardi, S. 2014: Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options. PharmacoTherapy 34(7): 733-744

Lucas, J.G.; Co, J.P.; Nwaogwugwu, U.T.; Dosani, I.; Sureshkumar, K.K. 2011: Antibody-mediated rejection in kidney transplantation: an update. Expert Opinion on PharmacoTherapy 12(4): 579-592

Taner, T.; Stegall, M.D.; Heimbach, J.K. 2014: Antibody-mediated rejection in liver transplantation: current controversies and future directions. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20(5): 514-527

Girnita, A.L.; McCurry, K.R.; Yousem, S.A.; Pilewski, J.; Zeevi, A. 2006: Antibody-mediated rejection in lung transplantation: case reports. Clinical Transplants 2006: 508-510

Westall, G.P.; Snell, G.I. 2014: Antibody-mediated rejection in lung transplantation: fable, spin, or fact?. Transplantation 98(9): 927-930

Glanville, A.R. 2010: Antibody-mediated rejection in lung transplantation: myth or reality?. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 29(4): 395-400

Glanville, A.R. 2013: Antibody-mediated rejection in lung transplantation: turning myth into reality. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 32(1): 12-13

Markiewicz-Kijewska, M.łg.; Kaliciński, P.; Kluge, P.ła.; Piątosa, B.; Rękawek, A.; Jankowska, I.; Kostecka, E.; Kurowski, P.ła.N. 2014: Antibody-mediated rejection in pediatric liver transplant recipients. Annals of Transplantation 19: 119-123

Racusen, L.C.; Haas, M. 2006: Antibody-mediated rejection in renal allografts: lessons from pathology. Clinical Journal of the American Society of Nephrology: Cjasn 1(3): 415-420

Biancone, L. 2008: Antibody-mediated rejection in renal transplant: where are we now?. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 25(3): 270

Hübscher, S.G. 2012: Antibody-mediated rejection in the liver allograft. Current Opinion in Organ Transplantation 17(3): 280-286

Splith, K.; Fellmer, P.; Matia, I.; Varga, M.; Oliverius, M.; Kuhn, S.; Feldbrügge, L.; Krenzien, F.; Hau, H.-M.; Wiltberger, G.; Schmelzle, M.; Jonas, S. 2014: Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats. Plos one 9(3): E91212

Barth, R.N.; Campos, L.; Kukuruga, D.L.; Drachenberg, C.; Philosophe, B. 2010: Antibody-mediated rejection of renal allograft in combined liver-kidney transplant. Clinical Transplantation 24(5): 685-690

Berry, G.J. 2012: Antibody-mediated rejection of the cardiac allograft: where do we stand in 2012?. Current Opinion in Organ Transplantation 17(3): 303-308

Lindley, K.J.; Ravichandran, A.K.; Schilling, J.; Joseph, S.M. 2012: Antibody-mediated rejection of the heart in the setting of autoimmune demyelinating polyneuropathy: a case report and review of the literature. Case Reports in Cardiology 2012: 639284

Torrealba, J.R.; Odorico, J. 2009: Antibody-mediated rejection of the pancreas allograft. Transplantation 88(2): 292-293

Swarnalatha, G.; Ram, R.; Santosh Pai, B.H.; Ramesh, V.; Dakshinamurty, K.V. 2011: Antibody-mediated rejection presenting as allograft hydronephrosis. International Urology and Nephrology 43(4): 1255-1256

Sis, B.; Grynoch, R.; Murray, A.G.; Campbell, P.; Solez, K. 2008: Antibody-mediated rejection with a striking interstitial monocyte/macrophage infiltration in a renal allograft under FTY720 treatment. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 51(1): 127-130

Angelini, A.; Castellani, C.; Poli, F.; Benazzi, E.; Torregrossa, G.; Tona, F.; Gambino, A.; Caforio, A.P.; Feltrin, G.; Toscano, G.; Valente, M.; Thiene, G.; Gerosa, G. 2008: Antibody-mediated rejection without acute graft dysfunction in adult ABO-compatible heart transplantation: a case of accommodation. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 27(12): 1357-1360

Tanabe, K.; Ishida, H.; Omoto, K.; Shimizu, T.; Shirakawa, H. 2006: Antibody-mediated rejection: a single center experience at Tokyo Women's Medical University. Clinical Transplants 2006: 363-369

Arias, M.; Rush, D.N.; Wiebe, C.; Gibson, I.W.; Blydt-Hansen, T.D.; Nickerson, P.W.; Sellarés, J.; López-Hoyos, M.; San Segundo, D.; Crespo-Leiro, M.ía.G.; Marzoa-Rivas, R.; Barge-Caballero, E.; Paniagua-Martín, M.ía.J.; Román, A.; Serón, D.; Böhmig, G.; Schwaiger, E. 2014: Antibody-mediated rejection: analyzing the risk, proposing solutions. Transplantation 98(Suppl 3): S3-21

Baldwin, W.M.; Valujskikh, A.; Fairchild, R.L. 2010: Antibody-mediated rejection: emergence of animal models to answer clinical questions. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 10(5): 1135-1142

Khan, T.T.; Mirza, A.B.; Zahid, R.; Haleem, A.; Al Hussaini, H.; Al Sulaiman, M.; Mousa, D. 2011: Antibody-mediated rejection: importance of lactate dehydrogenase and neutrophilia in early diagnosis. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 22(3): 525-530

Singh, N.; Pirsch, J.; Samaniego, M. 2009: Antibody-mediated rejection: treatment alternatives and outcomes. Transplantation Reviews 23(1): 34-46

Wan, R.; Ying, W.; Zeng, L.; Deng, X.; Chen, H.; Gao, L. 2011: Antibody-mediated response in rat liver chronic rejection. Transplantation Proceedings 43(5): 1976-1979

Li, Y.; Smith, D.; Li, Q.; Sheibani, N.; Huang, S.; Kern, T.; Nagaraj, R.H.; Lin, F. 2012: Antibody-mediated retinal pericyte injury: implications for diabetic retinopathy. Investigative Ophthalmology and Visual Science 53(9): 5520-5526

Geronimo, C.Lay.A.; MacCuspie, R.I. 2011: Antibody-mediated self-limiting self-assembly for quantitative analysis of nanoparticle surfaces by atomic force microscopy. Microscopy and Microanalysis: the Official Journal of Microscopy Society of America Microbeam Analysis Society Microscopical Society of Canada 17(2): 206-214

Bilyy, R.; Tomin, A.; Mahorivska, I.; Shalay, O.; Lohinskyy, V.; Stoika, R.; Kit, Y. 2011: Antibody-mediated sialidase activity in blood serum of patients with multiple myeloma. Journal of Molecular Recognition: Jmr 24(4): 576-584

Brase, J.C.; Mannsperger, H.; Sültmann, H.; Korf, U. 2011: Antibody-mediated signal amplification for reverse phase protein array-based protein quantification. Methods in Molecular Biology 785: 55-64

Holzer, F.Josef.; Rossetti, A.O.; Heritier-Barras, A-Chantal.; Zumsteg, D.; Roebling, R.; Huber, R.; Lerche, H.; Kiphuth, I.C.; Bardutzky, Jürgen.; Bien, C.G.; Tröger, M.; Schoch, G.; Prüss, H.; Seeck, M. 2012: Antibody-mediated status epilepticus: a retrospective multicenter survey. European Neurology 68(5): 310-317

Zhong, L.; Haynes, L.; Struble, E.B.; Tamin, A.; Virata-Theimer, M.L.; Zhang, P. 2009: Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein. Biochemical and Biophysical Research Communications 390(3): 1056-1060

Cao, H.; Zhang, G-Rong.; Geller, A.I. 2010: Antibody-mediated targeted gene transfer to NMDA NR1-containing neurons in rat neocortex by helper virus-free HSV-1 vector particles containing a chimeric HSV-1 glycoprotein C-staphylococcus A protein. Brain Research 1351: 1-12

Xia, C.-F.; Boado, R.J.; Pardridge, W.M. 2009: Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology. Molecular Pharmaceutics 6(3): 747-751

Cox, J.H.; Hussell, S.; Søndergaard, H.; Roepstorff, K.; Bui, J.-V.; Deer, J.R.; Zhang, J.; Li, Z.-G.; Lamberth, K.; Kvist, P.H.; Padkjær, S.ør.; Haase, C.; Zahn, S.; Odegard, V.H. 2013: Antibody-mediated targeting of the Orai1 calcium channel inhibits T cell function. Plos one 8(12): E82944

Lund, I.K.; Jögi, A.; Rønø, B.; Rasch, M.G.; Lund, L.R.; Almholt, K.; Gårdsvoll, H.; Behrendt, N.; Rømer, J.; Høyer-Hansen, G. 2008: Antibody-mediated targeting of the urokinase-type plasminogen activator proteolytic function neutralizes fibrinolysis in vivo. Journal of Biological Chemistry 283(47): 32506-32515

Nguan, C. 2013: Antibody-mediated vascular rejection of kidney allografts: a population-based study. Urology 82(3): 503-504

Nankivell, B.J. 2013: Antibody-mediated vascular rejection: relation to causation. Lancet 381(9863): 275-277

Pierson, R.N. 2009: Antibody-mediated xenograft injury: mechanisms and protective strategies. Transplant Immunology 21(2): 65-69

Newa, M.; Bhandari, K.H.; Tang, L.; Kalvapalle, R.; Suresh, M.; Doschak, M.R. 2011: Antibody-mediated "universal" osteoclast targeting platform using calcitonin as a model drug. Pharmaceutical Research 28(5): 1131-1143

Yu, B.; Wages, J.M.; Larrick, J.W. 2014: Antibody-membrane switch (AMS) technology for facile cell line development. Protein Engineering Design and Selection: Peds 27(10): 309-315

Zhou, X.; Zhou, J. 2007: Antibody-microarrays on hybrid polymeric thin film-coated slides for multiple-protein immunoassays. Methods in Molecular Biology 382: 259-271

Olivier, G.K.; Cho, A.; Sanii, B.; Connolly, M.D.; Tran, H.; Zuckermann, R.N. 2013: Antibody-mimetic peptoid nanosheets for molecular recognition. Acs Nano 7(10): 9276-9286

Maus, M.V.; Grupp, S.A.; Porter, D.L.; June, C.H. 2014: Antibody-modified T cells: CARs take the front seat for hematologic malignancies. Blood 123(17): 2625-2635

Okamoto, A.; Asai, T.; Kato, H.; Ando, H.; Minamino, T.; Mekada, E.; Oku, N. 2014: Antibody-modified lipid nanoparticles for selective delivery of siRNA to tumors expressing membrane-anchored form of HB-EGF. Biochemical and Biophysical Research Communications 449(4): 460-465

Torchilin, V. 2008: Antibody-modified liposomes for cancer chemotherapy. Expert Opinion on Drug Delivery 5(9): 1003-1025

Blackburn, D.; Highley, J.R.; Wharton, S.; Romanowski, C.; Bowen, J.; Sharrack, B. 2009: Antibody-negative neuromyelitis optica with heavy B-cell infiltration. Apmis: Acta Pathologica Microbiologica et Immunologica Scandinavica 117(10): 768-772

Donati, M.; Di Francesco, A.; Delucca, F.; Di Paolo, M.; Battilani, M.; Balboni, A.; Baldelli, R.; Cevenini, R. 2011: Antibody-neutralizing activity against all urogenital Chlamydia trachomatis serovars in Chlamydia suis-infected pigs. Fems Immunology and Medical Microbiology 61(1): 125-128

Rybak, S.M. 2008: Antibody-onconase conjugates: cytotoxicity and intracellular routing. Current Pharmaceutical Biotechnology 9(3): 226-230

Evoli, A. 2008: Antibody-phenotype correlation in stiff-person syndrome. Neurology 71(24): 1938-1939

Burbelo, P.D.; Ching, K.H.; Bush, E.R.; Han, B.L.; Iadarola, M.J. 2010: Antibody-profiling technologies for studying humoral responses to infectious agents. Expert Review of Vaccines 9(6): 567-578

Jin, T.; Tiwari, D.K.; Tanaka, S.-I.; Inouye, Y.; Yoshizawa, K.; Watanabe, T.M. 2010: Antibody-protein a conjugated quantum dots for multiplexed imaging of surface receptors in living cells. Molecular Biosystems 6(11): 2325-2331

Steiner, M.; Neri, D. 2011: Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(20): 6406-6416

Duquesnoy, R.J. 2011: Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications. Tissue Antigens 77(6): 525-534

McEnaney, P.J.; Parker, C.G.; Zhang, A.X.; Spiegel, D.A. 2012: Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease. Acs Chemical Biology 7(7): 1139-1151

Tanaka, K. 2010: Antibody-related neuroimmunological disorders: update on the diagnosis and treatment. Rinsho Shinkeigaku 50(11): 813-815

Doria-Rose, N.A.; Connors, M. 2009: Antibody-secreting B cells in HIV infection. Current Opinion in HIV and Aids 4(5): 426-430

Rahman, A.; Rashu, R.; Bhuiyan, T.R.; Chowdhury, F.; Khan, A.I.; Islam, K.; LaRocque, R.C.; Ryan, E.T.; Wrammert, J.; Calderwood, S.B.; Qadri, F.; Harris, J.B. 2013: Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh. Clinical and Vaccine Immunology: Cvi 20(10): 1592-1598

Maier-Moore, J.S.; Koelsch, K.A.; Smith, K.; Lessard, C.J.; Radfar, L.; Lewis, D.; Kurien, B.T.; Wolska, N.; Deshmukh, U.; Rasmussen, A.; Sivils, K.L.; James, J.A.; Farris, A.Darise.; Scofield, R.Hal. 2014: Antibody-secreting cell specificity in labial salivary glands reflects the clinical presentation and serology in patients with Sjögren's syndrome. Arthritis and Rheumatology 66(12): 3445-3456

Yoshida, Y.; Horii, K.; Sakai, N.; Masuda, H.; Furuichi, M.; Waga, I. 2009: Antibody-specific aptamer-based PCR analysis for sensitive protein detection. Analytical and Bioanalytical Chemistry 395(4): 1089-1096

Katzav, A.; Ben-Ziv, T.; Blank, M.; Pick, C.G.; Shoenfeld, Y.; Chapman, J. 2014: Antibody-specific behavioral effects: intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice. Journal of Neuroimmunology 272(1-2): 10-15

Li, Y.; Wang, H.; Oosterwijk, E.; Selman, Y.; Mira, J.C.; Medrano, T.; Shiverick, K.T.; Frost, S.C. 2009: Antibody-specific detection of CAIX in breast and prostate cancers. Biochemical and Biophysical Research Communications 386(3): 488-492

Zhao, L.; Wong, L.; Li, J. 2011: Antibody-specified B-cell epitope prediction in line with the principle of context-awareness. Ieee/Acm Transactions on Computational Biology and Bioinformatics 8(6): 1483-1494

Tsuji, T.; Matsuzaki, J.; Kelly, M.P.; Ramakrishna, V.; Vitale, L.; He, L.-Z.; Keler, T.; Odunsi, K.; Old, L.J.; Ritter, G.; Gnjatic, S. 2011: Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity. Journal of Immunology 186(2): 1218-1227

Dalmazzo, L.F.F.; Santana-Lemos, B.ár.A.; Jácomo, R.H.; Garcia, A.B.; Rego, E.M.; da Fonseca, L.M.; Falcão, R.P. 2011: Antibody-targeted horseradish peroxidase associated with indole-3-acetic acid induces apoptosis in vitro in hematological malignancies. Leukemia Research 35(5): 657-662

Gao, J.; Chen, H.; Song, H.; Su, X.; Niu, F.; Li, W.; Li, B.; Dai, J.; Wang, H.; Guo, Y. 2013: Antibody-targeted immunoliposomes for cancer treatment. Mini Reviews in Medicinal Chemistry 13(14): 2026-2035

Sofou, S.; Sgouros, G. 2008: Antibody-targeted liposomes in cancer therapy and imaging. Expert Opinion on Drug Delivery 5(2): 189-204

Fay, F.; Scott, C.J. 2011: Antibody-targeted nanoparticles for cancer therapy. ImmunoTherapy 3(3): 381-394

Sharpe, M.A.; Marcano, D.C.; Berlin, J.M.; Widmayer, M.A.; Baskin, D.S.; Tour, J.M. 2012: Antibody-targeted nanovectors for the treatment of brain cancers. Acs Nano 6(4): 3114-3120

Kaur, P.; Qiang-Fu; Fuhrmann, A.; Ros, R.; Kutner, L.O.; Schneeweis, L.A.; Navoa, R.; Steger, K.; Xie, L.; Yonan, C.; Abraham, R.; Grace, M.J.; Lindsay, S. 2011: Antibody-unfolding and metastable-state binding in force spectroscopy and recognition imaging. Biophysical Journal 100(1): 243-250

Nishida, Y.; Aida, K.; Kihara, M.; Kobayashi, T. 2014: Antibody-validated proteins in inflamed islets of fulminant type 1 diabetes profiled by laser-capture microdissection followed by mass spectrometry. Plos one 9(10): E107664

Cottingham, K. 2008: Antibodypedia seeks to answer the question: "how good is that antibody?". Journal of Proteome Research 7(10): 4213

Björling, E.; Uhlén, M. 2008: Antibodypedia, a portal for sharing antibody and antigen validation data. Molecular and Cellular Proteomics: Mcp 7(10): 2028-2037

Wang, S-Guang.; Qiu, Y-Xiang.; Schwarz, W.H.Eugen. 2010: Antibond breaking--the formation and decomposition of He@adamantane: descriptions, explanations, and meaning of concepts. Chemistry 16(30): 9107-9116

Doty, M.F.; Climente, J.I.; Korkusinski, M.; Scheibner, M.; Bracker, A.S.; Hawrylak, P.; Gammon, D. 2009: Antibonding ground states in InAs quantum-dot molecules. Physical Review Letters 102(4): 047401

Grzelczak, M.; Mezzasalma, S.A.; Ni, W.; Herasimenka, Y.; Feruglio, L.; Montini, T.; Pérez-Juste, J.; Fornasiero, P.; Prato, M.; Liz-Marzán, L.M. 2012: Antibonding plasmon modes in colloidal gold nanorod clusters. Langmuir: the Acs Journal of Surfaces and Colloids 28(24): 8826-8833

Zeng, W.-C.; Jia, L.-R.; Zhang, Y.; Cen, J.-Q.; Chen, X.; Gao, H.; Feng, S.; Huang, Y.-N. 2011: Antibrowning and antimicrobial activities of the water-soluble extract from pine needles of Cedrus deodara. Journal of Food Science 76(2): C318-C323

Fan, X.; Sokorai, K.J.B.; Liao, C.-H.; Cooke, P.; Zhang, H.Q. 2009: Antibrowning and antimicrobial properties of sodium acid sulfate in apple slices. Journal of Food Science 74(9): M485-M492

Zocca, F.; Lomolino, G.; Lante, A. 2010: Antibrowning potential of Brassicacaea processing water. Bioresource Technology 101(10): 3791-3795

Scheid, B.; Dorbolo, S.ép.; Arriaga, L.R.; Rio, E. 2012: Antibubble dynamics: the drainage of an air film with viscous interfaces. Physical Review Letters 109(26): 264502

Allahbadia, G.N.; Gandhi, G.; Kadam, K.; Arora, S.; Awasthi, A.; Nagwekar, A.; Allahbadia, S.; Wolman, I. 2008: Antibubble trajectory during embryo transfers in donor egg IVF does not predict success. Reproductive Biomedicine Online 16(6): 881-885

Ryan, W.; Smith, J.David. 2009: Antibullying programs in schools: how effective are evaluation practices?. Prevention Science: the Official Journal of the Society for Prevention Research 10(3): 248-259

Egues, A.L.; Leinung, E.Z. 2014: Antibullying workshops: shaping minority nursing leaders through curriculum innovation. Nursing Forum 49(4): 240-246

Huang, Y.-P.; Kumar, P. 2012: Antibunched emission of photon pairs via quantum Zeno blockade. Physical Review Letters 108(3): 030502

Carmele, A.; Richter, M.; Chow, W.W.; Knorr, A. 2010: Antibunching of thermal radiation by a room-temperature phonon bath: a numerically solvable model for a strongly interacting light-matter-reservoir system. Physical Review Letters 104(15): 156801

Yuan, C.T.; Yu, P.; Ko, H.C.; Huang, J.; Tang, J. 2009: Antibunching single-photon emission and blinking suppression of CdSe/ZnS quantum dots. Acs Nano 3(10): 3051-3056

Woods, D. 1982: Antibusiness attitudes strangling drug research. Canadian Medical Association Journal 127(7): 559

Thiene, G.; Valente, M. 2011: Anticalcification strategies to increase bioprosthetic valve durability. Journal of Heart Valve Disease 20(1): 37-44

Tulunay Kaya, C.; Sinan Ertas, F.; Hasan, T.; Candemir, B.; Ozdol, C.; Arikan Akan, O.; Kocum, T.; Dincer, I.; Sahin, M.; Atmaca, Y.; Conkbayır, C.; Erol, C. 2011: Anticalcifying nanoparticle antibody titer is an independent risk factor for coronary artery calcification. Coronary Artery Disease 22(6): 394-400

Schiff, T. 2007: Anticalculus effect of a cetylpyridinium chloride/zinc gluconate mucoadhesive gel: results of a randomized, double-blind, controlled clinical trial. Journal of Clinical Dentistry 18(3): 79-81

Grases, F.; Perelló, J.; Sanchis, P.; Isern, B.; Prieto, R.M.; Costa-Bauzá, A.; Santiago, C.; Ferragut, M.L.; Frontera, G. 2009: Anticalculus effect of a triclosan mouthwash containing phytate: a double-blind, randomized, three-period crossover trial. Journal of Periodontal Research 44(5): 616-621

Llena, C.; Forner, L.; Vento, C. 2009: Anticalculus efficacy of a new dentifrice. Quintessence International 40(6): 497-501

Skerra, A. 2007: Anticalins as alternative binding proteins for therapeutic use. Current Opinion in Molecular Therapeutics 9(4): 336-344

Gebauer, M.; Skerra, A. 2012: Anticalins small engineered binding proteins based on the lipocalin scaffold. Methods in Enzymology 503: 157-188

Richter, A.; Eggenstein, E.; Skerra, A. 2014: Anticalins: exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins. Febs Letters 588(2): 213-218

Hohlbaum, A.M.; Skerra, A. 2007: Anticalins: the lipocalin family as a novel protein scaffold for the development of next-generation immunotherapies. Expert Review of Clinical Immunology 3(4): 491-501

Schimler, S.D.; Hall, D.J.; Debbert, S.L. 2013: Anticancer (hexacarbonyldicobalt)propargyl aryl ethers: synthesis, antiproliferative activity, apoptosis induction, and effect on cellular oxidative stress. Journal of Inorganic Biochemistry 119: 28-37

Chinthala, Y.; Chinde, S.; Kumar, A.N.; Srinivas, K.V.N.S.; Kumar, J.K.; Sastry, K.P.; Grover, P.; Ramana, M.V. 2014: Anticancer Active Homoisoflavone from the Underground Bulbs of Ledebouria hyderabadensis. Pharmacognosy Research 6(4): 303-305

Medvetz, D.A.; Hindi, K.M.; Panzner, M.J.; Ditto, A.J.; Yun, Y.H.; Youngs, W.J. 2008: Anticancer Activity of Ag(I) N-Heterocyclic Carbene Complexes Derived from 4,5-Dichloro-1H-Imidazole. Metal-Based Drugs 2008: 384010

Berrington, D.; Lall, N. 2012: Anticancer Activity of Certain Herbs and Spices on the Cervical Epithelial Carcinoma (HeLa) Cell Line. Evidence-Based Complementary and Alternative Medicine: Ecam 2012: 564927

Amjadi, I.; Rabiee, M.; Hosseini, M-Sadat. 2013: Anticancer Activity of Nanoparticles Based on PLGA and its Co-polymer: In-vitro Evaluation. Iranian Journal of Pharmaceutical Research: Ijpr 12(4): 623-634

Wyrębska, A.; Gach, K.; Lewandowska, U.; Szewczyk, K.; Hrabec, E.żb.; Modranka, J.; Jakubowski, R.ł; Janecki, T.; Szymański, J.; Janecka, A. 2013: Anticancer Activity of new Synthetic α-Methylene-δ-Lactones on two Breast Cancer Cell Lines. Basic and Clinical Pharmacology and Toxicology 113(6): 391-400

Jo, S.-K.; Hong, J.-Y.; Park, H.J.; Lee, S.K. 2012: Anticancer Activity of Novel Daphnane Diterpenoids from Daphne genkwa through Cell-Cycle Arrest and Suppression of Akt/STAT/Src Signalings in Human Lung Cancer Cells. Biomolecules and Therapeutics 20(6): 513-519

Mishra, A.; Jung, H.; Park, J.W.; Kim, H.K.; Kim, H.; Stang, P.J.; Chi, K.-W. 2012: Anticancer Activity of Self-Assembled Molecular Rectangles via Arene-Ruthenium Acceptors and a new Unsymmetrical Amide Ligand. Organometallics 31(9): 3519-3526

Cutillas, N.; Martínez, A.; Yellol, G.S.; Rodríguez, V.; Zamora, A.; Pedreño, M.ón.; Donaire, A.; Janiak, C.; Ruiz, J.é 2013: Anticancer C,N-cycloplatinated(II) complexes containing fluorinated phosphine ligands: synthesis, structural characterization, and biological activity. Inorganic Chemistry 52(23): 13529-13535

Rosselet, A. 1948: Anticancer Centre Romand of the townships of Fribourg, Neuchatel, Valais and Vaud; report for the year 1947. Bulletin. Switzerland. Eidgenossisches Gesundheitsamt 48(38): Unknown

Gehdoo, R.P. 2009: Anticancer Chemotherapy and it's Anaesthetic Implications (Current Concepts). Indian Journal of Anaesthesia 53(1): 18-29

Hwang, T.; Han, H.D.; Song, C.K.; Seong, H.; Kim, J.H.; Chen, X.; Shin, B.C. 2007: Anticancer Drug-Phospholipid Conjugate for Enhancement of Intracellular Drug Delivery. Macromolecular Symposia: 249-250(1): 109-115

Viral, D.; Shivanand, P.; Jivani, N. 2011: Anticancer Evaluation of Adiantum venustum Don. Journal of Young Pharmacists: Jyp 3(1): 48-54

Mishra, T.; Khullar, M.; Bhatia, A. 2011: Anticancer Potential of Aqueous Ethanol Seed Extract of Ziziphus mauritiana against Cancer Cell Lines and Ehrlich Ascites Carcinoma. Evidence-Based Complementary and Alternative Medicine: Ecam 2011

Paul, S.; Bhattacharyya, S.Sundar.; Boujedaini, N.; Khuda-Bukhsh, A.Rahman. 2011: Anticancer Potentials of Root Extract of Polygala senega and Its PLGA Nanoparticles-Encapsulated Form. Evidence-BasedComplementaryandAlternativeMedicine:Ecam 2011

Parson, C.; Smith, V.; Krauss, C.; Banerjee, H.N.; Reilly, C.; Krause, J.A.; Wachira, J.M.; Giri, D.; Winstead, A.; Mandal, S.K. 2015: Anticancer Properties of Novel Rhenium Pentylcarbanato Compounds against MDA-MB-468(HTB-132) Triple Node Negative Human Breast Cancer Cell Lines. British Journal of Pharmaceutical Research 4(3): 362-367

Grabacka, M.; Reiss, K. 2008: Anticancer Properties of PPARalpha-Effects on Cellular Metabolism and Inflammation. PPAR research 2008: 930705

Simpson-Haidaris, P.J.; Pollock, S.J.; Ramon, S.; Guo, N.; Woeller, C.F.; Feldon, S.E.; Phipps, R.P. 2010: Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes. Ppar Research 2010: 814609

Qamar, S.; Carrasquer, C.A.; Cunningham, S.L.; Cunningham, A.R. 2011: Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines. Anticancer Research 31(10): 3247-3252

Raj, G.G.; Varghese, H.S.; Kotagiri, S.; Vrushabendra Swamy, B.M.; Swamy, A.; Pathan, R.K. 2014: Anticancer Studies of Aqueous Extract of Roots and Leaves of Pandanus Odoratissimus f. ferreus (Y. Kimura) Hatus: An in Vitro Approach. Journal of Traditional and Complementary Medicine 4(4): 279-284

Lu, Y.; Wang, Q.; Yi, Q. 2014: Anticancer Tc9 cells: Long-lived tumor-killing T cells for adoptive therapy. Oncoimmunology 3: E28542

Ahmad, A.; Sarkar, S.H.; Aboukameel, A.; Ali, S.; Biersack, B.; Seibt, S.; Li, Y.; Bao, B.; Kong, D.; Banerjee, S.; Schobert, R.; Padhye, S.B.; Sarkar, F.H. 2012: Anticancer action of garcinol in vitro and in vivo is in part mediated through inhibition of STAT-3 signaling. Carcinogenesis 33(12): 2450-2456

Han, S.Wei.; Roman, J. 2010: Anticancer actions of PPARγ ligands: Current state and future perspectives in human lung cancer. World Journal of Biological Chemistry 1(3): 31

Yu, W.; Jia, L.; Park, S.-K.; Li, J.; Gopalan, A.; Simmons-Menchaca, M.; Sanders, B.G.; Kline, K. 2009: Anticancer actions of natural and synthetic vitamin e forms: RRR-alpha-tocopherol blocks the anticancer actions of gamma-tocopherol. Molecular Nutrition and Food Research 53(12): 1573-1581

Wendel, M.; Heller, A.R. 2009: Anticancer actions of omega-3 fatty acids--current state and future perspectives. Anti-Cancer Agents in Medicinal Chemistry 9(4): 457-470

Plengsuriyakarn, T.; Viyanant, V.; Eursitthichai, V.; Picha, P.; Kupradinun, P.; Itharat, A.; Na-Bangchang, K. 2012: Anticancer activities against cholangiocarcinoma, toxicity and pharmacological activities of Thai medicinal plants in animal models. Bmc Complementary and Alternative Medicine 12: 23

De Pace, R.C.C.; Liu, X.; Sun, M.; Nie, S.; Zhang, J.; Cai, Q.; Gao, W.; Pan, X.; Fan, Z.; Wang, S. 2013: Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells. Journal of Liposome Research 23(3): 187-196

Khan, M.A.; Chen, H.-c.; Tania, M.; Zhang, D.-z. 2011: Anticancer activities of Nigella sativa (black cumin). African Journal of Traditional Complementary and Alternative Medicines: Ajtcam 8(5 Suppl): 226-232

Dong, J-Tang. 2013: Anticancer activities of PPARγ in breast cancer are context-dependent. American journal of pathology 182(6): 1972-1975

Shinohara, K.-I.; Bando, T.; Sugiyama, H. 2010: Anticancer activities of alkylating pyrrole-imidazole polyamides with specific sequence recognition. Anti-Cancer Drugs 21(3): 228-242

Hui, C.; Bin, Y.; Xiaoping, Y.; Long, Y.; Chunye, C.; Mantian, M.; Wenhua, L. 2010: Anticancer activities of an anthocyanin-rich extract from black rice against breast cancer cells in vitro and in vivo. Nutrition and Cancer 62(8): 1128-1136

Hsiao, Y.-C.; Wang, K.-S.; Tsai, S.-H.; Chao, W.-T.; Lung, F.-D.T. 2013: Anticancer activities of an antimicrobial peptide derivative of Ixosin-B amide. Bioorganic and Medicinal Chemistry Letters 23(20): 5744-5747

Huang, C.; Zhu, Y.; Jiang, Y.; Li, Z.; Yao, J.; Duan, G.; Li, D.; Wang, Q. 2013: Anticancer activities of anti-membrane antibodies against colon carcinoma cells undergoing chemotherapy. Tumori 99(1): 113-120

Firestone, G.L.; Sundar, S.N. 2009: Anticancer activities of artemisinin and its bioactive derivatives. Expert Reviews in Molecular Medicine 11: E32

Wang, L.; Wang, J.; Fang, L.; Zheng, Z.; Zhi, D.; Wang, S.; Li, S.; Ho, C.-T.; Zhao, H. 2014: Anticancer activities of citrus peel polymethoxyflavones related to angiogenesis and others. Biomed Research International 2014: 453972

Wang, T.; Yuan, Y.; Wang, J.; Han, C.; Chen, G. 2012: Anticancer activities of constituents from the stem of Polyalthia rumphii. Pakistan Journal of Pharmaceutical Sciences 25(2): 353-356

Neto, C.C.; Amoroso, J.W.; Liberty, A.M. 2008: Anticancer activities of cranberry phytochemicals: an update. Molecular Nutrition and Food Research 52 Suppl. 1: S18-S27

Wang, W.; Zhang, B.; Chen, H.; Zhang, L. 2010: Anticancer activities of curcumin on human hepatocarcinoma cell line Sk-hep-1. Zhongguo Zhong Yao Za Zhi 35(4): 485-488

Lesgards, J-François.; Baldovini, N.; Vidal, N.; Pietri, S. 2014: Anticancer activities of essential oils constituents and synergy with conventional therapies: a review. Phytotherapy research: PTR 28(10): 1423-1446

Hörmann, V.; Kumi-Diaka, J.; Durity, M.; Rathinavelu, A. 2012: Anticancer activities of genistein-topotecan combination in prostate cancer cells. Journal of Cellular and Molecular Medicine 16(11): 2631-2636

Huang, W.-H.; Shao, L.; Wang, C.-Z.; Yuan, C.-S.; Zhou, H.-H. 2014: Anticancer activities of polyynes from the root bark of Oplopanax horridus and their acetylated derivatives. Molecules 19(5): 6142-6162

Nikhil, K.; Sharan, S.; Singh, A.K.; Chakraborty, A.; Roy, P. 2014: Anticancer activities of pterostilbene-isothiocyanate conjugate in breast cancer cells: involvement of PPARγ. PloS one 9(8): e104592

Shrestha, G.; El-Naggar, A.M.; St Clair, L.L.; O'Neill, K.L. 2015: Anticancer activities of selected species of North American lichen extracts. Phytotherapy research: PTR 29(1): 100-107

Ma, G.; Chong, L.; Li, Z.; Cheung, A.H.T.; Tattersall, M.H.N. 2009: Anticancer activities of sesquiterpene lactones from Cyathocline purpurea in vitro. Cancer ChemoTherapy and Pharmacology 64(1): 143-152

Kuete, V.; Wabo, H.K.; Eyong, K.O.; Feussi, M.T.; Wiench, B.; Krusche, B.; Tane, P.; Folefoc, G.N.; Efferth, T. 2011: Anticancer activities of six selected natural compounds of some Cameroonian medicinal plants. Plos one 6(8): E21762

Du, J.; Guo, Y.; Bao, Y.; Xing, M.; Mahmoud, A.M.; Che, Z.; Chen, Z.; Yang, W. 2014: Anticancer activities of sulindac in prostate cancer cells associated with c-Jun NH2-terminal kinase 1/β-catenin signaling. Oncology Letters 8(1): 313-316

Ma, H.; Fan, Q.; Yu, J.; Xin, J.; Zhang, C. 2013: Anticancer activities of tanshinone microemulsion against hepatocellular carcinoma in vitro and in vivo. Molecular Medicine Reports 7(1): 59-64

Manosroi, A.; Jantrawut, P.; Sainakham, M.; Manosroi, W.; Manosroi, J. 2012: Anticancer activities of the extract from Longkong (Lansium domesticum) young fruits. Pharmaceutical Biology 50(11): 1397-1407

Srivastava, R.S.; Fronczek, F.R.; Perkins, R.S.; Fukuyama, T.; Xu, W. 2010: Anticancer activities of the ruthenium carboxylato, amido and pyridine complexes. International Journal of Oncology 36(6): 1591-1598

Norikura, T.; Fujiwara, K.; Narita, T.; Yamaguchi, S.; Morinaga, Y.; Iwai, K.; Matsue, H. 2011: Anticancer activities of thelephantin O and vialinin a isolated from Thelephora aurantiotincta. Journal of Agricultural and Food Chemistry 59(13): 6974-6979

Busto, N.; Valladolid, J.ús.; Martínez-Alonso, M.; Lozano, H.éc.J.; Jalón, F.él.A.; Manzano, B.R.; Rodríguez, A.M.; Carrión, M.C.; Biver, T.; Leal, J.é M.; Espino, G.; García, B.ña. 2013: Anticancer activity and DNA binding of a bifunctional Ru(II) arene aqua-complex with the 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine ligand. Inorganic Chemistry 52(17): 9962-9974

Zhu, T.; Wang, Y.; Ding, W.; Xu, J.; Chen, R.; Xie, J.; Zhu, W.; Jia, L.; Ma, T. 2015: Anticancer activity and DNA-binding investigations of the Cu(II) and Ni(II) complexes with coumarin derivative. Chemical Biology and Drug Design 85(3): 385-393

Jamshidi, M.; Yousefi, R.; Nabavizadeh, S.M.; Rashidi, M.; Haghighi, M.G.; Niazi, A.; Moosavi-Movahedi, A.-A. 2014: Anticancer activity and DNA-binding properties of novel cationic Pt(II) complexes. International Journal of Biological Macromolecules 66: 86-96

Mollah, M.L.; Song, J.-C.; Park, C.-H.; Lee, G.-D.; Hong, J.-H.; Ryoo, Z.Y.; Lee, S.; Chang, K.-T.; Kim, K.-S. 2009: Anticancer activity and apoptotic effects of Bulnesia sarmienti against human lung cancer H460 cells. Oncology Research 18(5-6): 259-267

Beckford, F.A.; Thessing, J.; Stott, A.; Holder, A.A.; Poluektov, O.G.; Li, L.; Seeram, N.P. 2012: Anticancer activity and biophysical reactivity of copper complexes of 2-(benzo[d][1,3]dioxol-5-ylmethylene)-N-alkylhydrazinecarbothioamides. Inorganic Chemistry Communications 15: 225-229

Caba, O.; Díaz-Gavilán, M.ón.; Rodríguez-Serrano, F.; Boulaiz, H.; Aránega, A.; Gallo, M.A.; Marchal, J.A.; Campos, J.ín.M. 2011: Anticancer activity and cDNA microarray studies of a (RS)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl]-6-chloro-9H-purine, and an acyclic (RS)-O,N-acetalic 6-chloro-7H-purine. European Journal of Medicinal Chemistry 46(9): 3802-3809

Boddupally, P.V.L.; Hahn, S.; Beman, C.; De, B.; Brooks, T.A.; Gokhale, V.; Hurley, L.H. 2012: Anticancer activity and cellular repression of c-MYC by the G-quadruplex-stabilizing 11-piperazinylquindoline is not dependent on direct targeting of the G-quadruplex in the c-MYC promoter. Journal of Medicinal Chemistry 55(13): 6076-6086

Click, R.E. 2013: Anticancer activity and chemoprevention of xenobiotic organosulfurs in preclinical model systems. Oncology Discovery 1(4)

Shin, H.C.; Song, D.W.; Baek, W.K.; Lee, S.R.; Kwon, T.K.; Lee, J.; Park, S.H.; Jang, B.-C.; Park, J.-W. 2009: Anticancer activity and differentially expressed genes in head and neck cancer cells treated with a novel cyclin-dependent kinase inhibitor. ChemoTherapy 55(5): 353-362

Zhang, W.; Liu, A.; Li, Y.; Zhao, X.; Lv, S.; Zhu, W.; Jin, Y. 2012: Anticancer activity and mechanism of juglone on human cervical carcinoma Hela cells. Canadian Journal of Physiology and Pharmacology 90(11): 1553-1558

Zhang, X.Y.; Lian Yan, X.; Guo, W.; Xu, B.; Li, M.; Zhou, Y.; Rong Cui, J. 2009: Anticancer activity and mechanisms of diacetyldianhydrogalactitol on hepatoma QGY-7703 cells. Anti-Cancer Drugs 20(10): 926-931

Olszewski, U.; Claffey, J.; Hogan, M.; Tacke, M.; Zeillinger, R.; Bednarski, P.J.; Hamilton, G. 2011: Anticancer activity and mode of action of titanocene C. Investigational new Drugs 29(4): 607-614

Guo, L.; Peng, Y.; Yao, J.; Sui, L.; Gu, A.; Wang, J. 2010: Anticancer activity and molecular mechanism of resveratrol-bovine serum albumin nanoparticles on subcutaneously implanted human primary ovarian carcinoma cells in nude mice. Cancer BioTherapy and Radiopharmaceuticals 25(4): 471-477

Mengesha, A.E.; Youan, B.-B.C. 2010: Anticancer activity and nutritional value of extracts of the seed of Glinus lotoides. Journal of Nutritional Science and Vitaminology 56(5): 311-318

Liu, S.; Zhang, J.; Li, D.; Liu, W.; Luo, X.; Zhang, R.; Li, L.; Zhao, J. 2007: Anticancer activity and quantitative analysis of flavone of Cirsium japonicum DC. Natural Product Research 21(10): 915-922

Pontiki, E.; Hadjipavlou-Litina, D.; Geromichalos, G.; Papageorgiou, A. 2009: Anticancer activity and quantitative-structure activity relationship (QSAR) studies of a series of antioxidant/anti-inflammatory aryl-acetic and hydroxamic acids. Chemical Biology and Drug Design 74(3): 266-275

Wang, L.; Zheng, C.; Liu, Y.; Le, F.; Yang, F.; Qin, X.; Wang, C.; Liu, J. 2014: Anticancer activity for targeting telomeric G-quadruplex and antiangiogenesis of a novel Ru(II)-Se complex. Biological Trace Element Research 157(2): 175-182

Liu, P.; Xu, S.; Zhang, M.; Wang, W.W.; Zhang, Y.F.; Rehman, K.; Naranmandura, H.; Chen, Z. 2013: Anticancer activity in human multiple myeloma U266 cells: synergy between cryptotanshinone and arsenic trioxide. Metallomics: Integrated Biometal Science 5(7): 871-878

Wang, O.; Liu, S.; Zou, J.; Lu, L.; Chen, L.; Qiu, S.; Li, H.; Lu, X. 2011: Anticancer activity of 2α, 3α, 19β, 23β-Tetrahydroxyurs-12-en-28-oic acid (THA), a novel triterpenoid isolated from Sinojackia sarcocarpa. Plos one 6(6): E21130

Ahmad, F.B.H.; Ghaffari Moghaddam, M.; Basri, M.; Abdul Rahman, M.B. 2010: Anticancer activity of 3-O-acylated betulinic acid derivatives obtained by enzymatic synthesis. Bioscience Biotechnology and Biochemistry 74(5): 1025-1029

Sakthivel, K.M.; Kannan, N.; Angeline, A.; Guruvayoorappan, C. 2012: Anticancer activity of Acacia nilotica (L.) Wild. Ex. Delile subsp. indica against Dalton's ascitic lymphoma induced solid and ascitic tumor model. Asian Pacific Journal of Cancer Prevention: Apjcp 13(8): 3989-3995

Wang, H.-Q.; Li, D.-L.; Lu, Y.-J.; Cui, X.-X.; Zhou, X.-F.; Lin, W.-P.; Conney, A.H.; Zhang, K.; Du, Z.-Y.; Zheng, X. 2014: Anticancer activity of Acanthopanax trifoliatus (L) Merr extracts is associated with inhibition of NF-kB activity and decreased Erk1/2 and Akt phosphorylation. Asian Pacific Journal of Cancer Prevention: Apjcp 15(21): 9341-9346

Jiao, C.; Xie, Y.-Z.; Yang, X.; Li, H.; Li, X.-M.; Pan, H.-H.; Cai, M.-H.; Zhong, H.-M.; Yang, B.B. 2013: Anticancer activity of Amauroderma rude. Plos one 8(6): E66504

Pai, K.S.R.; Srilatha, P.; Suryakant, K.; Setty, M.M.; Nayak, P.G.; Rao, C.M.; Baliga, M.S. 2012: Anticancer activity of Berberis aristata in Ehrlich ascites carcinoma-bearing mice: a preliminary study. Pharmaceutical Biology 50(3): 270-277

Drygin, D.; Siddiqui-Jain, A.; O'Brien, S.; Schwaebe, M.; Lin, A.; Bliesath, J.; Ho, C.B.; Proffitt, C.; Trent, K.; Whitten, J.P.; Lim, J.K.C.; Von Hoff, D.; Anderes, K.; Rice, W.G. 2009: Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. Cancer Research 69(19): 7653-7661

Raja, S.M.; Clubb, R.J.; Ortega-Cava, C.; Williams, S.H.; Bailey, T.A.; Duan, L.; Zhao, X.; Reddi, A.L.; Nyong, A.M.; Natarajan, A.; Band, V.; Band, H. 2011: Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers. Cancer Biology and Therapy 11(2): 263-276

Thavamani, B.S.; Mathew, M.; Palaniswamy, D.S. 2014: Anticancer activity of Cocculus hirsutus against Dalton's lymphoma ascites (DLA) cells in mice. Pharmaceutical Biology 52(7): 867-872

Lee, J.H.; Kim, I.-W.; Kim, S.-H.; Yun, E.-Y.; Nam, S.-H.; Ahn, M.-Y.; Kang, D.-C.; Hwang, J.S. 2015: Anticancer activity of CopA3 dimer peptide in human gastric cancer cells. Bmb Reports 48(6): 324-329

Geng, D.; Duan, Y.-L.; Xu, X.-L.; Wang, C.-M.; Cui, X.-D.; Ouyang, Z.; Chen, B. 2012: Anticancer activity of Crocodylus siamensis blood in vitro and in vivo. Zhong Yao Cai 35(12): 1901-1904

Mayakrishnan, V.; Kannappan, P.; Shanmugasundaram, K.; Abdullah, N. 2014: Anticancer activity of Cyathula prostrata (Linn) Blume against Dalton's lymphomae in mice model. Pakistan Journal of Pharmaceutical Sciences 27(6): 1911-1917

Salem, T.A.; Ibrahim, A.M. 2011: Anticancer activity of Egyptian marine alga Ulva rigida. International Journal of Health Sciences 5(2 Suppl 1: 6-8

Van Meeteren, L.A.; Brinkmann, V.; Saulnier-Blache, J.S.éb.; Lynch, K.R.; Moolenaar, W.H. 2008: Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D. Cancer Letters 266(2): 203-208

Sankar, R.; Maheswari, R.; Karthik, S.; Shivashangari, K.Subramanian.; Ravikumar, V. 2014: Anticancer activity of Ficus religiosa engineered copper oxide nanoparticles. Materials Science and Engineering. C Materials for Biological Applications 44: 234-239

Ryu, Y.-L.; Jung, K.H.; Son, M.K.; Yan, H.H.; Kim, S.J.; Shin, S.; Hong, S.; Hong, S.-S. 2014: Anticancer activity of HS-527, a novel inhibitor targeting PI3-kinase in human pancreatic cancer cells. Cancer Letters 353(1): 68-77

Yang, G.; Wang, Z.; Wang, W.; Zhou, X.; Hu, X.; Yang, J. 2014: Anticancer activity of Luteolin and its synergism effect with BCG on human bladder cancer cell line BIU-87. Zhong Nan da Xue Xue Bao. Yi Xue Ban 39(4): 371-378

Huang, H.-L.; Huang, H.-L.; Lee, H.-Y.; Tsai, A.-C.; Peng, C.-Y.; Lai, M.-J.; Wang, J.-C.; Pan, S.-L.; Teng, C.-M.; Liou, J.-P. 2012: Anticancer activity of MPT0E028, a novel potent histone deacetylase inhibitor, in human colorectal cancer HCT116 cells in vitro and in vivo. Plos one 7(8): E43645

Vasanth, K.; Ilango, K.; MohanKumar, R.; Agrawal, A.; Dubey, G.Prasad. 2014: Anticancer activity of Moringa oleifera mediated silver nanoparticles on human cervical carcinoma cells by apoptosis induction. Colloids and Surfaces. B Biointerfaces 117: 354-359

Luzina, E.L.; Popov, A.V. 2010: Anticancer activity of N-bis(trifluoromethyl)alkyl-N'-(polychlorophenyl) and N'-(1,2,4-triazolyl) ureas. European Journal of Medicinal Chemistry 45(11): 5507-5512

Randhawa, M.A.; Alghamdi, M.S. 2011: Anticancer activity of Nigella sativa (black seed) - a review. American Journal of Chinese Medicine 39(6): 1075-1091

Chougule, M.; Patel, A.R.; Sachdeva, P.; Jackson, T.; Singh, M. 2011: Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer. Lung Cancer 71(3): 271-282

Chen, P.; Zhao, S.-H.; Chu, Y.-L.; Xu, K.; Zhu, L.; Wu, Y.; Song, J.; Cao, C.-X.; Xue, X.; Niu, Y.-Y. 2009: Anticancer activity of PDSS2, prenyl diphosphate synthase, subunit 2, in gastric cancer tissue and the SGC7901 cell line. Anti-Cancer Drugs 20(2): 141-148

Lim, S.-H.; Jeong, Y.-I.; Moon, K.-S.; Ryu, H.-H.; Jin, Y.-H.; Jin, S.-G.; Jung, T.-Y.; Kim, I.-Y.; Kang, S.-S.; Jung, S. 2010: Anticancer activity of PEGylated matrix metalloproteinase cleavable peptide-conjugated adriamycin against malignant glioma cells. International Journal of Pharmaceutics 387(1-2): 209-214

Bi, X.; Zhao, Y.; Fang, W.; Yang, W. 2009: Anticancer activity of Panax notoginseng extract 20(S)-25-OCH3-PPD: Targetting beta-catenin signalling. Clinical and Experimental Pharmacology and Physiology 36(11): 1074-1078

Farshori, N.N.; Al-Sheddi, E.S.; Al-Oqail, M.M.; Musarrat, J.; Al-Khedhairy, A.A.; Siddiqui, M.A. 2013: Anticancer activity of Petroselinum sativum seed extracts on MCF-7 human breast cancer cells. Asian Pacific Journal of Cancer Prevention: Apjcp 14(10): 5719-5723

Mahata, S.; Pandey, A.; Shukla, S.; Tyagi, A.; Husain, S.Akhtar.; Das, B.Chandra.; Bharti, A.Chandra. 2013: Anticancer activity of Phyllanthus emblica Linn. (Indian gooseberry): inhibition of transcription factor AP-1 and HPV gene expression in cervical cancer cells. Nutrition and Cancer 65 Suppl. 1: 88-97

Lee, Y.; Kim, H.; Lee, J.; Kim, K. 2011: Anticancer activity of S-allylmercapto-L-cysteine on implanted tumor of human gastric cancer cell. Biological and Pharmaceutical Bulletin 34(5): 677-681

Zhao, Y.; Yu, D.; Wu, H.; Liu, H.; Zhou, H.; Gu, R.; Zhang, R.; Zhang, S.; Wu, G. 2014: Anticancer activity of SAHA, a potent histone deacetylase inhibitor, in NCI-H460 human large-cell lung carcinoma cells in vitro and in vivo. International journal of oncology 44(2): 451-458

Sertel, S.; Eichhorn, T.; Plinkert, P.K.; Efferth, T. 2011: Anticancer activity of Salvia officinalis essential oil against HNSCC cell line (UMSCC1). Hno 59(12): 1203-1208

Zandi, K.; Ahmadzadeh, S.; Tajbakhsh, S.; Rastian, Z.; Yousefi, F.; Farshadpour, F.; Sartavi, K. 2010: Anticancer activity of Sargassum oligocystum water extract against human cancer cell lines. European Review for Medical and Pharmacological Sciences 14(8): 669-673

Anjana, A.; Ahamed, K.F.H.N.; Ravichandiran, V.; Sumithra, M.; Anbu, J. 2014: Anticancer activity of Sargassum wightii Greville on Dalton's ascitic lymphoma. Chinese Journal of Natural Medicines 12(2): 114-120

Moon, S.-M.; Yun, S.J.; Kook, J.-K.; Kim, H.-J.; Choi, M.S.; Park, B.R.; Kim, S.-G.; Kim, B.-O.; Lee, S.-Y.; Ahn, H.; Chun, H.S.; Kim, D.K.; Kim, C.S. 2013: Anticancer activity of Saussurea lappa extract by apoptotic pathway in KB human oral cancer cells. Pharmaceutical Biology 51(11): 1372-1377

Sidhu, P.S.; Teske, K.; Feleke, B.; Yuan, N.Y.; Guthrie, M.L.; Fernstrum, G.B.; Vyas, N.D.; Han, L.; Preston, J.; Bogart, J.W.; Silvaggi, N.R.; Cook, J.M.; Singh, R.K.; Bikle, D.D.; Arnold, L.A. 2014: Anticancer activity of VDR-coregulator inhibitor PS121912. Cancer ChemoTherapy and Pharmacology 74(4): 787-798

Qazi, A.; Pal, J.; Maitah, M'in.; Fulciniti, M.; Pelluru, D.; Nanjappa, P.; Lee, S.; Batchu, R.B.; Prasad, M.; Bryant, C.S.; Rajput, S.; Gryaznov, S.; Beer, D.G.; Weaver, D.W.; Munshi, N.C.; Goyal, R.K.; Shammas, M.A. 2010: Anticancer activity of a broccoli derivative, sulforaphane, in barrett adenocarcinoma: potential use in chemoprevention and as adjuvant in chemotherapy. Translational Oncology 3(6): 389-399

Tripathi, R.; Samadder, T.; Gupta, S.; Surolia, A.; Shaha, C. 2011: Anticancer activity of a combination of cisplatin and fisetin in embryonal carcinoma cells and xenograft tumors. Molecular Cancer Therapeutics 10(2): 255-268

Huang, C-Hua.; Guh, J-Hwa.; Chen, G.Shiahuy.; Lu, P-Hsuan.; Chern, J-Wang. 2010: Anticancer activity of a cyclooxygenase inhibitor, CX9051, in human prostate cancer cells: the roles of NF-kappaB and crosstalk between the extrinsic and intrinsic apoptotic pathways. Naunyn-Schmiedeberg's Archives of Pharmacology 382(2): 159-169

Trombino, S.; Ferrarelli, T.; Pellegrino, M.; Ricchio, E.; Mauro, L.; Andò, S.; Picci, N.; Cassano, R. 2013: Anticancer activity of a hydrogel containing folic acid towards MCF-7 and MDA-MB-231 cells. Anticancer Research 33(11): 4847-4854

Saleh-Abady, M.M.; Naderi-Manesh, H.; Alizadeh, A.; Shamsipour, F.; Balalaie, S.; Arabanian, A. 2010: Anticancer activity of a new gonadotropin releasing hormone analogue. Biopolymers 94(3): 292-297

Toren, P.J.; Kim, S.; Pham, S.; Mangalji, A.; Adomat, H.; Guns, E.S.T.; Zoubeidi, A.; Moore, W.; Gleave, M.E. 2015: Anticancer activity of a novel selective CYP17A1 inhibitor in preclinical models of castrate-resistant prostate cancer. Molecular Cancer Therapeutics 14(1): 59-69

Jaggi, M.; Prasad, S.; Singh, A.T.; Praveen, R.; Dutt, S.; Mathur, A.; Sharma, R.; Gupta, N.; Ahuja, R.; Mukherjee, R.; Burman, A.C. 2008: Anticancer activity of a peptide combination in gastrointestinal cancers targeting multiple neuropeptide receptors. Investigational new Drugs 26(6): 489-504

Puoci, F.; Morelli, C.; Cirillo, G.; Curcio, M.; Parisi, O.I.; Maris, P.; Sisci, D.; Picci, N. 2012: Anticancer activity of a quercetin-based polymer towards Hela cancer cells. Anticancer Research 32(7): 2843-2847

Yaacob, N.S.; Hamzah, N.; Nik Mohamed Kamal, N.N.; Zainal Abidin, S.A.; Lai, C.S.; Navaratnam, V.; Norazmi, M.N. 2010: Anticancer activity of a sub-fraction of dichloromethane extract of Strobilanthes crispus on human breast and prostate cancer cells in vitro. Bmc Complementary and Alternative Medicine 10: 42

Kim, I.-W.; Lee, J.H.; Kwon, Y.-N.; Yun, E.-Y.; Nam, S.-H.; Ahn, M.-Y.; Kang, D.-C.; Hwang, J.S. 2013: Anticancer activity of a synthetic peptide derived from harmoniasin, an antibacterial peptide from the ladybug Harmonia axyridis. International Journal of Oncology 43(2): 622-628

Jahan, S.; Chaudhary, R.; Goyal, P.K. 2009: Anticancer activity of an Indian medicinal plant, Alstonia scholaris, on skin carcinogenesis in mice. Integrative Cancer Therapies 8(3): 273-279

Witort, E.; Lulli, M.; Carloni, V.; Capaccioli, S. 2013: Anticancer activity of an antisense oligonucleotide targeting TRADD combined with proteasome inhibitors in chemoresistant hepatocellular carcinoma cells. Journal of ChemoTherapy 25(5): 292-297

Sharma, P.R.; Mondhe, D.M.; Muthiah, S.; Pal, H.C.; Shahi, A.K.; Saxena, A.K.; Qazi, G.N. 2009: Anticancer activity of an essential oil from Cymbopogon flexuosus. Chemico-Biological Interactions 179(2-3): 160-168

Adinolfi, B.; Romanini, A.; Vanni, A.; Martinotti, E.; Chicca, A.; Fogli, S.; Nieri, P. 2013: Anticancer activity of anandamide in human cutaneous melanoma cells. European Journal of Pharmacology 718(1-3): 154-159

Menon, V.; Bhat, S. 2010: Anticancer activity of andrographolide semisynthetic derivatives. Natural Product Communications 5(5): 717-720

Damle, A.A.; Pawar, Y.P.; Narkar, A.A. 2013: Anticancer activity of betulinic acid on MCF-7 tumors in nude mice. Indian Journal of Experimental Biology 51(7): 485-491

Luo, W.; Liu, C.; Zhang, R.; He, J.; Han, B. 2014: Anticancer activity of binary toxins from Lysinibacillus sphaericus IAB872 against human lung cancer cell line A549. Natural Product Communications 9(1): 107-110

McGovern, P.E.; Christofidou-Solomidou, M.; Wang, W.; Dukes, F.; Davidson, T.; El-Deiry, W.S. 2010: Anticancer activity of botanical compounds in ancient fermented beverages (review). International Journal of Oncology 37(1): 5-14

Dailey, O.D.; Wang, X.; Chen, F.; Huang, G. 2011: Anticancer activity of branched-chain derivatives of oleic acid. Anticancer Research 31(10): 3165-3169

Kepp, O.; Menger, L.; Vacchelli, E.; Adjemian, S.; Martins, I.; Ma, Y.; Sukkurwala, A.Q.; Michaud, M.ël.; Galluzzi, L.; Zitvogel, L.; Kroemer, G. 2012: Anticancer activity of cardiac glycosides: at the frontier between cell-autonomous and immunological effects. Oncoimmunology 1(9): 1640-1642

Rapozzi, V.; Zorzet, S.; Zacchigna, M.; Della Pietra, E.; Cogoi, S.; Xodo, L.E. 2014: Anticancer activity of cationic porphyrins in melanoma tumour-bearing mice and mechanistic in vitro studies. Molecular Cancer 13: 75

Fang, W.; Liu, S.; Nie, Y. 2011: Anticancer activity of chamaejasmine: effect on tubulin protein. Molecules 16(8): 6243-6254

Salah, R.; Michaud, P.; Mati, F.; Harrat, Z.; Lounici, H.; Abdi, N.; Drouiche, N.; Mameri, N. 2013: Anticancer activity of chemically prepared shrimp low molecular weight chitin evaluation with the human monocyte leukaemia cell line, THP-1. International Journal of Biological Macromolecules 52: 333-339

Thavamani, B.S.; Mathew, M.; Dhanabal, S.P. 2014: Anticancer activity of cissampelos pareira against dalton's lymphoma ascites bearing mice. Pharmacognosy Magazine 10(39): 200-206

Connolly, K.; Brungs, D.; Szeto, E.; Epstein, R.J. 2014: Anticancer activity of combination targeted therapy using cetuximab plus vemurafenib for refractory BRAF (V600E)-mutant metastatic colorectal carcinoma. Current Oncology 21(1): E151-E154

Kaluderović, M.R.; Gómez-Ruiz, S.; Gallego, B.; Hey-Hawkins, E.; Paschke, R.; Kaluderović, G.N. 2010: Anticancer activity of dinuclear gallium(III) carboxylate complexes. European Journal of Medicinal Chemistry 45(2): 519-525

Yang, S.-M.; Wu, D.-G.; Liu, X.-K. 2010: Anticancer activity of diterpenoids from Amoora ouangliensis and Amoora stellato-squamosa. Zeitschrift für Naturforschung. C Journal of Biosciences 65(1-2): 39-42

Aras, A.; Iqbal, M.J.; Naqvi, S.K.-U.-H.; Gercek, Y.C.; Boztas, K.; Gasparri, M.L.; Shatynska-Mytsyk, I.; Fayyaz, S.; Farooqi, A.A. 2014: Anticancer activity of essential oils: targeting of protein networks in cancer cells. Asian Pacific Journal of Cancer Prevention: Apjcp 15(19): 8047-8050

Sandra, C.-M.; Elena, K.; Marcos, F.-A.; Elena, M.ín.-K.; Arturo, R.ír.-R.ír.; Teresa, R.ír.A.; Marcos, M.ín.-G.ía. 2014: Anticancer activity of ferrocenylthiosemicarbazones. Anti-Cancer Agents in Medicinal Chemistry 14(3): 459-465

Kim, H.-J.; Ryu, K.; Kang, J.-H.; Choi, A.-J.; Kim, T.-i.; Oh, J.-M. 2013: Anticancer activity of ferulic acid-inorganic nanohybrids synthesized via two different hybridization routes, reconstruction and exfoliation-reassembly. Thescientificworldjournal 2013: 421967

Yang, P.; Cartwright, C.; Chan, D.; Ding, J.; Felix, E.; Pan, Y.; Pang, J.; Rhea, P.; Block, K.; Fischer, S.M.; Newman, R.A. 2014: Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylation. Molecular Carcinogenesis 53(7): 566-577

Erharuyi, O.; Engel-Lutz, N.; Ahomafor, J.; Imieje, V.; Falodun, A.; Nebe, B.; Langer, P. 2014: Anticancer activity of five forest crops used in African folklore: antiproliferative and pro-apoptotic effects. Natural Product Research 2014

Fawzy, G.A.; Al-Taweel, A.M.; Perveen, S. 2014: Anticancer activity of flavane gallates isolated from Plicosepalus curviflorus. Pharmacognosy Magazine 10(Suppl 3): S519-S523

Majewska-Wierzbicka, M.; Czeczot, H. 2012: Anticancer activity of flavonoids. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 33(198): 364-369

Biscaro, F.; Parisotto, E.B.; Zanette, V.C.; Günther, T.M.F.; Ferreira, E.A.; Gris, E.F.; Correia, J.ão.F.G.; Pich, C.T.ög.; Mattivi, F.; Filho, D.W.; Pedrosa, R.C. 2013: Anticancer activity of flavonol and flavan-3-ol rich extracts from Croton celtidifolius latex. Pharmaceutical Biology 51(6): 737-743

Pandi, M.; Manikandan, R.; Muthumary, J. 2010: Anticancer activity of fungal taxol derived from Botryodiplodia theobromae Pat., an endophytic fungus, against 7, 12 dimethyl benz(a)anthracene (DMBA)-induced mammary gland carcinogenesis in Sprague Dawley rats. Biomedicine and PharmacoTherapy 64(1): 48-53

Davalli, P.; Rizzi, F.; Caporali, A.; Pellacani, D.; Davoli, S.; Bettuzzi, S.; Brausi, M.; D'Arca, D. 2012: Anticancer activity of green tea polyphenols in prostate gland. Oxidative Medicine and Cellular Longevity 2012: 984219

Aguirre, J.D.; Angeles-Boza, A.M.; Chouai, A.; Turro, C.; Pellois, J.-P.; Dunbar, K.R. 2009: Anticancer activity of heteroleptic diimine complexes of dirhodium: a study of intercalating properties, hydrophobicity and in cellulo activity. Dalton Transactions 48: 10806-10812

Lim, J.-H.; Lee, Y.-M.; Park, S.R.; Kim, D.H.; Lim, B.O. 2014: Anticancer activity of hispidin via reactive oxygen species-mediated apoptosis in colon cancer cells. Anticancer Research 34(8): 4087-4093

Mitra, R.; Das, S.; Shinde, S.V.; Sinha, S.; Somasundaram, K.; Samuelson, A.G. 2012: Anticancer activity of hydrogen-bond-stabilized half-sandwich Ru(II) complexes with heterocycles. Chemistry 18(39): 12278-12291

Celia, C.; Trapasso, E.; Locatelli, M.; Navarra, M.; Ventura, C.A.; Wolfram, J.; Carafa, M.; Morittu, V.M.; Britti, D.; Di Marzio, L.; Paolino, D. 2013: Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells. Colloids and Surfaces. B Biointerfaces 112: 548-553

Lim, H.K.; Bae, W.; Lee, H.-S.; Jung, J. 2014: Anticancer activity of marine sponge Hyrtios sp. extract in human colorectal carcinoma RKO cells with different p53 status. Biomed Research International 2014: 413575

Jungwirth, U.; Kowol, C.R.; Keppler, B.K.; Hartinger, C.G.; Berger, W.; Heffeter, P. 2011: Anticancer activity of metal complexes: involvement of redox processes. Antioxidants and Redox Signaling 15(4): 1085-1127

Voller, J.í; Zatloukal, M.; Lenobel, R.é; Dolezal, K.; Béres, T.; Krystof, V.ír.; Spíchal, L.ás.; Niemann, P.; Dzubák, P.; Hajdúch, M.án.; Strnad, M. 2010: Anticancer activity of natural cytokinins: a structure-activity relationship study. Phytochemistry 71(11-12): 1350-1359

El-Sayed, W.A.; El-Kosy, S.M.; Ali, O.M.; Emselm, H.M.; Abdel-Rahman, A.A.H. 2012: Anticancer activity of new (tetrazol-5-yl)methylindole derivatives and their acyclic c-nucleoside analogs. Acta Poloniae Pharmaceutica 69(4): 669-677

Rashid, M.; Husain, A.; Shaharyar, M.; Sarafroz, M. 2014: Anticancer activity of new compounds using benzimidazole as a scaffold. Anti-Cancer Agents in Medicinal Chemistry 14(7): 1003-1018

Nasr, T.; Bondock, S.; Youns, M. 2014: Anticancer activity of new coumarin substituted hydrazide-hydrazone derivatives. European Journal of Medicinal Chemistry 76: 539-548

Pluta, K.; Jeleń, M.łg.; Morak-Młodawska, B.; Zimecki, M.ł; Artym, J.; Kocieba, M. 2010: Anticancer activity of newly synthesized azaphenothiazines from NCI's anticancer screening bank. Pharmacological Reports: Pr 62(2): 319-332

Li, Z.; Sturm, S.; Svejda, B.; Höger, H.; Schraml, E.; Ingolic, E.; Siegl, V.; Stuppner, H.; Pfragner, R. 2008: Anticancer activity of novel extracts from Cautleya gracilis (Smith) Dandy: apoptosis in human medullary thyroid carcinoma cells. Anticancer Research 28(5a): 2705-2713

Romagnoli, R.; Baraldi, P.G.; Salvador, M.K.; Camacho, M.E.; Balzarini, J.; Bermejo, J.; Estévez, F. 2013: Anticancer activity of novel hybrid molecules containing 5-benzylidene thiazolidine-2,4-dione. European Journal of Medicinal Chemistry 63: 544-557

Svejda, B.; Aguiriano-Moser, V.; Sturm, S.; Höger, H.; Ingolic, E.; Siegl, V.; Stuppner, H.; Pfragner, R. 2010: Anticancer activity of novel plant extracts from Trailliaedoxa gracilis (W. W. Smith & Forrest) in human carcinoid KRJ-I Cells. Anticancer Research 30(1): 55-64

Boot, A.; Brito, A.; VAN Wezel, T.; Morreau, H.; Costa, M.; Proença, F. 2014: Anticancer activity of novel pyrido[2,3-b]indolizine derivatives: the relevance of phenolic substituents. Anticancer Research 34(4): 1673-1677

Adams, V.R.; Deremer, D.L.; Stevich, B.; Mattingly, C.A.; Gallt, B.; Subramanian, T.; Troutman, J.M.; Spielmann, H.P. 2010: Anticancer activity of novel unnatural synthetic isoprenoids. Anticancer Research 30(7): 2505-2512

Sarmah, P.; Deka, R.C. 2010: Anticancer activity of nucleoside analogues: a density functional theory based QSAR study. Journal of Molecular Modeling 16(3): 411-418

Mateos, R.; Pereira-Caro, G.; Bacon, J.R.; Bongaerts, R.; Sarriá, B.; Bravo, L.; Kroon, P.A. 2013: Anticancer activity of olive oil hydroxytyrosyl acetate in human adenocarcinoma Caco-2 cells. Journal of Agricultural and Food Chemistry 61(13): 3264-3269

Wang, J.; Yu, Y.; Yan, Z.; Hu, Z.; Li, L.; Li, J.; Jiang, X.; Qian, Q. 2013: Anticancer activity of oncolytic adenoviruses carrying p53 is augmented by 11R in gallbladder cancer cell lines in vitro and in vivo. Oncology Reports 30(2): 833-841

Barry, N.P.E.; Zava, O.; Furrer, J.; Dyson, P.J.; Therrien, B. 2010: Anticancer activity of opened arene ruthenium metalla-assemblies. Dalton Transactions 39(22): 5272-5277

Barry, N.P.E.; Edafe, F.; Dyson, P.J.; Therrien, B. 2010: Anticancer activity of osmium metalla-rectangles. Dalton Transactions 39(11): 2816-2820

Abakumova, O.I.; Podobed, O.V.; Beliaeva, N.F.; Tochilkin, A.I. 2013: Anticancer activity of oxovanadium compounds. Biomeditsinskaia Khimiia 59(3): 305-320

Nakachi, T.; Tabuchi, T.; Takasaki, A.; Arai, S.; Miyazawa, K.; Tomoda, A. 2010: Anticancer activity of phenoxazines produced by bovine erythrocytes on colon cancer cells. Oncology Reports 23(6): 1517-1522

Lee, J.S.; Yoon, I.S.; Lee, M.S.; Cha, E.Y.; Thuong, P.T.; Diep, T.T.; Kim, J.R. 2013: Anticancer activity of pristimerin in epidermal growth factor receptor 2-positive SKBR3 human breast cancer cells. Biological and Pharmaceutical Bulletin 36(2): 316-325

Choi, J.; Jiang, X.; Jeong, J.B.; Lee, S.-H. 2014: Anticancer activity of protocatechualdehyde in human breast cancer cells. Journal of Medicinal Food 17(8): 842-848

Chiu, C.C.; Lin, Y.T.; Sun, S.L.; Sung, K.H.; Wang, L.F. 2011: Anticancer activity of released doxorubicin from a folate-mediated polyelectrolyte complex. Journal of Biomaterials Science. Polymer Edition 22(11): 1487-1507

Chen, K-Chou.; Hsieh, C-Lan.; Huang, K-Dar.; Ker, Y-Bee.; Chyau, C-Cherng.; Peng, R.Y. 2009: Anticancer activity of rhamnoallosan against DU-145 cells is kinetically complementary to coexisting Polyphenolics in Psidium guajava budding leaves. Journal of Agricultural and Food Chemistry 57(14): 6114-6122

Chelopo, M.P.; Pawar, S.A.; Sokhela, M.K.; Govender, T.; Kruger, H.G.; Maguire, G.E.M. 2013: Anticancer activity of ruthenium(II) arene complexes bearing 1,2,3,4-tetrahydroisoquinoline amino alcohol ligands. European Journal of Medicinal Chemistry 66: 407-414

Giridharan, P.; Verekar, S.A.; Khanna, A.; Mishra, P.D.; Deshmukh, S.K. 2012: Anticancer activity of sclerotiorin, isolated from an endophytic fungus Cephalotheca faveolata Yaguchi, Nishim. and Udagawa. Indian Journal of Experimental Biology 50(7): 464-468

Moon, H.-I.; Zee, O. 2011: Anticancer activity of sesquiterpene lactone from plant food (Carpesium rosulatum) in human cancer cell lines. International Journal of Food Sciences and Nutrition 62(2): 102-105

Eloy, L.; Jarrousse, A.-S.; Teyssot, M.-L.; Gautier, A.; Morel, L.; Jolivalt, C.; Cresteil, T.; Roland, S. 2012: Anticancer activity of silver-N-heterocyclic carbene complexes: caspase-independent induction of apoptosis via mitochondrial apoptosis-inducing factor (AIF). Chemmedchem 7(5): 805-814

Hansen, T.; Ausbacher, D.; Zachariassen, Z.G.; Anderssen, T.; Havelkova, M.; Strøm, M.B. 2012: Anticancer activity of small amphipathic β²,²-amino acid derivatives. European Journal of Medicinal Chemistry 58: 22-29

Swindell, E.P.; Hankins, P.L.; Chen, H.; Miodragović, D.U.; O'Halloran, T.V. 2013: Anticancer activity of small-molecule and nanoparticulate arsenic(III) complexes. Inorganic Chemistry 52(21): 12292-12304

Işikdağ, I.; Ozkay, Y.; Incesu, Z.; Akalin, G.ül.şe. 2011: Anticancer activity of some bisbenzimidazoles. Zeitschrift für Naturforschung. C Journal of Biosciences 66(9-10): 465-470

Jones, B.; Komarnitsky, P.; Miller, G.T.; Amedio, J.; Wallner, B.P. 2012: Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin. Anti-Cancer Drugs 23(2): 173-184

Mohanraj, S.; Murugan, D.; Rengarajan, A.; Rajiv, S. 2014: Anticancer activity of starch/poly[N-(2-hydroxypropyl)methacrylamide]: biomaterial film to treat skin cancer. International Journal of Biological Macromolecules 70: 116-123

Côrte-Real, L.; Mendes, F.; Coimbra, J.; Morais, T.ân.S.; Tomaz, A.I.; Valente, A.; Garcia, M.H.; Santos, I.; Bicho, M.; Marques, F. 2014: Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes. Journal of Biological Inorganic Chemistry: Jbic: a Publication of the Society of Biological Inorganic Chemistry 19(6): 853-867

Chung, M.J.; Chung, C.-K.; Jeong, Y.; Ham, S.-S. 2010: Anticancer activity of subfractions containing pure compounds of Chaga mushroom (Inonotus obliquus) extract in human cancer cells and in Balbc/c mice bearing Sarcoma-180 cells. Nutrition Research and Practice 4(3): 177-182

Obeid, M. 2009: Anticancer activity of targeted proapoptotic peptides and chemotherapy is highly improved by targeted cell surface calreticulin-inducer peptides. Molecular Cancer Therapeutics 8(9): 2693-2707

Barry, N.P.E.; Edafe, F.; Therrien, B. 2011: Anticancer activity of tetracationic arene ruthenium metalla-cycles. Dalton Transactions 40(27): 7172-7180

Chinn, D.C.; Holland, W.S.; Mack, P.C. 2014: Anticancer activity of the Aurora a kinase inhibitor MK-5108 in non-small-cell lung cancer (NSCLC) in vitro as monotherapy and in combination with chemotherapies. Journal of Cancer Research and Clinical Oncology 140(7): 1137-1149

Sun, W.; Qiao, L.; Liu, Q.; Chen, L.; Ling, B.; Sammynaiken, R.; Yang, J. 2011: Anticancer activity of the PR domain of tumor suppressor RIZ1. International Journal of Medical Sciences 8(2): 161-167

Pilarski, R.ła.; Filip, B.; Wietrzyk, J.; Kuraś, M.ła.; Gulewicz, K. 2010: Anticancer activity of the Uncaria tomentosa (Willd.) DC. preparations with different oxindole alkaloid composition. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 17(14): 1133-1139

Rajesh, R.P.; Ramasamy, M.S.; Murugan, A. 2010: Anticancer activity of the ascidian polyclinum indicum against cervical cancer cells (HeLa) mediated through apoptosis induction. Medicinal Chemistry 6(6): 396-405

Smith, B.; Land, H. 2012: Anticancer activity of the cholesterol exporter ABCA1 gene. Cell Reports 2(3): 580-590

Li, Z.; Tanaka, H.; Galiano, F.; Glass, J. 2011: Anticancer activity of the iron facilitator LS081. Journal of Experimental and Clinical Cancer Research: Cr 30: 34

Kilian, G.; Davids, H.; Milne, P.J. 2013: Anticancer activity of the liposome-encapsulated cyclic dipeptides, cyclo(His-Gly) and cyclo(His-Ala). Die Pharmazie 68(3): 207-211

Akindele, A.J.; Mahajan, G.; Wani, Z.A.; Sharma, S.; Satti, N.K.; Adeyemi, O.O.; Mondhe, D.M.; Saxena, A.K. 2015: Anticancer activity of the phytomedicine DAS-77. Integrative Cancer Therapies 14(1): 57-64

Singh, N.K.; Singh, V.P. 2014: Anticancer activity of the roots of Ichnocarpus frutescens R. Br. and isolated triterpenes. Pakistan Journal of Pharmaceutical Sciences 27(1): 187-191

Tabernero, J.; Chawla, S.P.; Kindler, H.; Reckamp, K.; Chiorean, E.G.; Azad, N.S.; Lockhart, A.C.; Hsu, C.-P.; Baker, N.F.; Galimi, F.; Beltran, P.; Baselga, J.é 2015: Anticancer activity of the type i insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab. Targeted Oncology 10(1): 65-76

Liu, P.-x.; Gao, J.; Chen, Y.-j.; Long, W.; Shen, X.; Tang, W.-s. 2011: Anticancer activity of total flavonoids isolated from Xianhe Yanling Recipe (仙鹤延龄方). Chinese Journal of Integrative Medicine 17(6): 459-463

An, Y.; Li, L.; Yang, D.; Jia, N.; Xu, C.; Wang, Q.; Wang, S.; Yuan, S. 2014: Anticancer activity of tuftsin-derived T peptide in postoperative residual tumors. Anti-Cancer Drugs 25(8): 857-867

Mazzini, F.; Betti, M.; Canonico, B.; Netscher, T.; Luchetti, F.; Papa, S.; Galli, F. 2010: Anticancer activity of vitamin E-derived compounds in murine C6 glioma cells. Chemmedchem 5(4): 540-543

Li, Q.Q.; Lee, R.X.; Liang, H.; Zhong, Y. 2013: Anticancer activity of β-Elemene and its synthetic analogs in human malignant brain tumor cells. Anticancer Research 33(1): 65-76

Soeksmanto, A.; Subroto, M.A.; Wijaya, H.; Simanjuntak, P. 2010: Anticancer activity test for extracts of Sarang semut plant (Myrmecodya pendens) to Hela and MCM-B2 cells. Pakistan Journal of Biological Sciences: Pjbs 13(3): 148-151

Zhou, D.-F.; Chen, Q.-Y.; Qi, Y.; Fu, H.-J.; Li, Z.; Zhao, K.-D.; Gao, J. 2011: Anticancer activity, attenuation on the absorption of calcium in mitochondria, and catalase activity for manganese complexes of N-substituted di(picolyl)amine. Inorganic Chemistry 50(15): 6929-6937

Chanda, D.; Bhushan, S.; Guru, S.K.; Shanker, K.; Wani, Z.A.; Rah, B.A.; Luqman, S.; Mondhe, D.M.; Pal, A.; Negi, A.S. 2012: Anticancer activity, toxicity and pharmacokinetic profile of an indanone derivative. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 47(5): 988-995

Yeh, C.-H.; Chou, W.; Chu, C.-C.; So, E.C.; Chang, H.-C.; Wang, J.-J.; Hsing, C.-H. 2011: Anticancer agent 2-methoxyestradiol improves survival in septic mice by reducing the production of cytokines and nitric oxide. Shock 36(5): 510-516

Poljakova, J.; Hrebackova, J.; Dvorakova, M.; Moserova, M.; Eckschlager, T.; Hrabeta, J.; Göttlicherova, M.; Kopejtkova, B.; Frei, E.; Kizek, R.; Stiborova, M. 2011: Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma. Neuro Endocrinology Letters 32(Suppl 1): 101-116

Wu, H.; Xie, J.; Pan, Q.; Wang, B.; Hu, D.; Hu, X. 2013: Anticancer agent shikonin is an incompetent inducer of cancer drug resistance. Plos one 8(1): E52706

Savran, B.; Yerlikaya, A.; Erdoğan, E.; Genç, O. 2014: Anticancer agent ukrain and bortezomib combination is synergistic in 4T1 breast cancer cells. Anti-Cancer Agents in Medicinal Chemistry 14(3): 466-472

Liu, Y.; Gao, X.; Deeb, D.; Arbab, A.S.; Dulchavsky, S.A.; Gautam, S.C. 2012: Anticancer agent xanthohumol inhibits IL-2 induced signaling pathways involved in T cell proliferation. Journal of Experimental Therapeutics and Oncology 10(1): 1-8

Breton, D.; Jandard, V.; Cauet, Aélie.; Ginestet, Hélène.; Paillet, M.; Galvez, O.; Bohand, X. 2010: Anticancer agents and risks for the nursing personnel. Revue de l'Infirmiere 2010(163): 35-37

Liu, E.-H.; Qi, L.-W.; Wu, Q.; Peng, Y.-B.; Li, P. 2009: Anticancer agents derived from natural products. Mini Reviews in Medicinal Chemistry 9(13): 1547-1555

Bartzatt, R. 2012: Anticancer agents for treatment of tumors in the central nervous system by correspondent substituent substitution and elucidation by pattern recognition methods. Medicinal Chemistry ) 8(2): 138-144

Ye, J.; Zhou, F.; Al-Kareef, A.M.Q.; Wang, H. 2015: Anticancer agents from marine sponges. Journal of Asian Natural Products Research 17(1): 64-88

Dong, L.; Schill, H.; Grange, R.L.; Porzelle, A.; Johns, J.P.; Parsons, P.G.; Gordon, V.A.; Reddell, P.W.; Williams, C.M. 2009: Anticancer agents from the Australian tropical rainforest: Spiroacetals EBC-23, 24, 25, 72, 73, 75 and 76. Chemistry 15(42): 11307-11318

Granchi, C.; Minutolo, F. 2012: Anticancer agents that counteract tumor glycolysis. Chemmedchem 7(8): 1318-1350

Levêque, D. 2012: Anticancer agents: has the maximal tolerated price been reached?. Bulletin du Cancer 99(9): 808-810

Baunbaek, D.; Trinkler, N.; Ferandin, Y.; Lozach, O.; Ploypradith, P.; Rucirawat, S.; Ishibashi, F.; Iwao, M.; Meijer, L. 2008: Anticancer alkaloid lamellarins inhibit protein kinases. Marine Drugs 6(4): 514-527

Pia Schiavone, B.I.; Verotta, L.; Rosato, A.; Marilena, M.; Gibbons, S.; Bombardelli, E.; Franchini, C.; Corbo, F. 2014: Anticancer and Antibacterial Activity of Hyperforin and its Derivatives. Anti-Cancer Agents in Medicinal Chemistry 14(10): 1397-1401

Pouryasin, Z.; Yousefi, R.; Nabavizadeh, S.M.; Rashidi, M.; Hamidizadeh, P.; Alavianmehr, M.-M.; Moosavi-Movahedi, A.A. 2014: Anticancer and DNA binding activities of platinum (IV) complexes; importance of leaving group departure rate. Applied Biochemistry and Biotechnology 172(5): 2604-2617

Cha, Y.J.; Alam, N.; Lee, J.S.; Lee, K.R.; Shim, M.J.; Lee, M.W.; Kim, H.Y.; Shin, P.G.; Cheong, J.C.; Yoo, Y.B.; Lee, T.S. 2012: Anticancer and Immunopotentiating Activities of Crude Polysaccharides from Pleurotus nebrodensis on Mouse Sarcoma 180. Mycobiology 40(4): 236-243

Srivastava, S.K.; Jaggi, M.; Singh, A.T.; Madan, A.; Rani, N.; Vishnoi, M.; Agarwal, S.K.; Mukherjee, R.; Burman, A.C. 2007: Anticancer and anti-inflammatory activities of 1,8-naphthyridine-3-carboxamide derivatives. Bioorganic and Medicinal Chemistry Letters 17(23): 6660-6664

Mohammadi-Motlagh, H.-R.; Mostafaie, A.; Mansouri, K. 2011: Anticancer and anti-inflammatory activities of shallot (Allium ascalonicum) extract. Archives of Medical Science: Ams 7(1): 38-44

Lambert, J.D.; Sang, S.; Hong, J.; Yang, C.S. 2010: Anticancer and anti-inflammatory effects of cysteine metabolites of the green tea polyphenol, (-)-epigallocatechin-3-gallate. Journal of Agricultural and Food Chemistry 58(18): 10016-10019

Greish, K.; Ray, A.; Bauer, H.; Larson, N.; Malugin, A.; Pike, D.; Haider, M.; Ghandehari, H. 2011: Anticancer and antiangiogenic activity of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer therapy. Journal of Controlled Release: Official Journal of the Controlled Release Society 151(3): 263-270

Bladt, T.T.; Frisvad, J.C.; Knudsen, P.B.; Larsen, T.O. 2013: Anticancer and antifungal compounds from Aspergillus, Penicillium and other filamentous fungi. Molecules 18(9): 11338-11376

Halim, H.; Chunhacha, P.; Suwanborirux, K.; Chanvorachote, P. 2011: Anticancer and antimetastatic activities of Renieramycin M, a marine tetrahydroisoquinoline alkaloid, in human non-small cell lung cancer cells. Anticancer Research 31(1): 193-201

Liu, K.; Wang, J-Li.; Zhao, L.; Wang, Q. 2014: Anticancer and antimicrobial activities and chemical composition of the birch mazegill mushroom Lenzites betulina (higher Basidiomycetes). International journal of medicinal mushrooms 16(4): 327-337

Tamokou, J.d.D.; Chouna, J.R.; Fischer-Fodor, E.; Chereches, G.; Barbos, O.; Damian, G.; Benedec, D.; Duma, M.; Efouet, A.P.ép.N.; Wabo, H.K.; Kuiate, J.R.; Mot, A.; Silaghi-Dumitrescu, R. 2013: Anticancer and antimicrobial activities of some antioxidant-rich cameroonian medicinal plants. Plos one 8(2): E55880

Bhimba, B.V.; Agnel Defora Franco, D.A.; Mathew, J.M.; Jose, G.M.; Joel, E.L.; Thangaraj, M. 2012: Anticancer and antimicrobial activity of mangrove derived fungi Hypocrea lixii VB1. Chinese Journal of Natural Medicines 10(1): 77-80

Tagne, R.S.; Telefo, B.P.; Nyemb, J.N.; Yemele, D.M.; Njina, S.N.; Goka, S.ép.M.C.; Lienou, L.L.; Nwabo Kamdje, A.H.é; Moundipa, P.F.; Farooq, A.D. 2014: Anticancer and antioxidant activities of methanol extracts and fractions of some Cameroonian medicinal plants. Asian Pacific Journal of Tropical Medicine 7s1: S442-S447

Gawlik-Dziki, U.; Świeca, M.ł; Dziki, D.; Sęczyk, Łu.; Złotek, U.; Różyło, R.; Kaszuba, K.; Ryszawy, D.; Czyż, J.ła. 2014: Anticancer and antioxidant activity of bread enriched with broccoli sprouts. Biomed Research International 2014: 608053

Aydin, E.; Türkez, H.; Taşdemir, S. 2013: Anticancer and antioxidant properties of terpinolene in rat brain cells. Arhiv Za Higijenu Rada i Toksikologiju 64(3): 415-424

Malíková, J.; Swaczynová, J.; Kolár, Z.; Strnad, M. 2008: Anticancer and antiproliferative activity of natural brassinosteroids. Phytochemistry 69(2): 418-426

Adebayo, A.H.; Tan, N.H.; Akindahunsi, A.A.; Zeng, G.Z.; Zhang, Y.M. 2010: Anticancer and antiradical scavenging activity of Ageratum conyzoides L. (Asteraceae). Pharmacognosy Magazine 6(21): 62-66

Zorofchian Moghadamtousi, S.; Karimian, H.; Khanabdali, R.; Razavi, M.; Firoozinia, M.; Zandi, K.; Abdul Kadir, H. 2014: Anticancer and antitumor potential of fucoidan and fucoxanthin, two main metabolites isolated from brown algae. Thescientificworldjournal 2014: 768323

Kaur, M.; Agarwal, C.; Agarwal, R. 2009: Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products. Journal of Nutrition 139(9): 1806s-1812s

Fedorov, S.N.; Ermakova, S.P.; Zvyagintseva, T.N.; Stonik, V.A. 2013: Anticancer and cancer preventive properties of marine polysaccharides: some results and prospects. Marine Drugs 11(12): 4876-4901

López-Lázaro, M. 2008: Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Molecular Nutrition and Food Research 52 Suppl. 1: S103-S127

Karikas, G.A. 2010: Anticancer and chemopreventing natural products: some biochemical and therapeutic aspects. Journal of BUON: Official Journal of the Balkan Union of Oncology 15(4): 627-638

Gerlach, S.L.; Rathinakumar, R.; Chakravarty, G.; Göransson, U.; Wimley, W.C.; Darwin, S.P.; Mondal, D. 2010: Anticancer and chemosensitizing abilities of cycloviolacin 02 from Viola odorata and psyle cyclotides from Psychotria leptothyrsa. Biopolymers 94(5): 617-625

Verginadis, I.I.; Karkabounas, S.; Simos, Y.; Kontargiris, E.; Hadjikakou, S.K.; Batistatou, A.; Evangelou, A.; Charalabopoulos, K. 2011: Anticancer and cytotoxic effects of a triorganotin compound with 2-mercapto-nicotinic acid in malignant cell lines and tumor bearing Wistar rats. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 42(3): 253-261

Kumar, V.; Madaan, A.; Sanna, V.K.; Vishnoi, M.; Joshi, N.; Singh, A.T.; Jaggi, M.; Sharma, P.K.; Irchhaiya, R.; Burman, A.C. 2009: Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry 24(5): 1169-1178

Liu, J.; Zhang, L.; Ren, Y.; Gao, Y.; Kang, L.; Qiao, Q. 2014: Anticancer and immunoregulatory activity of Gynostemma pentaphyllum polysaccharides in H22 tumor-bearing mice. International Journal of Biological Macromolecules 69: 1-4

Chattopadhyay, S.; Dash, S.Kumar.; Ghosh, T.; Das, S.; Tripathy, S.; Mandal, D.; Das, D.; Pramanik, P.; Roy, S. 2013: Anticancer and immunostimulatory role of encapsulated tumor antigen containing cobalt oxide nanoparticles. Journal of Biological Inorganic Chemistry: Jbic: a Publication of the Society of Biological Inorganic Chemistry 18(8): 957-973

Zupkó, I.án.; Molnár, J.; Réthy, B.ál.; Minorics, R.át.; Frank, E.; Wölfling, J.án.; Molnár, J.; Ocsovszki, I.; Topcu, Z.; Bitó, T.ás.; Puskás, L.ás.ó G. 2014: Anticancer and multidrug resistance-reversal effects of solanidine analogs synthetized from pregnadienolone acetate. Molecules 19(2): 2061-2076

Ghorab, M.M.; Ragab, F.A.; Heiba, H.I.; El-Hazek, R.M. 2011: Anticancer and radio-sensitizing evaluation of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety. European Journal of Medicinal Chemistry 46(10): 5120-5126

Ghorab, M.M.; Shaaban, M.A.; Refaat, H.M.; Heiba, H.I.; Ibrahim, S.S. 2012: Anticancer and radiosensitizing evaluation of some new pyranothiazole-Schiff bases bearing the biologically active sulfonamide moiety. European Journal of Medicinal Chemistry 53: 403-407

Troeira Henriques, S.ón.; Huang, Y.-H.; Chaousis, S.; Wang, C.K.; Craik, D.J. 2014: Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting. Chembiochem: a European Journal of Chemical Biology 15(13): 1956-1965

Harlev, E.; Nevo, E.; Lansky, E.P.; Lansky, S.; Bishayee, A. 2012: Anticancer attributes of desert plants: a review. Anti-Cancer Drugs 23(3): 255-271

Chang, C.-H.; Fu, Y.-C.; Li, J.-R.; Shu, K.-H.; Ho, H.-C.; Shiu, Y.-N.; Wu, M.-J. 2014: Anticancer benefits of early versus late use of rapamycin in a rat model of urothelial carcinoma. Transplantation Proceedings 46(4): 1240-1242

Su, L.-Y.; Xin, H.-Y.; Liu, Y.-L.; Zhang, J.-L.; Xin, H.-W.; Su, X.-L. 2014: Anticancer bioactive peptide (ACBP) inhibits gastric cancer cells by upregulating growth arrest and DNA damage-inducible gene 45A (GADD45A). Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(10): 10051-10056

Su, L.; Xu, G.; Shen, J.; Tuo, Y.; Zhang, X.; Jia, S.; Chen, Z.; Su, X. 2010: Anticancer bioactive peptide suppresses human gastric cancer growth through modulation of apoptosis and the cell cycle. Oncology Reports 23(1): 3-9

Yu, L.; Yang, L.; An, W.; Su, X. 2014: Anticancer bioactive peptide-3 inhibits human gastric cancer growth by suppressing gastric cancer stem cells. Journal of Cellular Biochemistry 115(4): 697-711

Teiten, M.-H.él.èn.; Gaascht, F.ço.; Dicato, M.; Diederich, M. 2013: Anticancer bioactivity of compounds from medicinal plants used in European medieval traditions. Biochemical Pharmacology 86(9): 1239-1247

Paul, R.; Prasad, M.; Sah, N.K. 2011: Anticancer biology of Azadirachta indica L (neem): a mini review. Cancer Biology and Therapy 12(6): 467-476

Monti, S.M.; Supuran, C.T.; De Simone, G. 2013: Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013). Expert Opinion on Therapeutic Patents 23(6): 737-749

He, W.; Jiang, Y.; Zhang, X.; Zhang, Y.; Ji, H.; Zhang, N. 2014: Anticancer cardamonin analogs suppress the activation of NF-kappaB pathway in lung cancer cells. Molecular and Cellular Biochemistry 389(1-2): 25-33

Kratz, F.; Abu Ajaj, K.; Warnecke, A.é 2007: Anticancer carrier-linked prodrugs in clinical trials. Expert Opinion on Investigational Drugs 16(7): 1037-1058

Debrix, I.; Avenin, Dèle.; André, T.; Abbas, F.; Gligorov, J.; Milleron, B.; Lotz, J-Pierre.; Becker, A. 2008: Anticancer chemotherapy in the elderly: a review of the literature. Bulletin du Cancer 95 Fmc Onco: F37-F43

Kohga, K.; Takehara, T.; Tatsumi, T.; Miyagi, T.; Ishida, H.; Ohkawa, K.; Kanto, T.; Hiramatsu, N.; Hayashi, N. 2009: Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma. Cancer Research 69(20): 8050-8057

Jensen, M.; Nerdal, W. 2008: Anticancer cisplatin interactions with bilayers of total lipid extract from pig brain: A13C, 31P and 15N solid-state NMR study. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 34(2-3): 140-148

Zhang, Y.; Wang, J. 2010: Anticancer clinical utility of the apurinic/apyrimidinic endonuclease/redox factor-1 (APE/Ref-1). Chinese Journal of Cancer 29(3): 333-339

Jamal, M.S.; Parveen, S.; Beg, M.A.; Suhail, M.; Chaudhary, A.G.A.; Damanhouri, G.A.; Abuzenadah, A.M.; Rehan, M. 2014: Anticancer compound plumbagin and its molecular targets: a structural insight into the inhibitory mechanisms using computational approaches. Plos one 9(2): E87309

Kharwar, R.N.; Mishra, A.; Gond, S.K.; Stierle, A.; Stierle, D. 2011: Anticancer compounds derived from fungal endophytes: their importance and future challenges. Natural Product Reports 28(7): 1208-1228

Kim, S.-K.; Thomas, N.V.; Li, X. 2011: Anticancer compounds from marine macroalgae and their application as medicinal foods. Advances in Food and Nutrition Research 64: 213-224

Vortherms, A.R.; Dang, H.N.; Doyle, R.P. 2009: Anticancer conjugates and cocktails based on methotrexate and nucleoside synergism. Clinical Medicine. Oncology 3: 19-26

Intisar, A.; Zhang, L.; Luo, H.; Kiazolu, J.B.; Zhang, R.; Zhang, W. 2012: Anticancer constituents and cytotoxic activity of methanol-water extract of Polygonum bistorta L. African Journal of Traditional Complementary and Alternative Medicines: Ajtcam 10(1): 53-59

Arouri, A.; Mouritsen, O.G. 2011: Anticancer double lipid prodrugs: liposomal preparation and characterization. Journal of Liposome Research 21(4): 296-305

Chen, Y.-Y.; Yeh, C.-H.; So, E.C.; Sun, D.-P.; Wang, L.-Y.; Hsing, C.-H. 2014: Anticancer drug 2-methoxyestradiol protects against renal ischemia/reperfusion injury by reducing inflammatory cytokines expression. Biomed Research International 2014: 431524

Kumar, S.; Aninat, C.; Michaux, G.ég.; Morel, F. 2010: Anticancer drug 5-fluorouracil induces reproductive and developmental defects in Caenorhabditis elegans. Reproductive Toxicology 29(4): 415-420

Li, F. 2014: Anticancer drug FL118 is more than a survivin inhibitor: where is the Achilles' heel of cancer?. American Journal of Cancer Research 4(3): 304-311

Despas, F.; Roche, H.; Laurent, G. 2013: Anticancer drug adherence. Bulletin du Cancer 100(5): 473-484

Dickens, H.; Ullrich, A.; Runge, D.; Mueller, B.; Olszewski, U.; Hamilton, G. 2008: Anticancer drug cis-4-hydroxy-L-proline: Correlation of preclinical toxicology with clinical parameters of liver function. Molecular Medicine Reports 1(4): 459-464

Hino, M.; Matsuda, K.; Miyanaga, A.; Kuribayasi, H.; Mizutani, H.; Noro, R.; Minegishi, Y.; Okano, T.; Seike, M.; Kawakami, A.; Yoshimura, A.; Ogawa, N.; Uesaka, H.; Kudoh, S.; Gemma, A. 2010: Anticancer drug clustering based on proteomic profiles and a sensitivity database in a lung cancer cell line panel. Experimental and Therapeutic Medicine 1(1): 41-45

Svenskaya, Y.; Parakhonskiy, B.; Haase, A.; Atkin, V.; Lukyanets, E.; Gorin, D.; Antolini, R. 2013: Anticancer drug delivery system based on calcium carbonate particles loaded with a photosensitizer. Biophysical Chemistry 182: 11-15

Hill, R. 2013: Anticancer drug demonstrates histone eviction activity. Future Medicinal Chemistry 5(11): 1189

Kawabata-Shoda, E.; Masuda, S.; Kimura, H. 2012: Anticancer drug development from traditional cytotoxic to targeted therapies: evidence of shorter drug research and development time, and shorter drug lag in Japan. Journal of Clinical Pharmacy and Therapeutics 37(5): 547-552

Haney, S.A. 2006: Anticancer drug development incorporating high-content screening and RNAi: synergistic approaches to improve target identification and validation. Expert Opinion on Drug Discovery 1(1): 19-29

Ades, F.; Zardavas, D.; Aftimos, P.; Awada, A. 2014: Anticancer drug development: moving away from the old habits. Current Opinion in Oncology 26(3): 334-339

Colotta, F. 2008: Anticancer drug discovery and development. Advances in Experimental Medicine and Biology 610: 19-42

Ma, X.; Wang, Z. 2009: Anticancer drug discovery in the future: an evolutionary perspective. Drug Discovery Today 14(23-24): 1136-1142

Pétain, A.él.; Chatelut, E. 2008: Anticancer drug dose individualisation: from body surface area to physiology. Bulletin du Cancer 95(10): 895-901

Lehne, G.; Bjørheim, J.; Saeter, G. 2007: Anticancer drug dosing--pharmacogenomic biomarkers or body surface area?. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 127(8): 1040-1044

Nakamura, Y.; Ishida, Y.; Yamada, T.; Shimada, S. 2011: Anticancer drug irinotecan inhibits homomeric 5-HT3A and heteromeric 5-HT3AB receptor responses. Biochemical and Biophysical Research Communications 415(2): 416-420

Sittl, R.; Lampert, A.; Huth, T.; Schuy, E.T.; Link, A.S.; Fleckenstein, J.; Alzheimer, C.; Grafe, P.; Carr, R.W. 2012: Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype Na(V)1.6-resurgent and persistent current. Proceedings of the National Academy of Sciences of the United States of America 109(17): 6704-6709

Lin, Q.; Huang, Q.; Li, C.; Bao, C.; Liu, Z.; Li, F.; Zhu, L. 2010: Anticancer drug release from a mesoporous silica based nanophotocage regulated by either a one- or two-photon process. Journal of the American Chemical Society 132(31): 10645-10647

Suzuki, M.; Ishikawa, H.; Tanaka, A.; Mataga, I. 2010: Anticancer drug sensitivity testing using an oxygen electrode apparatus. Human Cell 23(3): 103-112

Lichtman, S.M.; Boparai, M.K. 2008: Anticancer drug therapy in the older cancer patient: pharmacology and polypharmacy. Current Treatment Options in Oncology 9(2-3): 191-203

Lau, D.T.; Jarzebowski, M.H.; McKoy, J.M. 2011: Anticancer drug use in geriatric patients: concerns and challenges. Clinical Therapeutics 33(10): 1408-1412

Yuan, J.; Guo, W.; Yang, X.; Wang, E. 2009: Anticancer drug-DNA interactions measured using a photoinduced electron-transfer mechanism based on luminescent quantum dots. Analytical Chemistry 81(1): 362-368

Kim, T-Hyun.; Lee, G.Jin.; Kang, J-Hee.; Kim, H-Jun.; Kim, T-Il.; Oh, J-Min. 2014: Anticancer drug-incorporated layered double hydroxide nanohybrids and their enhanced anticancer therapeutic efficacy in combination cancer treatment. Biomed Research International 2014: 193401

Kim, J.Y.; Choi, S.-J.; Oh, J.-M.; Park, T.; Choy, J.-H. 2007: Anticancer drug-inorganic nanohybrid and its cellular interaction. Journal of Nanoscience and Nanotechnology 7(11): 3700-3705

Gulfam, M.; Kim, J-eun.; Lee, J.Min.; Ku, B.; Chung, B.Hyun.; Chung, B.Geun. 2012: Anticancer drug-loaded gliadin nanoparticles induce apoptosis in breast cancer cells. Langmuir: the Acs Journal of Surfaces and Colloids 28(21): 8216-8223

Long, J-Ting.; Cheang, T-Yun.; Zhuo, S-Yu.; Zeng, R-Fang.; Dai, Q-Sheng.; Li, H-Ping.; Fang, S. 2014: Anticancer drug-loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in lung cancer metastasis. Journal of Nanobiotechnology 12: 37

Yan, G.-P.; Zong, R.-F.; Li, L.; Fu, T.; Liu, F.; Yu, X.-H. 2010: Anticancer drug-loaded nanospheres based on biodegradable amphiphilic ε-caprolactone and carbonate copolymers. Pharmaceutical Research 27(12): 2743-2752

Shkreta, L.; Froehlich, U.; Paquet, E.R.; Toutant, J.; Elela, S.A.; Chabot, B. 2008: Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes. Molecular Cancer Therapeutics 7(6): 1398-1409

Raschi, E.; Vasina, V.; Ursino, M.G.; Boriani, G.; Martoni, A.; De Ponti, F. 2010: Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. Pharmacology and Therapeutics 125(2): 196-218

Minisini, A.M.; Pauletto, G.; Andreetta, C.; Bergonzi, P.; Fasola, G. 2008: Anticancer drugs and central nervous system: clinical issues for patients and physicians. Cancer Letters 267(1): 1-9

Yuan, F.; Zhou, W.; Zhang, J.; Zhang, Z.; Zou, C.; Huang, L.; Zhang, Y.; Dai, Z. 2008: Anticancer drugs are synergistic with freezing in induction of apoptosis in HCC cells. Cryobiology 57(1): 60-65

Lv, L.-H.; Wan, Y.-L.; Lin, Y.; Zhang, W.; Yang, M.; Li, G.-L.; Lin, H.-M.; Shang, C.-Z.; Chen, Y.-J.; Min, J. 2012: Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro. Journal of Biological Chemistry 287(19): 15874-15885

Anonymous 2013: Anticancer drugs deliver themselves to cancer cells. Future Medicinal Chemistry 5(10): 1079-1081

Pédeboscq, S.ép.; L'Azou, B.éa.; Passagne, I.; De Giorgi, F.; Ichas, F.ço.; Liguoro, D.; Pometan, J.-P.; Cambar, J. 2009: Anticancer drugs exert differential apoptotic and cytotoxic effects on glioblastoma primary cultures with various EGFR and bcl-2 profiles. Journal of Experimental Therapeutics and Oncology 8(2): 105-116

Sithranga Boopathy, N.; Kathiresan, K. 2010: Anticancer drugs from marine flora: an overview. Journal of Oncology 2010: 214186

Altmann, K.-H.; Gertsch, J.ür. 2007: Anticancer drugs from nature--natural products as a unique source of new microtubule-stabilizing agents. Natural Product Reports 24(2): 327-357

Besse, J.-P.; Latour, J.-F.ço.; Garric, J. 2012: Anticancer drugs in surface waters: what can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs?. Environment International 39(1): 73-86

Zimmer-Rapuch, S.; Lheureux, S.ép.; Brocard, F.; Janus, N.; Launay-Vacher, V.; Ray-Coquard, I. 2012: Anticancer drugs management in renal insufficiency patients. Bulletin du Cancer 99(3): 323-331

Rohlena, J.; Dong, L.-F.; Ralph, S.J.; Neuzil, J. 2011: Anticancer drugs targeting the mitochondrial electron transport chain. Antioxidants and Redox Signaling 15(12): 2951-2974

Papandreou, I.; Goliasova, T.; Denko, N.C. 2011: Anticancer drugs that target metabolism: Is dichloroacetate the new paradigm?. International Journal of Cancer 128(5): 1001-1008

Ben Aïssa, A.; George, A-C.; El M'Rabet, F.Z.; Mach, N.; Dietrich, P-Y.; Pechère-Bertschi, A. 2011: Anticancer drugs under pressure. Revue Medicale Suisse 7(308): 1761-1766

Malinowska, K.; Modranka, R.; Kedziora, J.óz. 2007: Anticancer drugs used in medicine and being in clinical research. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 23(135): 165-169

Zheng, S.-Y.; Li, Y.; Jiang, D.; Zhao, J.; Ge, J.-F. 2012: Anticancer effect and apoptosis induction by quercetin in the human lung cancer cell line A-549. Molecular Medicine Reports 5(3): 822-826

Wang, L.; Dong, J.; Ouyang, W.; Wang, X.; Tang, J. 2012: Anticancer effect and feasibility study of hyperthermia treatment of pancreatic cancer using magnetic nanoparticles. Oncology Reports 27(3): 719-726

Gao, X.; Wang, B.; Wei, X.; Men, K.; Zheng, F.; Zhou, Y.; Zheng, Y.; Gou, M.; Huang, M.; Guo, G.; Huang, N.; Qian, Z.; Wei, Y. 2012: Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer. Nanoscale 4(22): 7021-7030

Liu, Z-Jia.; Lv, H-Ning.; Li, H-Yan.; Zhang, Y.; Zhang, H-Jing.; Su, F-Qin.; Si, Y-Kang.; Yu, S-Shan.; Chen, X-Guang. 2011: Anticancer effect and neurotoxicity of S-(+)-deoxytylophorinidine, a new phenanthroindolizidine alkaloid that interacts with nucleic acids. Journal of Asian Natural Products Research 13(5): 400-408

Tao, L.-y.; Zhang, J.-y.; Liang, Y.-j.; Chen, L.-m.; Zhen, L.-s.; Wang, F.; Mi, Y.-j.; She, Z.-g.; To, K.K.W.; Lin, Y.-c.; Fu, L.-w. 2010: Anticancer effect and structure-activity analysis of marine products isolated from metabolites of mangrove fungi in the South China Sea. Marine Drugs 8(4): 1094-1105

Chae, Y.S.; Kim, J.G.; Jung, H.J.; Yang, J.D.; Jung, J.H.; Aiyar, S.E.; Kim, S.; Park, H. 2011: Anticancer effect of (E)-2-hydroxy-3',4,5'-trimethoxystilbene on breast cancer cells by mitochondrial depolarization. Cancer ChemoTherapy and Pharmacology 68(2): 349-358

Li, L.; Liu, H.; Zhang, S.-H.; Hu, L.; Zhen, Y.-S. 2013: Anticancer effect of 17-(6-cinnamamido-hexylamino-)-17-demethoxygeldanamycin: in vitro and in vivo. Yao Xue Xue Bao 48(12): 1771-1777

Dai, Z.-k.; Yang, X.-s.; Yu, L.-m. 2011: Anticancer effect of 5-fluorouracil combined with extract of Rosa roxburghii Tratt on human endometrial adenocarcinoma. Zhongguo Zhong Xi Yi Jie he Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 31(8): 1108-1112; 1117

Bednarczyk-Cwynar, B.; Zaprutko, L.; Ruszkowski, P.; Hładoń, B.ła. 2012: Anticancer effect of A-ring or/and C-ring modified oleanolic acid derivatives on KB, MCF-7 and Hela cell lines. Organic and Biomolecular Chemistry 10(11): 2201-2205

Dai, Z.-k.; Yu, L.-m.; Yang, X.-s. 2007: Anticancer effect of CL extract of Rosa roxburghii. Zhongguo Zhong Yao Za Zhi 32(14): 1453-1457

Altun, A.; Turgut, N.H.; Kaya, T.T. 2014: Anticancer effect of COX-2 inhibitor DuP-697 alone and in combination with tyrosine kinase inhibitor (E7080) on colon cancer cell lines. Asian Pacific Journal of Cancer Prevention: Apjcp 15(7): 3113-3121

Mao, F.; Xiao, B.; Jiang, Z.; Zhao, J.; Huang, X.; Guo, J. 2011: Anticancer effect of Lycium barbarum polysaccharides on colon cancer cells involves G0/G1 phase arrest. Medical Oncology 28(1): 121-126

Zheng, A.; Li, H.; Wang, X.; Feng, Z.; Xu, J.; Cao, K.; Zhou, B.; Wu, J.; Liu, J. 2014: Anticancer effect of a curcumin derivative B63: ROS production and mitochondrial dysfunction. Current Cancer Drug Targets 14(2): 156-166

Prasanna, R.; Harish, C.C. 2010: Anticancer effect of a novel 2-arylidene-4,7-dimethyl indan-1-one against human breast adenocarcinoma cell line by G2/M cell cycle arrest. Oncology Research 18(10): 461-468

Daniele, G.; Giordano, P.; De Luca, A.; Piccirillo, M.C.; Di Maio, M.; Del Giudice, A.; De Feo, G.; Bryce, J.; Lamura, L.; Vecchione, A.; Normanno, N.; Perrone, F. 2011: Anticancer effect of bisphosphonates: new insights from clinical trials and preclinical evidence. Expert Review of Anticancer Therapy 11(2): 299-307

Pillai, K.; Ehteda, A.; Akhter, J.; Chua, T.C.; Morris, D.L. 2014: Anticancer effect of bromelain with and without cisplatin or 5-FU on malignant peritoneal mesothelioma cells. Anti-Cancer Drugs 25(2): 150-160

Esmaeili, M.A.; Farimani, M.M.; Kiaei, M. 2014: Anticancer effect of calycopterin via PI3K/Akt and MAPK signaling pathways, ROS-mediated pathway and mitochondrial dysfunction in hepatoblastoma cancer (HepG2) cells. Molecular and Cellular Biochemistry 397(1-2): 17-31

Liu, H.; Huang, P.; Xu, X.; Liu, J.; Guo, C. 2009: Anticancer effect of celecoxib via COX-2 dependent and independent mechanisms in human gastric cancers cells. Digestive Diseases and Sciences 54(7): 1418-1424

Aung, W.; Sogawa, C.; Furukawa, T.; Saga, T. 2011: Anticancer effect of dihydroartemisinin (DHA) in a pancreatic tumor model evaluated by conventional methods and optical imaging. Anticancer Research 31(5): 1549-1558

Oh, B.; Kim, J.; Lu, W.; Rosenthal, D. 2014: Anticancer effect of fucoidan in combination with tyrosine kinase inhibitor lapatinib. Evidence-Based Complementary and Alternative Medicine: Ecam 2014: 865375

Hwang, K-A.; Park, M-Ah.; Kang, N-Hee.; Yi, B-Rim.; Hyun, S-Hwan.; Jeung, E-Bae.; Choi, K-Chul. 2013: Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor α and insulin-like growth factor-1 receptor signaling pathways. Toxicology and Applied Pharmacology 272(3): 637-646

Zheng, Q.; Liu, W.-W.; Li, B.; Chen, H.-J.; Zhu, W.-S.; Yang, G.-X.; Chen, M.-J.; He, G.-Y. 2014: Anticancer effect of icaritin on human lung cancer cells through inducing S phase cell cycle arrest and apoptosis. Journal of Huazhong University of Science and Technology. Medical Sciences 34(4): 497-503

Moon, Y.-H.; Park, J.-H.; Kim, S.-A.; Lee, J.-B.; Ahn, S.-G.; Yoon, J.-H. 2010: Anticancer effect of photodynamic therapy with hexenyl ester of 5-aminolevulinic acid in oral squamous cell carcinoma. Head and Neck 32(9): 1136-1142

Zhao, Q-Hong.; Zhang, Y.; Liu, Y.; Wang, H-Li.; Shen, Y-Yuan.; Yang, W-Jun.; Wen, L-Ping. 2010: Anticancer effect of realgar nanoparticles on mouse melanoma skin cancer in vivo via transdermal drug delivery. Medical Oncology 27(2): 203-212

Wang, J.; Li, J.-Z.; Lu, A.-X.; Zhang, K.-F.; Li, B.-J. 2014: Anticancer effect of salidroside on A549 lung cancer cells through inhibition of oxidative stress and phospho-p38 expression. Oncology Letters 7(4): 1159-1164

Kil, W.H.; Kim, S.M.; Lee, J.E.; Park, K.S.; Nam, S.J. 2014: Anticancer effect of silibinin on the xenograft model using MDA-MB-468 breast cancer cells. Annals of Surgical Treatment and Research 87(4): 167-173

Guo, J.; Zhang, Y.; Zhang, J.; Liang, J.; Zeng, L.; Guo, G. 2012: Anticancer effect of tert-butyl-2(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2)-pyrrolidine-1-carboxylic ester on human hepatoma HepG2 cell line. Chemico-Biological Interactions 199(1): 38-48

Machana, S.; Weerapreeyakul, N.; Barusrux, S. 2012: Anticancer effect of the extracts from Polyalthia evecta against human hepatoma cell line (HepG2). Asian Pacific Journal of Tropical Biomedicine 2(5): 368-374

Yang, R.-m.; Li, W.-m.; Hu, W.-j.; Huang, W.-h.; Zhu, C.-y.; Yu, J.-g.; Zhao, X.; Cai, D.-y.; Gao, N.-n. 2015: Anticancer effect of total annonaceous acetogenins on hepatocarcinoma. Chinese Journal of Integrative Medicine 21(9): 682-688

Hu, T.-n.; Wang, Q.-w.; Jin, X.; Hu, Q.-d.; Wang, X.-s.; Xu, S.; Zhou, J.; Tang, G.-p. 2012: Anticancer effect of triptolide-polyethylenimine-cyclodextrin in vitro. Zhejiang da Xue Xue Bao. Yi Xue Ban 41(6): 610-619

Wang, J.; Peng, C.-A. 2011: Anticancer effectiveness of polymeric drug nanocarriers on colorectal cancer cells. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2011: 3249-3252

De Jong, E.; Winkel, P.; Poelstra, K.; Prakash, J. 2011: Anticancer effects of 15d-prostaglandin-J2 in wild-type and doxorubicin-resistant ovarian cancer cells: novel actions on SIRT1 and HDAC. Plos one 6(9): E25192

Xu, Y.; Zhang, J.; Shi, W.; Liu, Y. 2013: Anticancer effects of 3,3'-diindolylmethane are associated with G1 arrest and mitochondria-dependent apoptosis in human nasopharyngeal carcinoma cells. Oncology Letters 5(2): 655-662

Jiang, J.; Cao, D.-H.; Tsukamoto, T.; Wang, G.-Q.; Jia, Z.-F.; Suo, J.; Cao, X.-Y. 2013: Anticancer effects of 4-vinyl-2,6-dimethoxyphenol (canolol) against SGC-7901 human gastric carcinoma cells. Oncology Letters 5(5): 1562-1566

Zhong, Y.-J.; Liu, S.-P.; Firestone, R.A.; Hong, Y.-P.; Li, Y. 2013: Anticancer effects of Ac‑Phe‑Lys‑PABC‑doxorubicin via mitochondria‑centered apoptosis involving reactive oxidative stress and the ERK1/2 signaling pathway in MGC‑803 cells. Oncology Reports 30(4): 1681-1686

Hsu, C.-L.; Yu, Y.-S.; Yen, G.-C. 2010: Anticancer effects of Alpinia pricei Hayata roots. Journal of Agricultural and Food Chemistry 58(4): 2201-2208

Ahmadi, A.; Mohagheghi, M.; Karimi, M.; Seyed Ali Golestanha; Naseri, M. 2009: Anticancer effects of HESA-A in patients with metastatic colon cancer. Integrative Cancer Therapies 8(1): 71-74

Ahmadi, A.; Habibi, G.; Farrokhnia, M. 2010: Anticancer effects of HESA-A: an herbal marine compound. Chinese Journal of Integrative Medicine 16(4): 366-367

Xu, X.; Wei, Q.; Wang, K.; Ling, Q.; Xie, H.; Zhou, L.; Zheng, S. 2011: Anticancer effects of Huaier are associated with down-regulation of P53. Asian Pacific Journal of Cancer Prevention: Apjcp 12(9): 2251-2254

Hong, S.-W.; Jung, K.H.; Choi, M.-J.; Kim, D.Y.; Lee, H.-S.; Zheng, H.-M.; Li, G.Y.; El-Deeb, I.M.; Park, B.S.; Lee, S.H.; Hong, S.-S. 2012: Anticancer effects of KI-10F: a novel compound affecting apoptosis, angiogenesis and cell growth in colon cancer. International Journal of Oncology 41(5): 1715-1722

Xie, X.; Tian, Y.; Yin, S.; Lin, Y.; Tan, G. 2013: Anticancer effects of Ligusticum chuanxiong Hort alcohol extracts on HS766T cell. African Journal of Traditional Complementary and Alternative Medicines: Ajtcam 10(6): 542-546

Choi, E.J.; Lee, J.-I.; Kim, G.-H. 2013: Anticancer effects of O-desmethylangolensin are mediated through cell cycle arrest at the G2/M phase and mitochondrial-dependent apoptosis in Hep3B human hepatocellular carcinoma cells. International Journal of Molecular Medicine 31(3): 726-730

Sun, M-Lei.; Wang, C-Mei.; Wen, Y-Ming. 2010: Anticancer effects of Pingyangmycin-activated carbon nanoparticles against human oral squamous carcinoma Tca8113 and BcaCD885 cell lines in vitro. Hua Xi Kou Qiang Yi Xue Za Zhi 28(3): 257-260

Wang, M.-q.; Liu, Y.-n.; Zhao, X.; Zhang, Y. 2009: Anticancer effects of a novel indolinone compound in nasopharyngeal carcinoma cells. Beijing da Xue Xue Bao. Yi Xue Ban 41(6): 640-644

Roomi, M.W.; Kalinovsky, T.; Roomi, N.W.; Rath, M.; Niedzwiecki, A. 2012: Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines. Oncology Reports 27(1): 17-27

Nakajima, K.; Yokoyama, A.; Nakajima, Y. 2009: Anticancer effects of a tertiary sulfonium compound, dimethylsulfoniopropionate, in green sea algae on Ehrlich ascites carcinoma-bearing mice. Journal of Nutritional Science and Vitaminology 55(5): 434-438

Raykov, Z.; Georgieva, P.B.; Angelova, A.; Galabov, A.S.; Rommelaere, J. 2009: Anticancer effects of an oncolytic parvovirus combined with non-conventional therapeutics on pancreatic carcinoma cell lines. Acta Virologica 53(1): 57-60

Park, S.-W.; Kim, J.-E.; Oh, S.-M.; Cha, W.-J.; Hah, J.-H.; Sung, M.-W. 2015: Anticancer effects of anandamide on head and neck squamous cell carcinoma cells via the production of receptor-independent reactive oxygen species. Head and Neck 37(8): 1187-1192

Zheng, Y.-H.; Yin, L.-H.; Grahn, T.H.M.; Ye, A.-F.; Zhao, Y.-R.; Zhang, Q.-Y. 2014: Anticancer effects of baicalein on hepatocellular carcinoma cells. PhytoTherapy Research: Ptr 28(9): 1342-1348

Serasanambati, M.; Chilakapati, S.Reddy.; Manikonda, P.Kumar.; Kanala, J.Reddy.; Chilakapati, D.Reddy. 2015: Anticancer effects of brucine and gemcitabine combination in MCF-7 human breast cancer cells. Natural Product Research 29(5): 484-490

Miao, Q.; Bi, L.-L.; Li, X.; Miao, S.; Zhang, J.; Zhang, S.; Yang, Q.; Xie, Y.-H.; Zhang, J.; Wang, S.-W. 2013: Anticancer effects of bufalin on human hepatocellular carcinoma HepG2 cells: roles of apoptosis and autophagy. International Journal of Molecular Sciences 14(1): 1370-1382

Liu, D.-B.; Long, G.-X.; Mei, Q.; Wang, J.-F.; Hu, G.-Y.; Gan, L.; Li, W.-W.; Sun, W.; Liu, S.-F.; Jiang, J.-Z.; Hu, G.-Q. 2014: Anticancer effects of celecoxib through inhibiton of STAT3 phosphorylation and AKT phosphorylation in nasopharyngeal carcinoma cell lines. Die Pharmazie 69(5): 358-361

Liu, W.; Wang, Y.; Wang, H.; Wang, A. 2014: Anticancer effects of chemokine receptor 4(CXCR4) gene silenced by CXCR4-siRNA in nude mice model of ovarian cancer. Cell Biochemistry and Biophysics 70(3): 1893-1900

Karagozlu, M.Z.; Kim, S.-K. 2014: Anticancer effects of chitin and chitosan derivatives. Advances in Food and Nutrition Research 72: 215-225

Huang, Y.; Zeng, F.; Xu, L.; Zhou, J.; Liu, X.; Le, H. 2013: Anticancer effects of cinnamic acid in lung adenocarcinoma cell line h1299-derived stem-like cells. Oncology Research 20(11): 499-507

Bathaie, S.Z.; Hoshyar, R.; Miri, H.; Sadeghizadeh, M. 2013: Anticancer effects of crocetin in both human adenocarcinoma gastric cancer cells and rat model of gastric cancer. Biochemistry and Cell Biology 91(6): 397-403

Xiang, J.; Xiang, Y.; Lin, S.; Xin, D.; Liu, X.; Weng, L.; Chen, T.; Zhang, M. 2014: Anticancer effects of deproteinized asparagus polysaccharide on hepatocellular carcinoma in vitro and in vivo. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(4): 3517-3524

Moussavou, G.; Kwak, D.H.; Obiang-Obonou, B.W.; Maranguy, C.A.O.; Dinzouna-Boutamba, S.-D.; Lee, D.H.; Pissibanganga, O.G.M.; Ko, K.; Seo, J.I.; Choo, Y.K. 2014: Anticancer effects of different seaweeds on human colon and breast cancers. Marine Drugs 12(9): 4898-4911

Lee, Y.-P.; Tsai, W.-C.; Ko, C.-J.; Rao, Y.K.; Yang, C.-R.; Chen, D.-R.; Yang, M.-H.; Yang, C.-C.; Tzeng, Y.-M. 2012: Anticancer effects of eleven triterpenoids derived from Antrodia camphorata. Anticancer Research 32(7): 2727-2734

Lemieszek, M.K.; Langner, E.; Kaczor, J.óz.; Kandefer-Szerszeń, M.; Sanecka, B.; Mazurkiewicz, W.; Rzeski, W. 2011: Anticancer effects of fraction isolated from fruiting bodies of Chaga medicinal mushroom, Inonotus obliquus (Pers.:Fr.) Pilát (Aphyllophoromycetideae): in vitro studies. International Journal of Medicinal Mushrooms 13(2): 131-143

Senthilkumar, K.; Kim, S.-K. 2014: Anticancer effects of fucoidan. Advances in Food and Nutrition Research 72: 195-213

Liao, F.; Saitoh, Y.; Miwa, N. 2011: Anticancer effects of fullerene [C60] included in polyethylene glycol combined with visible light irradiation through ROS generation and DNA fragmentation on fibrosarcoma cells with scarce cytotoxicity to normal fibroblasts. Oncology Research 19(5): 203-216

Niknejad, H.; Yazdanpanah, G. 2014: Anticancer effects of human amniotic membrane and its epithelial cells. Medical Hypotheses 82(4): 488-489

Luo, K.-w.; Sun, J.-g.; Chan, J.Y.-W.; Yang, L.; Wu, S.-h.; Fung, K.-P.; Liu, F.-y. 2011: Anticancer effects of imperatorin isolated from Angelica dahurica: induction of apoptosis in HepG2 cells through both death-receptor- and mitochondria-mediated pathways. ChemoTherapy 57(6): 449-459

Zhang, Y.; Lima, C.F.; Rodrigues, L.R. 2014: Anticancer effects of lactoferrin: underlying mechanisms and future trends in cancer therapy. Nutrition Reviews 72(12): 763-773

Rokkaku, T.; Kimura, R.; Ishikawa, C.; Yasumoto, T.; Senba, M.; Kanaya, F.; Mori, N. 2013: Anticancer effects of marine carotenoids, fucoxanthin and its deacetylated product, fucoxanthinol, on osteosarcoma. International Journal of Oncology 43(4): 1176-1186

Guppy, A.; Jamal-Hanjani, M.; Pickering, L. 2011: Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer. Future Oncology 7(6): 727-736

Vlotides, G.; Tanyeri, A.; Spampatti, M.; Zitzmann, K.; Chourdakis, M.; Spttl, C.; Maurer, J.; Nölting, S.; Göke, B.; Auernhammer, C.J. 2014: Anticancer effects of metformin on neuroendocrine tumor cells in vitro. Hormones 13(4): 498-508

Wieland, A.; Trageser, D.; Gogolok, S.; Reinartz, R.; Höfer, H.; Keller, M.; Leinhaas, A.; Schelle, R.; Normann, S.; Klaas, L.; Waha, A.; Koch, P.; Fimmers, R.; Pietsch, T.; Yachnis, A.T.; Pincus, D.W.; Steindler, D.A.; Brüstle, O.; Simon, M.; Glas, M.; Scheffler, B.ör. 2013: Anticancer effects of niclosamide in human glioblastoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 19(15): 4124-4136

Tanaka, M.; Kataoka, H.; Mabuchi, M.; Sakuma, S.; Takahashi, S.; Tujii, R.; Akashi, H.; Ohi, H.; Yano, S.; Morita, A.; Joh, T. 2011: Anticancer effects of novel photodynamic therapy with glycoconjugated chlorin for gastric and colon cancer. Anticancer Research 31(3): 763-769

Miyano-Kurosaki, N.; Ikegami, K.; Kurosaki, K.; Endo, T.; Aoyagi, H.; Hanami, M.; Yasumoto, J.; Tomoda, A. 2009: Anticancer effects of phenoxazine derivatives revealed by inhibition of cell growth and viability, disregulation of cell cycle, and apoptosis induction in HTLV-1-positive leukemia cells. Journal of Pharmacological Sciences 110(1): 87-97

Zhao, J.; Wu, Y.; Alfred, A.T.; Wei, P.; Yang, S. 2014: Anticancer effects of pyocyanin on HepG2 human hepatoma cells. Letters in Applied Microbiology 58(6): 541-548

Ohgidani, M.; Ichihara, H.; Goto, K.; Matsumoto, Y.; Ueoka, R. 2012: Anticancer effects of residual powder from Barley-Shochu distillation remnants against the orthotopic xenograft mouse models of hepatocellular carcinoma in vivo. Biological and Pharmaceutical Bulletin 35(6): 984-987

Wang, H.-G.; Huang, X.-D.; Shen, P.; Li, L.-R.; Xue, H.-T.; Ji, G.-Z. 2013: Anticancer effects of sodium butyrate on hepatocellular carcinoma cells in vitro. International Journal of Molecular Medicine 31(4): 967-974

Tzao, C.; Jin, J.-S.; Chen, B.-H.; Chung, H.-Y.; Chang, C.-C.; Hsu, T.-Y.; Sun, G.-H. 2014: Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo. Diseases of the Esophagus: Official Journal of the International Society for Diseases of the Esophagus 27(7): 693-702

Li, P.-G.; Mu, T.-H.; Deng, L. 2013: Anticancer effects of sweet potato protein on human colorectal cancer cells. World Journal of Gastroenterology 19(21): 3300-3308

Ferreira, A.K.; Meneguelo, R.; Pereira, A.; Mendonça Filho, O. R.; Chierice, G.O.; Maria, D.A. 2012: Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study. Anticancer Research 32(1): 95-104

Lee, C.-Y.; Sher, H.-F.; Chen, H.-W.; Liu, C.-C.; Chen, C.-H.; Lin, C.-S.; Yang, P.-C.; Tsay, H.-S.; Chen, J.J.W. 2008: Anticancer effects of tanshinone i in human non-small cell lung cancer. Molecular Cancer Therapeutics 7(11): 3527-3538

Zhao, Q.; Wu, C.-Z.; Lee, J.K.; Zhao, S.-R.; Li, H.-M.; Huo, Q.; Ma, T.; Zhang, J.; Hong, Y.-S.; Liu, H. 2014: Anticancer effects of the Hsp90 inhibitor 17-demethoxy-reblastatin in human breast cancer MDA-MB-231 cells. Journal of Microbiology and Biotechnology 24(7): 914-920

Jeon, H.S.; Ahn, M.Y.; Park, J.H.; Kim, T.H.; Chun, P.; Kim, W.H.; Kim, J.; Moon, H.R.; Jung, J.H.; Kim, H.S. 2010: Anticancer effects of the MHY218 novel hydroxamic acid-derived histone deacetylase inhibitor in human ovarian cancer cells. International Journal of Oncology 37(2): 419-428

Kim, H.-S.; Yi, B.-R.; Hwang, K.-A.; Kim, S.U.; Choi, K.-C. 2013: Anticancer effects of the engineered stem cells transduced with therapeutic genes via a selective tumor tropism caused by vascular endothelial growth factor toward Hela cervical cancer cells. Molecules and Cells 36(4): 347-354

Androutsopoulos, V.P.; Mahale, S.; Arroo, R.R.J.; Potter, G. 2009: Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation. Oncology Reports 21(6): 1525-1528

Androutsopoulos, V.P.; Ruparelia, K.C.; Papakyriakou, A.; Filippakis, H.; Tsatsakis, A.M.; Spandidos, D.A. 2011: Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: structural requirements for potency. European Journal of Medicinal Chemistry 46(6): 2586-2595

Rothweiler, F.; Michaelis, M.; Brauer, P.; Otte, J.ür.; Weber, K.; Fehse, B.; Doerr, H.W.; Wiese, M.; Kreuter, J.ör.; Al-Abed, Y.; Nicoletti, F.; Cinatl, J. 2010: Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells. Neoplasia 12(12): 1023-1030

Sonnemann, J.ür.; Palani, C.D.; Wittig, S.; Becker, S.; Eichhorn, F.; Voigt, A.; Beck, J.F. 2011: Anticancer effects of the p53 activator nutlin-3 in Ewing's sarcoma cells. European Journal of Cancer 47(9): 1432-1441

Ulasli, S.S.; Celik, S.; Gunay, E.; Ozdemir, M.; Hazman, O.; Ozyurek, A.; Koyuncu, T.; Unlu, M. 2013: Anticancer effects of thymoquinone, caffeic acid phenethyl ester and resveratrol on A549 non-small cell lung cancer cells exposed to benzo(a)pyrene. Asian Pacific Journal of Cancer Prevention: Apjcp 14(10): 6159-6164

Liu, J.-S.; He, S.-C.; Zhang, Z.-L.; Chen, R.; Fan, L.; Qiu, G.-L.; Chang, S.; Li, L.; Che, X.-M. 2014: Anticancer effects of β-elemene in gastric cancer cells and its potential underlying proteins: a proteomic study. Oncology Reports 32(6): 2635-2647

Yim, E-Kyoung.; Tong, S-Yun.; Ho, E-Mi.; Bae, J-Hoon.; Um, S-Jong.; Park, J-Sup. 2009: Anticancer effects on TACC3 by treatment of paclitaxel in HPV-18 positive cervical carcinoma cells. Oncology reports 21(2): 549-557

Lee, C.-I.; Wu, C.-C.; Hsieh, S.-L.; Lee, C.-L.; Chang, Y.-P.; Chang, C.-C.; Wang, Y.-Z.; Wang, J.-J. 2014: Anticancer effects on human pancreatic cancer cells of triterpenoids, polysaccharides and 1,3-β-D-glucan derived from the fruiting body of Antrodia camphorata. Food and Function 5(12): 3224-3232

Avdikos, A.; Karkabounas, S.; Metsios, A.; Kostoula, O.; Havelas, K.; Binolis, J.; Verginadis, I.; Hatziaivazis, G.; Simos, I.; Evangelou, A. 2007: Anticancer effects on leiomyosarcoma-bearing Wistar rats after electromagnetic radiation of resonant radiofrequencies. Hellenic Journal of Nuclear Medicine 10(2): 95-101

Wang, Y.; Qi, X.; Li, D.; Zhu, T.; Mo, X.; Li, J. 2014: Anticancer efficacy and absorption, distribution, metabolism, and toxicity studies of aspergiolide a in early drug development. Drug Design Development and Therapy 8: 1965-1977

Zheng, X.T.; Chen, P.; Li, C.M. 2012: Anticancer efficacy and subcellular site of action investigated by real-time monitoring of cellular responses to localized drug delivery in single cells. Small 8(17): 2670-2674

Chen, Y.; Wan, Y.; Wang, Y.; Zhang, H.; Jiao, Z. 2011: Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles. International Journal of Nanomedicine 6: 2321-2326

Li, M.-Y.; Leung, J.; Kong, A.W.Y.; Liang, N.C.; Wu, K.; Hsin, M.K.Y.; Deng, Y.F.; Gong, X.; Lv, Y.; Mok, T.S.K.; Underwood, M.J.; Chen, G.G. 2010: Anticancer efficacy of 5F in NNK-induced lung cancer development of A/J mice and human lung cancer cells. Journal of Molecular Medicine 88(12): 1265-1276

Zinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Findlay, D.M.; Zannettino, A.C.W.; Evdokiou, A. 2011: Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 26(3): 630-643

Selvendiran, K.; Tong, L.; Bratasz, A.; Kuppusamy, M.Lakshmi.; Ahmed, S.; Ravi, Y.; Trigg, N.J.; Rivera, B.K.; Kálai, Tás.; Hideg, Kálmán.; Kuppusamy, P. 2010: Anticancer efficacy of a difluorodiarylidenyl piperidone (HO-3867) in human ovarian cancer cells and tumor xenografts. Molecular Cancer Therapeutics 9(5): 1169-1179

Khan, A.A.; Jabeen, M.; Khan, A.A.; Owais, M. 2013: Anticancer efficacy of a novel propofol-linoleic acid-loaded escheriosomal formulation against murine hepatocellular carcinoma. Nanomedicine 8(8): 1281-1294

Thamilselvan, V.; Menon, M.; Thamilselvan, S. 2011: Anticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase-3 β/β-catenin pathway. International Journal of Cancer 129(12): 2916-2927

Gevorkyan, L.; Gambashidze, K. 2014: Anticancer efficacy of hydroxyethylthiamine diphosphate in vivo. Experimental Oncology 36(1): 48-49

Farazuddin, M.; Sharma, B.; Khan, A.Ahmed.; Joshi, B.; Owais, M. 2012: Anticancer efficacy of perillyl alcohol-bearing PLGA microparticles. International Journal of Nanomedicine 7: 35-47

Chang, J-Eun.; Yoon, I-Soo.; Sun, P-Li.; Yi, E.; Jheon, S.; Shim, C-Koo. 2014: Anticancer efficacy of photodynamic therapy with hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver cancer. Journal of Photochemistry and Photobiology. B Biology 140: 49-56

Kochuparambil, S.T.; Al-Husein, B.; Goc, A.; Soliman, S.; Somanath, P.R. 2011: Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression. Journal of Pharmacology and Experimental Therapeutics 336(2): 496-505

Reddy, L.H.; Renoir, J.-M.; Marsaud, V.; Lepetre-Mouelhi, S.; Desmaële, D.; Couvreur, P. 2009: Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor. Molecular Pharmaceutics 6(5): 1526-1535

Ganapathy-Kanniappan, S.; Kunjithapatham, R.; Geschwind, J.-F. 2013: Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting. Anticancer Research 33(1): 13-20

Sugitachi, A.; Kimura, Y.; Itabashi, T.; Ikeda, M.; Ishida, K.; Noda, H.; Matsuo, T.; Nishizuka, S.; Otsuka, K.; Koeda, K.; Sato, A.; Takahashi, T.; Wakabayashi, G. 2010: Anticancer efficacy with cisplatin delivery systems. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(12): 2274-2276

Rajpoot, P.; Bali, V.; Pathak, K. 2012: Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan. International Journal of Pharmaceutics 426(1-2): 219-230

Figová, K.; Hraběta, J.; Eckschlager, T. 2013: Anticancer efficiency of reovirus in normoxia and hypoxia. Folia Biologica 59(2): 68-75

Shamroukh, A.H.; El-Shahat, M.; Drabowicz, J.óz.; Ali, M.M.; Rashad, A.E.; Ali, H.S. 2013: Anticancer evaluation of some newly synthesized N-nicotinonitrile derivative. European Journal of Medicinal Chemistry 69: 521-526

Costa, L.; Harper, P.; Coleman, R.E.; Lipton, A. 2011: Anticancer evidence for zoledronic acid across the cancer continuum. Critical Reviews in Oncology/Hematology 77(Suppl 1): S31-S37

Cheng, Y.-s.; Xu, F. 2010: Anticancer function of polyinosinic-polycytidylic acid. Cancer Biology and Therapy 10(12): 1219-1223

Pazarentzos, E.; Mazarakis, N.D. 2014: Anticancer gene transfer for cancer gene therapy. Advances in Experimental Medicine and Biology 818: 255-280

Grimm, S.; Noteborn, M. 2010: Anticancer genes: inducers of tumour-specific cell death signalling. Trends in Molecular Medicine 16(2): 88-96

Tian, S.; Siu, F.-M.; Kui, S.C.F.; Lok, C.-N.; Che, C.-M. 2011: Anticancer gold(I)-phosphine complexes as potent autophagy-inducing agents. Chemical Communications 47(33): 9318-9320

Nepali, K.; Sharma, S.; Kumar, D.; Budhiraja, A.; Dhar, K.L. 2014: Anticancer hybrids--a patent survey. Recent Patents on Anti-Cancer Drug Discovery 9(3): 303-339

Paradziej-Łukowicz, J.; Skwarska, A.; Peszyńska-Sularz, G.ży.; Brillowska-Dąbrowska, A.; Konopa, J. 2011: Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis. Cancer Biology and Therapy 12(7): 586-597

Bernal, S.D.; Ona, E.T.; Riego-Javier, A.; DE Villa, R.; Cristal-Luna, G.R.; Laguatan, J.B.; Batac, E.R.; Canlas, O.Q. 2012: Anticancer immune reactivity and long-term survival after treatment of metastatic ovarian cancer with dendritic cells. Oncology Letters 3(1): 66-74

Zitvogel, L.; Kroemer, G. 2009: Anticancer immunochemotherapy using adjuvants with direct cytotoxic effects. Journal of Clinical Investigation 119(8): 2127-2130

Nisa, S.; Bibi, Y.; Zia, M.; Waheed, A.; Chaudhary, M.F. 2013: Anticancer investigations on Carissa opaca and Toona ciliata extracts against human breast carcinoma cell line. Pakistan Journal of Pharmaceutical Sciences 26(5): 1009-1012

Ionkova, I. 2011: Anticancer lignans--from discovery to biotechnology. Mini Reviews in Medicinal Chemistry 11(10): 843-856

Bao, Y.-Y.; Zhou, S.-H.; Fan, J.; Wang, Q.-Y. 2013: Anticancer mechanism of apigenin and the implications of GLUT-1 expression in head and neck cancers. Future Oncology 9(9): 1353-1364

Choi, E.J.; Kim, G.-H. 2011: Anticancer mechanism of equol in 7,12-dimethylbenz(a)anthracene-treated animals. International Journal of Oncology 39(3): 747-754

Tang, C.; Shao, X.; Sun, B.; Huang, W.; Qiu, F.; Chen, Y.; Shi, Y.-k.; Zhang, E.-y.; Wang, C.; Zhao, X. 2010: Anticancer mechanism of peptide P18 in human leukemia K562 cells. Organic and Biomolecular Chemistry 8(5): 984-987

Ausbacher, D.; Svineng, G.ør.; Hansen, T.; Strøm, M.B. 2012: Anticancer mechanisms of action of two small amphipathic β(2,2)-amino acid derivatives derived from antimicrobial peptides. Biochimica et Biophysica Acta 1818(11): 2917-2925

Ottewell, P.D.; Woodward, J.K.; Lefley, D.V.; Evans, C.A.; Coleman, R.E.; Holen, I. 2009: Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone. Molecular Cancer Therapeutics 8(10): 2821-2832

Dong, Y.-H.; Guo, Y.-H.; Gu, X.-B. 2009: Anticancer mechanisms of vitamin e succinate. Ai Zheng 28(10): 1114-1118

Samra, Z.Qadir.; Ahmad, S.; Javeid, M.; Dar, N.; Aslam, M.Shahbaz.; Gull, I.; Ahmad, M.Mustaneer. 2013: Anticancer medicines (Doxorubicin and methotrexate) conjugated with magnetic nanoparticles for targeting drug delivery through iron. Preparative Biochemistry and Biotechnology 43(8): 781-797

Ganot, N.; Meker, S.; Reytman, L.; Tzubery, A.; Tshuva, E.Y. 2013: Anticancer metal complexes: synthesis and cytotoxicity evaluation by the MTT assay. Journal of Visualized Experiments: Jove 81: E50767

Barahuie, F.; Hussein, M.Z.; Abd Gani, S.; Fakurazi, S.; Zainal, Z. 2014: Anticancer nanodelivery system with controlled release property based on protocatechuate-zinc layered hydroxide nanohybrid. International Journal of Nanomedicine 9: 3137-3149

Taurin, S.; Nehoff, H.; Greish, K. 2012: Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?. Journal of Controlled Release: Official Journal of the Controlled Release Society 164(3): 265-275

Banna, G.L.; Collovà, E.; Gebbia, V.; Lipari, H.; Giuffrida, P.; Cavallaro, S.; Condorelli, R.; Buscarino, C.; Tralongo, P.; Ferraù, F. 2010: Anticancer oral therapy: emerging related issues. Cancer Treatment Reviews 36(8): 595-605

Dara, A.; Sangamwar, A.T. 2014: Anticancer patent landscape and technology assessment of Indian public-funded research institutes and organizations. Expert Opinion on Therapeutic Patents 24(8): 893-912

Perera, Y.; Farina, H.án.G.; Gil, J.; Rodriguez, A.; Benavent, F.; Castellanos, L.; Gómez, R.E.; Acevedo, B.E.; Alonso, D.F.; Perea, S.E. 2009: Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity. Molecular Cancer Therapeutics 8(5): 1189-1196

Gross, S.; Andrä, J.ör. 2012: Anticancer peptide NK-2 targets cell surface sulphated glycans rather than sialic acids. Biological Chemistry 393(8): 817-827

Sarafraz-Yazdi, E.; Bowne, W.B.; Adler, V.; Sookraj, K.A.; Wu, V.; Shteyler, V.; Patel, H.; Oxbury, W.; Brandt-Rauf, P.; Zenilman, M.E.; Michl, J.; Pincus, M.R. 2010: Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes. Proceedings of the National Academy of Sciences of the United States of America 107(5): 1918-1923

Gaspar, D.; Veiga, A.S.é; Sinthuvanich, C.; Schneider, J.P.; Castanho, M.A.R.B. 2012: Anticancer peptide SVS-1: efficacy precedes membrane neutralization. Biochemistry 51(32): 6263-6265

Wang, Y.; Li, P.; Wang, S.; Hu, J.; Chen, X.A.; Wu, J.; Fisher, M.; Oshaben, K.; Zhao, N.; Gu, Y.; Wang, D.; Chen, G.; Wang, Y. 2012: Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity. Journal of Biological Chemistry 287(31): 25941-25953

Scherer, K.M.; Bisby, R.H.; Botchway, S.W.; Hadfield, J.A.; Parker, A.W. 2015: Anticancer phototherapy using activation of E-combretastatins by two-photon-induced isomerization. Journal of Biomedical Optics 20(5): 051004

Dandawate, P.; Ahmad, A.; Deshpande, J.; Swamy, K.V.; Khan, E.M.; Khetmalas, M.; Padhye, S.; Sarkar, F. 2014: Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells. Bioorganic and Medicinal Chemistry Letters 24(13): 2900-2904

Chin, C.F.; Wong, D.Y.Q.; Jothibasu, R.; Ang, W.H. 2011: Anticancer platinum (IV) prodrugs with novel modes of activity. Current Topics in Medicinal Chemistry 11(21): 2602-2612

Alemán, J.é; del Solar, V.; Navarro-Ranninger, C. 2010: Anticancer platinum complexes as non-innocent compounds for catalysis in aqueous media. Chemical Communications 46(3): 454-456

Markovsky, E.; Baabur-Cohen, H.; Satchi-Fainaro, R. 2014: Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs. Journal of Controlled Release: Official Journal of the Controlled Release Society 187: 145-157

Zong, A.; Cao, H.; Wang, F. 2012: Anticancer polysaccharides from natural resources: a review of recent research. Carbohydrate Polymers 90(4): 1395-1410

Dubey, A.; Min, J.W.; Koo, H.J.; Kim, H.; Cook, T.R.; Kang, S.C.; Stang, P.J.; Chi, K.-W. 2013: Anticancer potency and multidrug-resistant studies of self-assembled arene-ruthenium metallarectangles. Chemistry 19(35): 11622-11628

Yu, T.; Zhang, Y.; He, H.; Zhou, S.; Liu, Y.; Huang, P. 2011: Anticancer potency of cytotoxic drugs after exposure to high-intensity focused ultrasound in the presence of microbubbles and hematoporphyrin. Molecular Pharmaceutics 8(4): 1408-1415

Zhao, J.; Gou, S.; Liu, F.; Sun, Y.; Gao, C. 2013: Anticancer potency of platinum(II) complexes containing both chloride anion and chelated carboxylate as leaving groups. Inorganic Chemistry 52(14): 8163-8170

Sivertsen, A.; Tørfoss, V.; Isaksson, J.; Ausbacher, D.; Anderssen, T.; Brandsdal, B.ør.-O.; Havelkova, M.; Skjørholm, A.E.; Strøm, M.B. 2014: Anticancer potency of small linear and cyclic tetrapeptides and pharmacokinetic investigations of peptide binding to human serum albumin. Journal of Peptide Science: An Official Publication of the European Peptide Society 20(4): 279-291

Mishra, A.; Jeong, Y.J.; Jo, J.-H.; Kang, S.C.; Lah, M.S.; Chi, K.-W. 2014: Anticancer potency studies of coordination driven self-assembled arene–Ru-based metalla-bowls. Chembiochem: a European Journal of Chemical Biology 15(5): 695-700

Ludwig, G.; Ranđelović, I.; Maksimović-Ivanić, D.; Mijatović, S.; Bulatović, M.Z.; Miljković, D.; Korb, M.; Lang, H.; Steinborn, D.; Kaluđerović, G.N. 2014: Anticancer potential of (pentamethylcyclopentadienyl)chloridoiridium(III) complexes bearing κP and κP,κS-coordinated Ph2 PCH2 CH2 CH2 S(O)x Ph (x=0-2) ligands. Chemmedchem 9(7): 1586-1593

Das, S.; Chatterjee, N.; Bose, D.; Dey, S.K.; Munda, R.N.; Nandy, A.; Bera, S.; Biswas, S.K.; Das Saha, K. 2012: Anticancer potential of 3-(arylideneamino)-2-phenylquinazoline-4(3H)-one derivatives. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 29(1-2): 251-260

Mondal, J.; Panigrahi, A.K.; Khuda-Bukhsh, A.R. 2014: Anticancer potential of Conium maculatum extract against cancer cells in vitro: Drug-DNA interaction and its ability to induce apoptosis through ROS generation. Pharmacognosy Magazine 10(Suppl 3): S524-S533

Li, G.; Yu, K.; Li, F.; Xu, K.; Li, J.; He, S.; Cao, S.; Tan, G. 2014: Anticancer potential of Hericium erinaceus extracts against human gastrointestinal cancers. Journal of Ethnopharmacology 153(2): 521-530

Kumar, P.S.; Febriyanti, R.M.; Sofyan, F.F.; Luftimas, D.E.; Abdulah, R. 2014: Anticancer potential of Syzygium aromaticum L. in MCF-7 human breast cancer cell lines. Pharmacognosy Research 6(4): 350-354

Oh, S.-M.; Kim, J.; Lee, J.; Yi, J.-M.; Oh, D.-S.; Bang, O.-S.; Kim, N.S. 2013: Anticancer potential of an ethanol extract of Asiasari radix against HCT-116 human colon cancer cells in vitro. Oncology Letters 5(1): 305-310

Byambaragchaa, M.; Dela Cruz, J.; Kh, A.; Hwang, S.-G. 2014: Anticancer potential of an ethanol extract of Saussurea involucrata against hepatic cancer cells in vitro. Asian Pacific Journal of Cancer Prevention: Apjcp 15(18): 7527-7532

Gomes, A.; Bhattacharjee, P.; Mishra, R.; Biswas, A.K.; Dasgupta, S.C.; Giri, B. 2010: Anticancer potential of animal venoms and toxins. Indian Journal of Experimental Biology 48(2): 93-103

Fang, S.; Lin, C.; Zhang, Q.; Wang, L.; Lin, P.; Zhang, J.; Wang, X. 2012: Anticancer potential of aqueous extract of alocasia macrorrhiza against hepatic cancer in vitro and in vivo. Journal of Ethnopharmacology 141(3): 947-956

Paul, A.; Das, J.; Das, S.; Samadder, A.; Khuda-Bukhsh, A.R. 2013: Anticancer potential of myricanone, a major bioactive component of Myrica cerifera: novel signaling cascade for accomplishing apoptosis. Journal of Acupuncture and Meridian Studies 6(4): 188-198

Saleem, S.; Shaharyar, M.A.; Khusroo, M.J.; Ahmad, P.; Rahman, R.U.; Ahmad, K.; Alam, M.J.; Al-Harbi, N.O.; Iqbal, M.; Imam, F. 2013: Anticancer potential of rhamnocitrin 4'-β-D-galactopyranoside against N-diethylnitrosamine-induced hepatocellular carcinoma in rats. Molecular and Cellular Biochemistry 384(1-2): 147-153

Paul, S.; Bhattacharyya, S.S.; Samaddar, A.; Boujedaini, N.; Khuda-Bukhsh, A.R. 2011: Anticancer potentials of root extract of Polygala senega against benzo[a]pyrene-induced lung cancer in mice. Zhong Xi Yi Jie he Xue Bao 9(3): 320-327

Wang, Y.-H.; Morris-Natschke, S.L.; Yang, J.; Niu, H.-M.; Long, C.-L.; Lee, K.-H. 2014: Anticancer principles from medicinal piper ( hú jiāo) plants. Journal of Traditional and Complementary Medicine 4(1): 8-16

Rubbiani, R.; Zehnder, T.N.; Mari, C.; Blacque, O.; Venkatesan, K.; Gasser, G. 2014: Anticancer profile of a series of gold(III) (2-phenyl)pyridine complexes. Chemmedchem 9(12): 2781-2790

Demin, E.V.; Merabishvili, V.M. 2014: Anticancer propaganda: myth or reality?. Voprosy Onkologii 60(1): 96-101

Xue, M.; Ge, Y.; Zhang, J.; Wang, Q.; Hou, L.; Liu, Y.; Sun, L.; Li, Q. 2012: Anticancer properties and mechanisms of fucoidan on mouse breast cancer in vitro and in vivo. Plos one 7(8): E43483

Ismail, M.; Bagalkotkar, G.; Iqbal, S.; Adamu, H.A. 2012: Anticancer properties and phenolic contents of sequentially prepared extracts from different parts of selected medicinal plants indigenous to Malaysia. Molecules 17(5): 5745-5756

Hu, W.; Zhang, C.; Fang, Y.; Lou, C. 2011: Anticancer properties of 10-hydroxycamptothecin in a murine melanoma pulmonary metastasis model in vitro and in vivo. Toxicology in Vitro: An International Journal Published in Association with Bibra 25(2): 513-520

Mezencev, R.; Kutschy, P.; Salayová, A.; Curillová, Z.; Mojzis, J.án.; Pilátová, M.; McDonald, J. 2008: Anticancer properties of 2-piperidyl analogues of the natural indole phytoalexin 1-methoxyspirobrassinol. ChemoTherapy 54(5): 372-378

Harhaji Trajković, L.M.; Mijatović, S.A.; Maksimović-Ivanić, D.D.; Stojanović, I.D.; Momcilović, M.B.; Tufegdzić, S.J.; Maksimović, V.M.; Marjanović, Z.S.; Stosić-Grujicić, S.D. 2009: Anticancer properties of Ganoderma lucidum methanol extracts in vitro and in vivo. Nutrition and Cancer 61(5): 696-707

Yang, T.; Liu, J.; Luo, F.; Lin, Q.; Rosol, T.J.; Deng, X. 2014: Anticancer properties of Monascus metabolites. Anti-Cancer Drugs 25(7): 735-744

Tafrihi, M.; Toosi, S.; Minaei, T.; Gohari, A.R.; Niknam, V.; Arab Najafi, S.M. 2014: Anticancer properties of Teucrium persicum in PC-3 prostate cancer cells. Asian Pacific Journal of Cancer Prevention: Apjcp 15(2): 785-791

Magedov, I.V.; Frolova, L.; Manpadi, M.; Bhoga, U.d.; Tang, H.; Evdokimov, N.M.; George, O.; Georgiou, K.H.; Renner, S.; Getlik, M.äu.; Kinnibrugh, T.L.; Fernandes, M.A.; Van slambrouck, S.; Steelant, W.F.A.; Shuster, C.B.; Rogelj, S.; van Otterlo, W.A.L.; Kornienko, A. 2011: Anticancer properties of an important drug lead podophyllotoxin can be efficiently mimicked by diverse heterocyclic scaffolds accessible via one-step synthesis. Journal of Medicinal Chemistry 54(12): 4234-4246

Gibot, L.; Chabaud, S.ép.; Bouhout, S.; Bolduc, S.ép.; Auger, F.ço.A.; Moulin, V.ér.J. 2015: Anticancer properties of chitosan on human melanoma are cell line dependent. International Journal of Biological Macromolecules 72: 370-379

Hooft van Huijsduijnen, R.; Guy, R.K.; Chibale, K.; Haynes, R.K.; Peitz, I.; Kelter, G.; Phillips, M.A.; Vennerstrom, J.L.; Yuthavong, Y.; Wells, T.N.C. 2013: Anticancer properties of distinct antimalarial drug classes. Plos one 8(12): E82962

Hahm, S.-W.; Park, J.; Oh, S.-Y.; Lee, C.-W.; Park, K.-Y.; Kim, H.; Son, Y.-S. 2015: Anticancer properties of extracts from Opuntia humifusa against human cervical carcinoma cells. Journal of Medicinal Food 18(1): 31-44

Clere, N.; Faure, S.éb.; Martinez, M.C.; Andriantsitohaina, R. 2011: Anticancer properties of flavonoids: roles in various stages of carcinogenesis. Cardiovascular and Hematological Agents in Medicinal Chemistry 9(2): 62-77

Bahrami, F.; Morris, D.L.; Rufener, L.; Pourgholami, M.H. 2014: Anticancer properties of novel aminoacetonitrile derivative monepantel (ADD 1566) in pre-clinical models of human ovarian cancer. American Journal of Cancer Research 4(5): 545-557

Markowicz, S.; Matalinska, J.; Kurzepa, K.; Bochynska, M.; Biernacka, M.; Samluk, A.; Dudek, D.; Skurzak, H.; Yoshikawa, M.; Lipkowski, A.W. 2014: Anticancer properties of peptide fragments of hair proteins. Plos one 9(6): E98073

Lemieszek, M.; Rzeski, W. 2012: Anticancer properties of polysaccharides isolated from fungi of the Basidiomycetes class. Contemporary Oncology 16(4): 285-289

Youn, S.H.; Lee, J.S.; Lee, M.S.; Cha, E.Y.; Thuong, P.T.; Kim, J.R.; Chang, E.S. 2012: Anticancer properties of pomolic acid-induced AMP-activated protein kinase activation in MCF7 human breast cancer cells. Biological and Pharmaceutical Bulletin 35(1): 105-110

Chirumbolo, S. 2013: Anticancer properties of the flavone wogonin. Toxicology 314(1): 60-64

Green, J.; Lipton, A. 2010: Anticancer properties of zoledronic acid. Cancer Investigation 28(9): 944-957

Pillai, K.; Akhter, J.; Chua, T.C.; Morris, D.L. 2013: Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma. Cancer Investigation 31(4): 241-250

Maurya, D.K.; Nandakumar, N.; Devasagayam, T.P.A. 2011: Anticancer property of gallic acid in A549, a human lung adenocarcinoma cell line, and possible mechanisms. Journal of Clinical Biochemistry and Nutrition 48(1): 85-90

Ravikumar, S.; Fredimoses, M.; Gnanadesigan, M. 2012: Anticancer property of sediment actinomycetes against MCF-7 and MDA-MB-231 cell lines. Asian Pacific Journal of Tropical Biomedicine 2(2): 92-96

Sadafi, F.-Z.; Massai, L.; Bartolommei, G.; Moncelli, M.R.; Messori, L.; Tadini-Buoninsegni, F. 2014: Anticancer ruthenium(III) complex KP1019 interferes with ATP-dependent Ca2+ translocation by sarco-endoplasmic reticulum Ca2+-ATPase (SERCA). Chemmedchem 9(8): 1660-1664

Muktapuram, P.R.; Gara, R.K.; Sharma, K.; Rohit, C.; Srinivas, K.; Mishra, D.P.; Bathula, S.R. 2012: Anticancer siRNA delivery by new anticancer molecule: a novel combination strategy for cancer cell killing. European Journal of Medicinal Chemistry 56: 400-408

Woo, L.W.L.; Fischer, D.S.; Sharland, C.M.; Trusselle, M.; Foster, P.A.; Chander, S.K.; Di Fiore, A.; Supuran, C.T.; De Simone, G.; Purohit, A.; Reed, M.J.; Potter, B.V.L. 2008: Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography. Molecular Cancer Therapeutics 7(8): 2435-2444

Salvador, J.A.R.; Carvalho, J.ão.F.S.; Neves, M.A.C.; Silvestre, S.M.; Leitão, A.J.; Silva, M.M.C.; Sá e Melo, M.L. 2013: Anticancer steroids: linking natural and semi-synthetic compounds. Natural Product Reports 30(2): 324-374

Kumar, K.S.; Kumar, P.S.; Vijayalakshmi, S. 2011: Anticancer studies of drug encapsulated polyethylene terephthalate-Co-polylactic acid nanocapsules. Journal of Pharmacy and Bioallied Sciences 3(2): 286-293

Ivanova, T.S.; Krupodorova, T.A.; Barshteyn, V.Y.; Artamonova, A.B.; Shlyakhovenko, V.A. 2014: Anticancer substances of mushroom origin. Experimental Oncology 36(2): 58-66

Porporato, P.E.; Dhup, S.; Dadhich, R.K.; Copetti, T.; Sonveaux, P. 2011: Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review. Frontiers in Pharmacology 2: 49

Vergara, E.; Casini, A.; Sorrentino, F.; Zava, O.; Cerrada, E.; Rigobello, M.P.; Bindoli, A.; Laguna, M.; Dyson, P.J. 2010: Anticancer therapeutics that target selenoenzymes: synthesis, characterization, in vitro cytotoxicity, and thioredoxin reductase inhibition of a series of gold(I) complexes containing hydrophilic phosphine ligands. Chemmedchem 5(1): 96-102

Broxterman, H.J.; Georgopapadakou, N.H. 2007: Anticancer therapeutics: a surge of new developments increasingly target tumor and stroma. Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer ChemoTherapy 10(4-5): 182-193

Bay, J.-O.; Larsen, C.-J. 2009: Anticancer therapeutics: should a different therapeutic concept be considered?. Bulletin du Cancer 96(9): 815-816

Platt, V.M.; Szoka, F.C. 2008: Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Molecular Pharmaceutics 5(4): 474-486

Chamberlain, M.C. 2010: Anticancer therapies and CNS relapse: overcoming blood-brain and blood-cerebrospinal fluid barrier impermeability. Expert Review of Neurotherapeutics 10(4): 547-561

Compton, L.A.; Hiebert, S.W. 2010: Anticancer therapy SMRT-ens up: targeting the BCL6-SMRT interaction in B cell lymphoma. Cancer Cell 17(4): 315-316

Yang, T.J.; Haimovitz-Friedman, A.; Verheij, M. 2012: Anticancer therapy and apoptosis imaging. Experimental Oncology 34(3): 269-276

Schwöppe, C.; Zerbst, C.; Fröhlich, M.; Schliemann, C.; Kessler, T.; Liersch, R.; Overkamp, L.; Holtmeier, R.; Stypmann, J.ör.; Dreiling, A.; König, S.; Höltke, C.; Lücke, M.; Müller-Tidow, C.; Mesters, R.M.; Berdel, W.E. 2013: Anticancer therapy by tumor vessel infarction with polyethylene glycol conjugated retargeted tissue factor. Journal of Medicinal Chemistry 56(6): 2337-2347

Varol, U.; Yildiz, I.; Alacacioglu, A.; Uslu, R. 2014: Anticancer therapy for breast cancer patients with skin metastases refractory to conventional treatments. Asian Pacific journal of cancer prevention: APJCP 15(4): 1885-1887

Thiery-Vuillemin, A.; Chaigneau, L.; Meaux-Ruault, N.; Villanueva, C.; N'guyen, T.; Maurina, T.; Stein, U.; Lorgis, V.ér.; Demarchi, M.; Pivot, X. 2008: Anticancer therapy in patients with porphyrias: evidence today. Expert Opinion on Drug Safety 7(2): 159-165

Geiger, S.; Lange, V.; Suhl, P.; Heinemann, V.; Stemmler, H-Joachim. 2010: Anticancer therapy induced cardiotoxicity: review of the literature. Anti-Cancer Drugs 21(6): 578-590

Parkinson, E.K.; Minty, F. 2007: Anticancer therapy targeting telomeres and telomerase : current status. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 21(6): 375-385

Garrett, M.D.; Collins, I. 2011: Anticancer therapy with checkpoint inhibitors: what, where and when?. Trends in Pharmacological Sciences 32(5): 308-316

Lacouture, M.E.; Lenihan, D.; Wu, S. 2012: Anticancer therapy-induced adverse events: practicing damage control. Expert Opinion on Drug Safety 11 Suppl. 1: S1-S3

Hendrickson, A.W.; Meng, X.W.; Kaufmann, S.H. 2008: Anticancer therapy: boosting the bang of Bim. Journal of Clinical Investigation 118(11): 3582-3584

Byers, T. 2010: Anticancer vitamins du Jour--The ABCED's so far. American Journal of Epidemiology 172(1): 1-3

Sinthuvanich, C.; Veiga, A.S.é; Gupta, K.; Gaspar, D.; Blumenthal, R.; Schneider, J.P. 2012: Anticancer β-hairpin peptides: membrane-induced folding triggers activity. Journal of the American Chemical Society 134(14): 6210-6217

Rani, P.; Pal, D.; Hegde, R.R.; Hashim, S.R. 2014: Anticancer, anti-inflammatory, and analgesic activities of synthesized 2-(substituted phenoxy) acetamide derivatives. Biomed Research International 2014: 386473

Ismail, M.A.; Arafa, R.K.; Youssef, M.M.; El-Sayed, W.M. 2014: Anticancer, antioxidant activities, and DNA affinity of novel monocationic bithiophenes and analogues. Drug Design Development and Therapy 8: 1659-1672

Yu, J.-Q.; Lei, J.-C.; Zhang, X.-Q.; Yu, H.-D.; Tian, D.-Z.; Liao, Z.-X.; Zou, G.-L. 2011: Anticancer, antioxidant and antimicrobial activities of the essential oil of Lycopus lucidus Turcz. var. hirtus Regel. Food Chemistry 126(4): 1593-1598

Baliga, M.Shrinath. 2011: Anticancer, chemopreventive and radioprotective potential of black plum (Eugenia jambolana lam.). Asian Pacific Journal of Cancer Prevention: Apjcp 12(1): 3-15

Meinig, J.M.; Peterson, B.R. 2015: Anticancer/antiviral agent Akt inhibitor-IV massively accumulates in mitochondria and potently disrupts cellular bioenergetics. Acs Chemical Biology 10(2): 570-576

Hussain, S.S.; Agoumi, A.; Amghar, S.; Boukachabine, K. 2011: Anticandida activity of the marketed essential oil of Thymus vulgaris L and its concomitant action with amphotericin B. Therapie 66(2): 167-169

Uma, B.; Prabhakar, K.; Rajendran, S. 2009: Anticandidal Activity of Asparagus racemosus. Indian Journal of Pharmaceutical Sciences 71(3): 342-343

Tayel, A.A.; Moussa, S.; el-Tras, W.F.; Knittel, D.; Opwis, K.; Schollmeyer, E. 2010: Anticandidal action of fungal chitosan against Candida albicans. International Journal of Biological Macromolecules 47(4): 454-457

Irshad; Shreaz, S.; Manzoor, N.; Khan, L.A.; Rizvi, M.M.A. 2011: Anticandidal activity of Cassia fistula and its effect on ergosterol biosynthesis. Pharmaceutical Biology 49(7): 727-733

Nyanzi, R.; Awouafack, M.D.; Steenkamp, P.; Jooste, P.J.; Eloff, J.N. 2014: Anticandidal activity of cell extracts from 13 probiotic Lactobacillus strains and characterisation of lactic acid and a novel fatty acid derivative from one strain. Food Chemistry 164: 470-475

Shreaz, S.; Sheikh, R.A.; Rimple, B.; Hashmi, A.A.; Nikhat, M.; Khan, L.A. 2010: Anticandidal activity of cinnamaldehyde, its ligand and Ni(II) complex: effect of increase in ring and side chain. Microbial Pathogenesis 49(3): 75-82

Khan, N.; Shreaz, S.; Bhatia, R.; Ahmad, S.I.; Muralidhar, S.; Manzoor, N.; Khan, L.A. 2012: Anticandidal activity of curcumin and methyl cinnamaldehyde. Fitoterapia 83(3): 434-440

Celik, A.; Ergin, C.; Arslan, I.; Kartal, T. 2010: Anticandidal activity of endemic Salvia potentillifolia Boiss. and Heldr. ex Bentham and Origanum hypericifolium Schwartz and P.H. Davis in Turkey. Journal of Natural Science Biology and Medicine 1(1): 22-24

Sanjenbam, P.; Gopal, J.V.; Kannabiran, K. 2014: Anticandidal activity of silver nanoparticles synthesized using Streptomyces sp.VITPK1. Journal de Mycologie Medicale 24(3): 211-219

Işcan, G.ök.; Köse, Y.B.ül.; Demirci, B.ül.; Başer, K.H.üs.ü C. 2011: Anticandidal activity of the essential oil of Nepeta transcaucasica Grossh. Chemistry and Biodiversity 8(11): 2144-2148

Saad, A.; Fadli, M.; Bouaziz, M.; Benharref, A.; Mezrioui, N.-E.; Hassani, L. 2010: Anticandidal activity of the essential oils of Thymus maroccanus and Thymus broussonetii and their synergism with amphotericin B and fluconazol. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 17(13): 1057-1060

Geweely, N.S. 2009: Anticandidal cytotoxicity, antitumor activities, and purified cell wall modulation by novel Schiff base ligand and its metal (II) complexes against some pathogenic yeasts. Archives of Microbiology 191(9): 687-695

Amber, K.; Aijaz, A.; Immaculata, X.; Luqman, K.A.; Nikhat, M. 2010: Anticandidal effect of Ocimum sanctum essential oil and its synergy with fluconazole and ketoconazole. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 17(12): 921-925

Baltch, A.L.; Bopp, L.H.; Smith, R.P.; Ritz, W.J.; Michelsen, P.B. 2008: Anticandidal effects of voriconazole and caspofungin, singly and in combination, against Candida glabrata, extracellularly and intracellularly in granulocyte-macrophage colony stimulating factor (GM-CSF)-activated human monocytes. Journal of Antimicrobial ChemoTherapy 62(6): 1285-1290

Shetty, P.J.; Hegde, V.; Gomes, L. 2014: Anticandidal efficacy of denture cleansing tablet, Triphala, Aloe vera, and Cashew leaf on complete dentures of institutionalized elderly. Journal of Ayurveda and Integrative Medicine 5(1): 11-14

De León, P.G.óm.; Díaz García, F.J.; Arredondo, J.L.; Segura, J.; Cerezo, S.G.; Santos, J.I. 2007: Anticapsular polysaccharide IgG concentrations in Mexican children formerly immunized with Haemophilus influenzae b PRP-T vaccine. Human Vaccines 3(5): 187-191

Muller, P.C.E.H.; Anink, J.; Shi, J.; Levarht, E.W.N.; Reinards, T.H.C.M.; Otten, M.H.; van Tol, M.J.D.; Jol-van der Zijde, C.M.; Brinkman, D.M.C.; Allaart, C.F.; Hoppenreijs, E.P.; Koopman-Keemink, Y.; Kamphuis, S.S.M.; Dolman, K.; van den Berg, J.M.; van Rossum, M.A.J.; van Suijlekom-Smit, L.W.A.; Schilham, M.W.; Huizinga, T.W.J.; Toes, R.E.M.; Ten Cate, R.; Trouw, L.A. 2013: Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patients. Annals of the Rheumatic Diseases 72(12): 2053-2055

Malickova, K.; Lakatos, P.L.; Bortlik, M.; Komarek, V.; Janatkova, I.; Lukas, M. 2010: Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort. European Journal of Gastroenterology and Hepatology 22(2): 144-150

Gopalakrishnan, A.; Tony Kong, A.-N. 2008: Anticarcinogenesis by dietary phytochemicals: cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-kappa B and AP-1 in abnormal cancer cells. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 46(4): 1257-1270

Iigo, M.; Alexander, D.B.; Long, N.; Xu, J.; Fukamachi, K.; Futakuchi, M.; Takase, M.; Tsuda, H. 2009: Anticarcinogenesis pathways activated by bovine lactoferrin in the murine small intestine. Biochimie 91(1): 86-101

Manwaring, W.H. 1947: Anticarcinogenic Serum. California Medicine 66(1): 52

Bespalov, V.G.; Alexandrov, V.A.; Semenov, A.L.; Kovan'Ko, E.G.; Ivanov, S.D. 2014: Anticarcinogenic activity of alpha-difluoromethylornithine, ginseng, eleutherococcus, and leuzea on radiation-induced carcinogenesis in female rats. International Journal of Radiation Biology 90(12): 1191-1200

Firdous, A.Pararikkal.; Sindhu, E.Raghavan.; Ramnath, V.; Kuttan, R. 2013: Anticarcinogenic activity of meso-zeaxanthin in rodents and its possible mechanism of action. Nutrition and Cancer 65(6): 850-856

Ghosh, A.; Ghosh, D.; Sarkar, S.; Mandal, A.K.; Thakur Choudhury, S.; Das, N. 2012: Anticarcinogenic activity of nanoencapsulated quercetin in combating diethylnitrosamine-induced hepatocarcinoma in rats. European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 21(1): 32-41

Sahpazidou, D.; Geromichalos, G.D.; Stagos, D.; Apostolou, A.; Haroutounian, S.A.; Tsatsakis, A.M.; Tzanakakis, G.N.; Hayes, A.W.; Kouretas, D. 2014: Anticarcinogenic activity of polyphenolic extracts from grape stems against breast, colon, renal and thyroid cancer cells. Toxicology Letters 230(2): 218-224

Sen, A.; Atmaca, P.; Terzioglu, G.; Arslan, S. 2013: Anticarcinogenic effect and carcinogenic potential of the dietary phenolic acid: o-coumaric acid. Natural Product Communications 8(9): 1269-1274

Saraswati, S.; Alhaider, A.A.; Agrawal, S.S. 2013: Anticarcinogenic effect of brucine in diethylnitrosamine initiated and phenobarbital-promoted hepatocarcinogenesis in rats. Chemico-Biological Interactions 206(2): 214-221

Bespalov, V.G.; Aleksandrov, V.A. 2012: Anticarcinogenic effect of potassium salts of glucaric and glucuronic acid in induced models of cervical and esophageal tumors. Voprosy Onkologii 58(4): 537-540

Kumar, M.; Verma, V.; Nagpal, R.; Kumar, A.; Behare, P.V.; Singh, B.; Aggarwal, P.K. 2012: Anticarcinogenic effect of probiotic fermented milk and chlorophyllin on aflatoxin-B₁-induced liver carcinogenesis in rats. British Journal of Nutrition 107(7): 1006-1016

Jung, M.; Bu, S.Y.; Tak, K.-H.; Park, J.-E.; Kim, E. 2013: Anticarcinogenic effect of quercetin by inhibition of insulin-like growth factor (IGF)-1 signaling in mouse skin cancer. Nutrition Research and Practice 7(6): 439-445

Samarghandian, S.; Borji, A. 2014: Anticarcinogenic effect of saffron (Crocus sativus L.) and its ingredients. Pharmacognosy Research 6(2): 99-107

Agrawal, R.C.; Jain, R.; Raja, W.; Ovais, M. 2009: Anticarcinogenic effects of Solanum lycopersicum fruit extract on Swiss albino and C57 Bl mice. Asian Pacific Journal of Cancer Prevention: Apjcp 10(3): 379-382

Noratto, G.D.; Bertoldi, M.C.; Krenek, K.; Talcott, S.T.; Stringheta, P.C.; Mertens-Talcott, S.U. 2010: Anticarcinogenic effects of polyphenolics from mango (Mangifera indica) varieties. Journal of Agricultural and Food Chemistry 58(7): 4104-4112

Jang, H.-J.; Han, I.-H.; Kim, Y.-J.; Yamabe, N.; Lee, D.; Hwang, G.S.; Oh, M.; Choi, K.-C.; Kim, S.-N.; Ham, J.; Eom, D.-W.; Kang, K.S. 2014: Anticarcinogenic effects of products of heat-processed ginsenoside Re, a major constituent of ginseng berry, on human gastric cancer cells. Journal of Agricultural and Food Chemistry 62(13): 2830-2836

Enayat, S.; Ceyhan, Müşerref.Şeyma.; Başaran, A.Ahmet.; Gürsel, M.; Banerjee, S. 2013: Anticarcinogenic effects of the ethanolic extract of Salix aegyptiaca in colon cancer cells: involvement of Akt/PKB and MAPK pathways. Nutrition and Cancer 65(7): 1045-1058

Norazalina, S.; Norhaizan, M.E.; Hairuszah, I.; Norashareena, M.S. 2010: Anticarcinogenic efficacy of phytic acid extracted from rice bran on azoxymethane-induced colon carcinogenesis in rats. Experimental and Toxicologic Pathology: Official Journal of the Gesellschaft für Toxikologische Pathologie 62(3): 259-268

Bukowska, A. 2011: Anticarcinogenic role of melatonin--potential mechanisms. Medycyna Pracy 62(4): 425-434

Friedman, M. 2013: Anticarcinogenic, cardioprotective, and other health benefits of tomato compounds lycopene, α-tomatine, and tomatidine in pure form and in fresh and processed tomatoes. Journal of Agricultural and Food Chemistry 61(40): 9534-9550

Marie, I.; Jouen, F.; Hellot, M.-F.; Levesque, H. 2008: Anticardiolipin and anti-beta2 glycoprotein i antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis. British Journal of Dermatology 158(1): 141-144

Zimmermann-Górska, I.; Grodecka-Gazdecka, S.; Białkowska-Puszczewicz, G.; Puszczewicz, M.; Goździecka, M.; Kondarewicz, P.ł 2007: Anticardiolipin and anti-beta2 glycoprotein-1 antibodies patients with breast carcinoma: a pilot study. Polskie Archiwum Medycyny Wewnetrznej 117 Suppl: 24-27

Devreese, K.M.J.; Van Hoecke, F. 2011: Anticardiolipin and anti-β2glycoprotein-i antibody cut-off values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles, even for new automated assays. Thrombosis Research 128(6): 598-600

Habibagahi, Z.; Nazarinia, M.A.; Aflaki, E.; Rajaee, A. 2007: Anticardiolipin and antibeta2glycoproteini antibodies in patients with hepatitis B and C infections. Iranian Journal of Immunology: Iji 4(3): 161-166

Mohammed, S.N.; Mousawy, K.M.; AL Bayati, A.K.M.; Shawki, H.B.; Ghanim, N. 2008: Anticardiolipin and antiphospholipid antibodies in Iraqi patients with angina pectoris. Iranian Journal of Immunology: Iji 5(1): 68-69

DaCosta, V.; Chin, L.; Wynter, S.; Harriott, J.; Christie, L.; Frederick-Johnston, S.; Frederick, J.; McKenzie, C.; Everett, D.; Foster, R.; Walters, Y.; Pottinger, A. 2012: Anticardiolipin antibodies and lupus anticoagulants among women undergoing in vitro fertilization in Jamaica. West Indian Medical Journal 61(8): 789-794

Ma, J.; Zhang, C.-f.; Dong, F.-t.; Zhong, Y. 2007: Anticardiolipin antibodies and ocular diseases. Chinese Journal of Ophthalmology 43(5): 477-480

Clark, C.A.; Laskin, C.A.; Spitzer, K.A. 2012: Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence. Human Reproduction Update 18(5): 474-484

Homayoon, N.; Schwingenschuh, P.; Hofer, E.; Katschnig-Winter, P.; Schmidt, R. 2014: Anticardiolipin antibodies are associated with cognitive dysfunction in stroke-free individuals. European Journal of Neurology 21(3): 427

Anonymous 2009: Anticardiolipin antibodies are associated with epileptic seizure frequency. Nature clinical practice. Neurology 5(3): 124

De Godoy, J.é M.P.; de Godoy, M.F.; Braile, D.M. 2009: Anticardiolipin antibodies associated with alcoholic cardiomyopathy. Clinical Cardiology 32(6): E63-E64

Martinez, V.ér.; Diemert, M.-C.; Braibant, M.; Potard, V.ér.; Charuel, J.-L.; Barin, F.; Costagliola, D.; Caumes, E.; Clauvel, J.-P.; Autran, B.; Musset, L. 2009: Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 48(1): 123-132

Ozmen, S.; Danis, R.; Akin, D.; Batun, S. 2009: Anticardiolipin antibodies in hemodialysis patients with hepatitis C and their role in fistula failure. Clinical Nephrology 72(3): 193-198

Skare, T.L.; Ribas, C.A.P.M.; Malafaia, O.; Ribas Filho, J.M.; Nassif, P.A.N.; Nascimento, M.M.d.; Fonseca, V.íc.R.C.D. 2009: Anticardiolipin antibodies in leg ulcers. Revista do Colegio Brasileiro de Cirurgioes 36(2): 152-156

Loncar, D. 2010: Anticardiolipin antibodies in pathogenesis of infertility. Vojnosanitetski Pregled 67(3): 216-219

Zivkovic, M.; Zlatanovic, M.; Zlatanovic, G.; Djordjevic-Jocic, J.; Cekic, S. 2011: Anticardiolipin antibodies in patients with Behcet's disease. Bosnian Journal of Basic Medical Sciences 11(1): 58-61

Calvo-Romero, J.é M.ía.; Lima-Rodríguez, E.M.ía. 2009: Anticardiolipin antibodies in patients with type 2 diabetes mellitus. Clinical Medicine and Research 7(3): 93-95

Paraskevas, K.I.; Stathopoulos, V.; Mikhailidis, D.P.; Perrea, D. 2009: Smoking, abdominal aortic aneurysms, and ischemic heart disease: is there a link?. Angiology 59(6): 664-666

Shahin, M.; El-Diasty, A.M.; Mabed, M. 2009: Anticardiolipin antibodies in proliferative diabetic retinopathy: An additional risk factor. Saudi Journal of Ophthalmology: Official Journal of the Saudi Ophthalmological Society 23(2): 165-169

Ali, H.A.; Osman, R.R.; Idris, M.N.; Sokrab, T.-E.O. 2007: Anticardiolipin antibodies in stroke patients in Sudan. Appraisal of their significance in a region of high burden of endemic infections. Neurosciences 12(1): 21-24

Hokama, Y.; Campora, C.E.; Hara, C.; Kuribayashi, T.; Le Huynh, D.; Yabusaki, K. 2009: Anticardiolipin antibodies in the sera of patients with diagnosed chronic fatigue syndrome. Journal of Clinical Laboratory Analysis 23(4): 210-212

Lioger, B.; Debiais, S.; Lauvin, M.A.; Bonnaud, I.; Maillot, F.; Ferreira-Maldent, N. 2013: Anticardiolipin antibodies-associated stroke in primary CMV infection. European Journal of Neurology 20(8): E105-E106

Raby, A.; Moffat, K.; Crowther, M. 2013: Anticardiolipin antibody and anti-beta 2 glycoprotein i antibody assays. Methods in Molecular Biology 992: 387-405

Giacaman, R.A.; Contzen, M.P.; Yuri, J.A.; Muñoz-Sandoval, C. 2014: Anticaries effect of an antioxidant-rich apple concentrate on enamel in an experimental biofilm-demineralization model. Journal of Applied Microbiology 117(3): 846-853

Xie, Q.; Li, J.; Zhou, X. 2008: Anticaries effect of compounds extracted from Galla chinensis in a multispecies biofilm model. Oral Microbiology and Immunology 23(6): 459-465

Delbem, A.C.B.; Bergamaschi, M.íc.; Rodrigues, E.; Sassaki, K.T.; Vieira, A.E.d.M.; Missel, E.M.C. 2012: Anticaries effect of dentifrices with calcium citrate and sodium trimetaphosphate. Journal of Applied Oral Science: Revista Fob 20(1): 94-98

Heifetz, S.B.; Yaari, A.; Proskin, H. 2007: Anticaries effectiveness of a fluoride and nonfluoride sealant. Journal of the California Dental Association 35(8): 573-577

Moi, G.P.; Tenuta, L.ív.M.A.ó; Cury, J.A. 2008: Anticaries potential of a fluoride mouthrinse evaluated in vitro by validated protocols. Brazilian Dental Journal 19(2): 91-96

Faller, R.V.; Eversole, S.L.; Yan, J. 2010: Anticaries potential of a stabilized stannous-containing sodium fluoride dentifrice. American Journal of Dentistry 23(Special Issue B): 32b-38b

Casals, E.; Boukpessi, T.; McQueen, C.M.; Eversole, S.L.; Faller, R.V. 2007: Anticaries potential of commercial dentifrices as determined by fluoridation and remineralization efficiency. Journal of Contemporary Dental Practice 8(7): 1-10

Faller, R.V.; Casey, K.; Amburgey, J. 2011: Anticaries potential of commercial fluoride rinses as determined by fluoridation and remineralization efficiency. Journal of Clinical Dentistry 22(2): 29-35

Téllez, N.í; Téllez, M.; Perdomo, M.; Alvarado, A.; Gamboa, F. 2010: Anticariogenic activity of the active fraction from Isertia laevis against S. mutans and S. sobrinus: comparison of two extraction methods. Acta Odontologica Latinoamericana: Aol 23(3): 188-195

Thneibat, A.; Fontana, M.; Cochran, M.A.; Gonzalez-Cabezas, C.; Moore, B.K.; Matis, B.A.; Lund, M.R. 2008: Anticariogenic and antibacterial properties of a copper varnish using an in vitro microbial caries model. Operative Dentistry 33(2): 142-148

Miura, K.K.; Ito, I.Y.; Enoki, C.; Elias, A.M.; Matsumoto, M.ír.A.N. 2007: Anticariogenic effect of fluoride-releasing elastomers in orthodontic patients. Brazilian Oral Research 21(3): 228-233

Mickenautsch, S.; Yengopal, V. 2012: Anticariogenic effect of xylitol versus fluoride - a quantitative systematic review of clinical trials. International Dental Journal 62(1): 6-20

Delbem, A.C.B.; Tiano, G.C.; Alves, K.M.R.P.; Cunha, R.F. 2006: Anticariogenic potencial of acidulate solutions with low fluoride concentration. Journal of Applied Oral Science: Revista Fob 14(4): 233-237

Severiano, M.E.; Simão, M.íl.R.; Porto, T.S.; Martins, C.H.G.; Veneziani, R.C.S.; Furtado, N.A.J.C.; Arakawa, N.S.; Said, S.; de Oliveira, D.éi.C.R.; Cunha, W.R.; Gregório, L.E.; Ambrósio, S.ér.R. 2010: Anticariogenic properties of ent-pimarane diterpenes obtained by microbial transformation. Molecules 15(12): 8553-8566

Llena, C.; Forner, L.; Baca, P. 2009: Anticariogenicity of casein phosphopeptide-amorphous calcium phosphate: a review of the literature. Journal of Contemporary Dental Practice 10(3): 1-9

Schricker, T.; Meterissian, S.; Lattermann, R.; Adegoke, O.A.J.; Marliss, E.B.; Mazza, L.; Eberhart, L.; Carli, F.; Nitschman, E.; Wykes, L. 2008: Anticatabolic effects of avoiding preoperative fasting by intravenous hypocaloric nutrition: a randomized clinical trial. Annals of Surgery 248(6): 1051-1059

Ohno, Y.; Shimizu, S.; Imaki, J.; Ishihara, S.; Sofue, N.; Sasa, M.; Kawai, Y. 2008: Anticataleptic 8-OH-DPAT preferentially counteracts with haloperidol-induced Fos expression in the dorsolateral striatum and the core region of the nucleus accumbens. Neuropharmacology 55(5): 717-723

Champatisingh, D.; Sahu, P.K.; Pal, A.; Nanda, G.S. 2011: Anticataleptic and antiepileptic activity of ethanolic extract of leaves of Mucuna pruriens: A study on role of dopaminergic system in epilepsy in albino rats. Indian Journal of Pharmacology 43(2): 197-199

Wang, H.; Chen, X.-Y.; Chen, W.-F.; Xue, Y.; Wei, L.; Chen, L. 2013: Anticataleptic effects of 5-HT(1B) receptors in the globus pallidus. Neuroscience Research 77(3): 162-169